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Chapter I 
INTRODUCTION 
1.1 History of myocardial protection In cardiac surgery 
The Byzantine saint John Chrysostomos (347-407) typified the heart as the 
body's noblest organ. Surgeons considered operating on the heart "off limits"; a 
cardiac injury inevitably led to death. In 1766, Morgagni (1) first described 
"cardiac tamponade", caused by blood leaking from the heart into the pericardial 
space, eventually leading to compression of the heart and cardiac arrest. The 
only treatment consists of pericardiocentesis. Cardiac surgery began in 1897, 
when Rehn (1849-1930), closed a cardiac perforation, and saved the patient's 
life (2). In 1923, Cutler (3) performed the first "closed commissurotomy" for 
mitral stenosis. Surgery for mitral stenosis, was done on a beating heart, since 
the procedure proper was only of brief duration. Surgery for additional congeni-
tal anomalies, (such as atrial or ventricular septal defects), however, needed 
more time. To increase the allowable operating time, the idea was postulated to 
decrease body temperature, because the metabolic demand of brain and other 
organs is considerably decreased at lower temperature. Bigelow in Toronto was 
the first surgeon to pioneer with this technique (4). Using hypothermia and 
inflow occlusion, many successful operations on human septum defects were 
reported by Swan (5). For more complicated heart defects, such as tetralogy of 
Fallot, longer time was needed to correct the defect and the time allowed by 
hypothermia was not sufficient. In 1953, Gibbon (1903-1973) performed a 
break through: he temporarily replaced cardiac and pulmonary function by a 
heart-lung machine (6). His finding introduced modern heart surgery. Though, 
cardiac surgeons continued to be confronted with the adverse effects of 
myocardial ischemia. 
In 1955, Melrose first performed elective cardiac arrest induced by a potassium-
rich, citrate-containing solution (7). Its use in that particular form, however, 
appeared to cause myocardial necrosis. Therefore, the technique was abandon-
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ed soon thereafter (8). At that time, several methods were used for maintenan-
ce of myocardial perfusion. When it was not necessary to open the aorta, and if 
the aortic valve remained sufficiently competent to prevent excessive regurgi-
tant flow into the left ventricle, coronary perfusion was maintained by retrogra-
de flow from the pump oxygenator. When the aorta had to be opened and 
cross-clamped, myocardial perfusion was maintained by direct cannulation of 
the coronary ostia. The idea of myocardial protection with sustained coronary 
perfusion became the standard method of myocardial protection during the 
1960s. Several techniques, including coronary perfusion, ischemic arrest, 
fibrillatory arrest, and topical hypothermia, were clinically accepted (9-12), 
albeit that the incidence of postoperative low-cardiac-output syndrome and 
perioperative myocardial infarction was high (13-15). Besides, there was the 
technical problem of the impaired access to a with blood perfused fibrillating 
heart, and coronary stenosis after selective cannulation. 
The early 1970s were characterized by a renewed interest in the use of potassi-
um-rich cardioplegia (16,17). The successful use of acellular hypothermic or-
gan perfusion for kidney preservation, resulted in the clinical use of hypother-
mic, crystalloid, potassium-based cardioplegia. The experimental results had 
shown that careful control of the osmolarity and potassium concentration in the 
'cardioplegie' solution, and elimination of excessive citrate were important 
factors (18-21). Clinical results in terms of cardiac performance and operative 
survival were gratifying (22,23). The method was soon generally applied in 
surgery for congenital and valvular disease. Because of difficulties associated 
with locating and incising the bloodless coronary arteries, it was initially not 
used in coronary artery surgery. With the use of magnification during the 
operation this problem was solved and cold cardioplegia became routine for all 
intracardiac operations. With the use of the heart-lung machine no other 
innovation has had such a positive effect on the safety of cardiac surgery. The 
cardioplegie solution decreases energy requirements, minimizes energy losses 
during ischemic arrest, and provides sources of energy for the ischemic myocar-
dium. 
Many investigators and clinicians have studied the limitations and functional 
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consequences of myocardial protection, although the ideal cardioplegie solution 
has not yet been developed. 
Research and development of myocardial protection focuse on several aspects. 
Initially the quantity of the cardioplegie solution, the temperature, flow rate, 
infusion pressure, frequency of infusion, were emphasized (24-26). With better 
understanding of the pathophysiology of myocardial ischemia and reperfusion 
(27), the use of nutrients, membrane stabilizers, oxygen free-radical scavengers 
during global myocardial ischemia or the early reperfusion period came on the 
forefront (28-32). Recent developments in the field of myocardial protection 
consist of the use of oxygenated cardioplegie solution, oxygenated crystalloid 
cardioplegia or blood cardioplegia (33-36), and the use of normothermic blood 
cardioplegia (37). 
Another interesting topic is the method of delivery of cardioplegia (38). Antero-
grade delivery of cardioplegie solutions is the classic technique. It is known, 
however, that the presence of coronary artery stenosis prevents a homogene-
ous distribution in the myocardium resulting in inadequate myocardial protection 
(39). With the extention of the indications for myocardial revascularization to 
more diseased patients (40), the extensive use of the internal mammary artery 
as graft, prohibiting anterograde delivery of cardioplegie solution (38), and the 
risk of embolization of debris from atherosclerotic vein grafts in reoperations 
(41), the use of retrograde delivered cardioplegia came on the forefront. 
1.2 History of clinical trials 
In surgery several investigators have made significant basic scientific contribu-
tions with regard to practical clinical application, Ambroise Paré's contributions 
(1510-1590) probably being the most important. This sixteenth century military 
surgeon reintroduced not only the use of ligation to control hemorrhage and 
placed it on a firm basis, but famous is his report of a comparison of treatments 
of battlefield wounds. In 1545, in a dissertation on shot wounds. Paré presen-
ted his findings on wound treatment, which in fact were the results of a first 
clinical trial. 
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John Hunter (1728-1793) introduced the idea of an " Experimental method " by 
using animals and Joseph Lister (1872-1912) initiated aseptic surgery, based on 
the bacteriologie studies of Louis Pasteur (1822-1895). 
In the nineteenth century and the beginning of this century, the progress of 
some innovations (such as general anesthesia), were so great that the need for 
evaluation was obviated. Other innovations were the subject of many and lively 
discussions in medical journals; crucial was the lack of a proper way to conduct 
clinical trials and statistical methods to analyze the data. 
In 1923, Fisher and MacKenzie proposed the idea of randomization. In 1935, in 
his textbook 'The Design of Experiments' Fisher described the requirement for 
setup and analysis of modern clinical trials. In 1948, the British Medical Re-
search Council published a randomized clinical trial demonstrating the effective-
ness of streptomycin in the treatment of tuberculosis. 
During the last thirty years, the concept of randomized prospective clinical trials, 
as an element of surgical practices, became widely accepted. The work of John 
Goligher, clarifying the role of vagotomy and gastrectomy in the treatment for 
peptic ulcer disease, was essential in this evolution. 
I.3 Aim of the study 
The study concerning the efficacy and efficiency of retrograde delivery of the 
cardioplegie solution compared to the 'classic' anterograde delivery was 
triggered by the following two experiences in the operation room. 
The death of a patient, due to a perioperative myocardial infarction caused by 
spreading of debris from an atherosclerotic vein graft, was my personal incenti-
ve to explore the possibility of retrograde delivery of cardioplegie solution. The 
reoperation was done in an 68 years old woman, with three vessel coronary 
artery disease, an occlusion of the left main coronary artery, and a 90% 
stenosis in the proximal right coronary artery. At the first operation, a snake 
graft was constructed from the aorta, over the right and circumflex coronary 
arteries, and ending on the left anterior descending coronary artery. At reopera-
tion the snake graft was found to be extremely diseased. After anterograde 
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delivery of cardioplegia, asystole was reached. Incision of the coronary arteries, 
however, showed a spreading of debris from the snake graft distally into the 
coronary arterial circulation. The debris was rinsed out of the coronary arteries 
as good as possible and subsequently several grafts were constructed. It was 
impossible, however, to wean the patient off extracorporeal circulation. Autopsy 
showed a massive myocardial infarction with fresh atheromatous emboli in 
several coronary artery branches. 
On 16 June 1988 the first cardiac operation with use of retrograden delivered 
cardioplegia was performed at the University Hospital of Nijmegen St.Radboud. 
A 56 years old man, with impaired left ventricular function and mitral valve 
insufficiency (grade II), living on a diseased venous graft to a circumflex 
coronary artery, underwent a coronary reoperation. Retrograde delivery of 
cardioplegia was preferred because of the risk of spreading debris from this vein 
graft with use of anterogradely delivered cardioplegia. After separate cannula-
tion of the vena cava inferior and vena cava superior, the right atrium was 
opened and St.Thomas'Hospital cardioplegia was directly infused into the 
coronary sinus, which was cannulated using a Foley catheter. The heart rapidly 
became asystolic and the operation proceeded successfully. 
Since then an increasing number of cardiac operations were performed with the 
use of retrogradely delivered cardioplegia, especially coronary reoperations and 
aortic valve replacements, but also primary coronary revascularizations with 
extensive use of the internal mammary artery as graft. 
In 1990-1991 a prospective randomized clinical trial concerning the use of 
retrograde cardioplegia in aorta-coronary bypass surgery was performed. The 
goal of this trial was to compare myocardial protection after anterograde and 
retrograde delivery of cardioplegie solution. 
In the first study, the preservation of left ventricular function was evaluated. 
The aim of this study was to compare the hemodynamic preservation of the left 
ventricular function after anterograde versus retrograde delivery of cardioplegia, 
and secundarely to select indications for retrograde delivery of cardioplegia. 
In a second study, we evaluated the preservation of right ventricular function. In 
an experimental set up (42,43) it had been shown that retrograde cardioplegia 
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provided only minor protection of the right ventricle. The aim of that study was 
to evaluate the hemodynamic preservation of the right ventricular function after 
anterograde versus retrograde delivery of cardioplegia. Additionally, the impor­
tance of the coronary collateral circulation for the distribution of cardioplegia 
was evaluated. 
In summary the objectives of this study are: 
1. A comparison of the preservation of left ventricular function in myocardial 
revascularization using anterograde or retrograde delivery of cardioplegia. 
2. A comparison of the preservation of right ventricular function in myocardial 
revascularization using anterograde or retrograde delivery of cardioplegia. 
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Chapter II 
INTRODUCTION TO RETROGRADE CARDIOPLEGIA 
11.1 Principles of cold crystalloid cardioplegie myocardial protection 
Cardioplegie myocardial protection was introduced by Melrose in 1955 (1), 
using cold hypertonic potassium citrate blood. Subsequently it was shown, 
however, that the method as used by Melrose was associated with myocardial 
injury and late cardiomyopathy and therefore it was soon discontinued (2). In 
the late 1960s, however, studies by Bretschneider (3), Kirsch (4), Hearse (5), 
and Gay (6) provided a solid base for the use of cardioplegia, which has resulted 
in the intraoperative use of cardioplegia by most " second generation " cardiac 
surgeons because it allows better exposure of cardiac structures and time for 
technical precision, careful endarterectomy, and total revascularization (7). The 
hypothesis underlying the use of cold cardioplegie myocardial preservation is 
that it reduces myocardial oxygen demand during the ischemic period of cross-
clamping to such a low level that the myocardial energy stores are sufficient to 
maintain cell structure and basal cellular functions (8-10). 
Three points are essential in the use of cold cardioplegia: temperature, composi-
tion of the cardioplegie solution, and strategies for distribution and maintenance 
of cardioplegia. 
11.1.1 Temperature 
The temperature should be lowered to reduce the metabolic rate, the rate and 
force of the process leading to myocardial cell death, and to promote electrome-
chanical quiescence. Hearse (5) has shown that the protective effect of myocar-
dial hypothermia varies inversely with myocardial temperature. Lowering cardiac 
temperature to less than 8 to 10°C, however, does not reduce energy require-
ments much further below those achieved at 15 to 20°C (0.015 versus 0.013 
ml O2/100g per min, respectively). Temperatures of 4°C or less are associated 
with temporary modifications of the membrane lipids and membrane ATPase 
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damage (11-13) and a delayed regeneration of vital metabolites (14). Different 
studies indicate that the temperature of the cardioplegie solution should be at 4 
to 8°C, that the myocardial temperature should be lowered to 12- 15°C and be 
kept at 15-20°C throughout the ischemic period (14-18). 
11.1.2 Cardioplegie composition 
The cardioplegie solution should induce cardioplegia with some degree of 
membrane stabilization, should minimize intracellular ionic changes, and should 
avoid edema. 
First, the solution must be cardioplegie, immediate arrest should be produced to 
lower energy demands and avoid energy depletion by electromechanical work. 
This is especially true with nonoxygenated cardioplegie solutions. Arrest can be 
achieved either by use of potassium, magnesium, procaine, or hypocalcémie 
solutions. By reducing the transsarcolemmal gradient for sodium and potassium 
ions the excitability of the cells is lowered. Two fundamental types of crystal-
loid cardioplegie solutions can be distinguished. First, the "intracellular" ionic 
equivalent composition, producing cardiac arrest by reduction of the sodium 
level to nearly intracellular concentrations, and simultaneous minimalization of 
the calcium level (Bretschneider) (19). Second, the "extracellular" solution, 
which induces cardiac arrest by increasing the extracellular potassium and 
magnesium content (St.Thomas' Hospital No. 2) (Table I) (20). 
Energy requirements are determinated principally by cardiac electromechanical 
work and secondly by temperature. The lowest oxygen demand occurs when 
the heart is arrested and decompressed, because electromechanical work is 
stopped completely (21). 
Second, there must be membrane stabilization, largely to prevent calcium fluxes 
during reperfusion. Within a few seconds ischemia results in a drop in high-
energy phosphate production and in an accumulation of catabolites. The drop in 
high-energy phosphates results in a decrease of the membrane-pumpfunction, 
leading to an intracellular accumulation of Na+ and cell swelling, secondly 
resulting in accumulation of cystolic Ca2*, activation of phospholipases and 
proteases, and destruction of phospholipid bilayers and proteins. This process 
22 
leads to sarcolemma rupture, mainly in the presence of reperfusion, and initiates 
a Ca2+-influx leading to cell death (22). On this basis a solution without calcium 
ions may seem desirable. Also calcium-free cardioplegie solutions, however, 
damage the sarcolemma membrane (23-26). Calcium overload blockers (lidofla-
zine) and calcium entry blockers (nifidipine, verapamil) may be important 
cardioplegie additives, not only acting via the ATP-sparing effect but also via a 
membrane-stabilizing effect (22,27,28). Not only does Ca2* initiate sarcolemmal 
rupture, but accumulation of acylcarnitine and acylCoA and free radicals act as 
detergents on the membranes. Therefore, oxygen radical scavengers may be 
useful as membrane stabilizing additives (29,30). The role of steroids (31) and 
procaine (8) in membrane stabilization remains uncertain. 
Table I. Composition of St.Thomas'Hospital cardioplegie solution No. 2 
used in our trials. 
Cardioplegie solution mmol/L 
Sodiurn chloride 
Potassium chloride 
Magnesium chloride 
Calcium chloride 
Sodium bicarbonate 
pH 
Osmolality 
110 
16 
16 
1 .2 
10 
7 . 8 
324 Osm/kg 
Third, the solution must have an appropriate pH (7.4 to 7.8) to allow continued 
enzymatic function during hypothermia and some buffering capacity. The 
metabolic activity during ischemia results in an increase of intracellular and 
extracellular acidosis, which has a negative result on postischemic recovery 
(32,33). Consequently, a buffer is a necessary component in all cardioplegie 
solutions. Bicarbonate, phosphate, imidazole, or other buffer systems may be 
appropriate (34,35). 
Fourth, myocardial ischemia results in myocardial edema (36). Consequently 
there must be attention to the osmolarity and the colloid osmotic pressure of 
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the cardioplegie solution. Using potassium cardioplegia, edema is avoided by 
making the solution hyperosmotic (37). Although edema seems not to be related 
to the infusion pressure, infusion pressures of more than 150 mm Hg result in a 
significant fall in regional myocardial function (37,38). 
Because it is known that during aortic cross-clamp the anaerobic and aerobic 
energy production depends on the intrinsic substrate stores, the enrichment of 
the cardioplegie solution with substrates, ATP-producing metabolites as precur-
sors of Krebs cycle intermediates, exogenous creatine phosphate, and the use 
of oxygenated solutions, will result in more available energy (39-42). 
11.1.3 Strategies for distribution and maintenance of cardioplegia 
Inhomogeneous distribution of anterogradely delivered cardioplegia is of course 
a specific problem in patients with coronary artery disease, but also in patients 
with aortic valve insufficiency. Hilton (43) and Grondin (44) showed that 
maldistribution of cardioplegie solution beyond coronary artery stenoses causes 
postischemic abnormalities in regional wall motion and functional recovery. 
Nonhomogeneous ventricular cooling and persistent electromechanical activity 
in areas distal to obstructed coronary vessels is a frequently reported phenome-
non (45). The problem of maldistribution of cardioplegia beyond stenoses can 
be circumvented in several ways. First, by performing the proximal anastomosis 
first; second, construction of a distal anastomosis and delivery of cardioplegia 
into the graft (46). In case of aortic valve insufficiency, direct coronary ostial 
perfusion (47) can be used. The problem of maldistribution due to coronary 
artery stenoses or in case of aortic valve insufficiency can be circumvented by 
retrograde delivery of cardioplegia (48-50). In this context, the role of external 
cardiac cooling is also important (51) . 
Besides the problem of inhomogeneous distribution of cardioplegia, periodic 
replenishment to counteract noncoronary collateral wash-out is necessary. 
During aortic cross-clamping noncoronary collateral blood flow persists. This 
blood flow results not only in a wash-out of the cardioplegie solution (52), but 
also rewarms the heart, and furnishes energy, resulting in a return of electro-
mechanical activity. Periodic replenishment at 20-minute intervals or after each 
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anastomosis counteracts noncoronary collateral wash-out of cardioplegie 
solution (53). Multidosis cardioplegia should be given even if electromechanical 
activity does not return since low level electrical activity may occur before 
electromechanical activity becomes visible (54), which may lead to delayed 
myocardial recovery (40). Periodic reinfusion of cardioplegie solution maintains 
arrest, restores hypothermia, washes out and buffers acidic metabolites that 
inhibits anaerobic metabolism, replenishes substrate, and counteracts edema. 
11.2 The human coronary venous anatomy 
With the increasing interest in retrograde delivery of cardioplegia in cardiac 
surgery (55), knowledge of the coronary venous vascular system is important. 
Normal myocardial venous drainage has three pathways: 1) the anterior right 
ventricular veins emptying into the right atrium, 2) the coronary sinus, also 
emptying into the right atrium and 3) the Thebesian veins (ThV) emptying into 
all chambers of the heart. These three pathways are interconnected by veno-
venous anastomoses. 
About 60% of the coronary venous blood returns to the right atrium through the 
coronary sinus (56). The other 4 0 % is drained through the anterior right 
ventricular veins, the ThV, coronary veno-venous anastomoses, and perhaps 
arterio-venous connections. This venous vascular circulation resembles a sponge 
with multiple interconnections. 
11.2.1. Cardiac veins 
The nomenclature of the cardiac veins used in this thesis is corresponding with 
the agreements of the first International Symposium on Myocardial Protection 
via the Coronary Sinus, in Vienna, 1984 (fig. 1). 
1) Coronary Sinus (CS) 
The CS drains most of the left ventricular venous blood. It is a short, wide vein, 
lying in the atrio-ventricular sulcus, on the diaphragmatic surface of the heart. 
The CS has a muscular coat, which is not fully circular, and which covers only 
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the posterior wall. The opening of the CS into the right atrium is situated on the 
posterior wall, below the inferior cavai vein. 
RCA 
ARVV 
AW 
ANTERIOR VIEW 
RCA-RIGHT CORONARY ARTERY 
LCA- LEFT CORONARY ARTERY 
CS-CORONARY SINUS 
LCV-LEFT CORONARY VEIN 
AIV-ANTERIOR INTERVENTRICULAR VEIN 
ARVV-ANTERIOR RIGHT VENTRICULAR VEIN 
PLVV 
LMV 
ARW 
PIV 
POSTERIOR VIEW 
LMV-LEFT MARGINAL VEIN 
PLVV- POSTERIOR LEFT VENTRICULAR VEIN 
PIV- POSTERIOR INTERVENTRICULAR VEIN 
RMV- RIGHT MARGINAL VEIN 
SCV- SMALL CARDIAC VEIN 
Fig. 1 Scheme of the cardiac veins1 
2) Anterior interventricular vein (AIV) and left coronary vein (LCV) 
The AIV is situated in the anterior interventricular sulcus and ascends next to 
the left anterior descending coronary artery, then turns down to reach the 
coronary sulcus as LCV. The LCV usually drains into the CS, only exceptionally 
it empties directly into the right atrium (57,58). 
Different superficial branches are emptying into the AIV and the LCV: a) vessels 
of the anterior wall of right and left ventricle, b) the left ventricular oblique vein 
"With permission from Steinkopff Verlag Gmbh&Co.KG, Darmstadt. 
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(LVOV),which in most individuals has a diameter equal to that of the AIV and 
enters into it in the mid segment of the anterior interventricular sulcus (57), 
c) left marginal vein (LMV), d) posterior veins of the left ventricle, e) venous 
interventricular vessels and, f) vessels of the left atrial wall. 
3) The left marginal vein (LMV) 
The LMV is a branch of the LCV, occasionally, however, the LMV opens into 
the CS (59). 
4) Posterior left ventricular veins (PLVV) 
The PLVV do not have a uniform anatomic pattern, as evidenced by a varying 
incidence and number in several reports (57-61). The PLVV always drains into 
the CS or the LCV. 
5) Posterior interventricular vein (PIV) 
The PIV is localized in the posterior interventricular sulcus near the apex (57). In 
90% of the individuals the PIV opens into the distal segment of the CS and in 
10% directly into the right atrium. There seems to be a complementary rela-
tionship between the PLVV and the PIV because the PLVV are small, in case of 
a well developed PIV, and vice versa. 
6) Left atrial oblique vein (LAOV) 
The LAOV is a short vein which originates on the lateral surface of the left 
atrium below the inferior left pulmonary vein. From here it takes a downward 
course to the right and empties into the CS. However, the LAOV is not always 
present; frequently, at this site, a band of connective tissue is present, which is 
called the ligament of the left superior vena cava. 
7) Small cardiac vein (SCV) 
The SCV is usually described as an inconstantly present vein, originating at the 
right cardiac margin or on the diaphragmatic surface of the heart. Mostly the 
SCV empties into the CS, rarely directly into the right atrium (57). The SCV has 
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several branches, originating from the anterior and posterior wall of the right 
ventricle, and the posterior wall of the right atrium. 
8) Anterior right ventricular veins (ARVV) 
They exist in 80% to 90% of individuals, in varying frequency. They empty into 
the right atrium, either with a common orifice or with separate ostia; or they 
drain into the SCV (57-60). The ARVV are also known as the Viessens veins 
and one of them, the Galen vein is also called the right marginal vein (RMV). 
11.2.2. Valves of the cardiac veins 
In 30-45% of individuals valves are present in the ostia of larger cardiac veins 
(62). They are functionally inefficient, since during retrograde injection of the 
cardiac veins from the CS, little or no flow resistance is found. In 15 to 38% of 
the cases there is lack of a valve at the outlet of the CS, and when there is a 
valve it usually is a semilunar valve (57,62). From the point of view of catheteri-
zing the sinus from the right atrium, the valve is seldom a problem, as eviden-
ced by the fact that Gorlin (63) met difficulties of probing the CS in only 10% 
of individuals. Also in clinical reports on the use of retrogradely delivered 
cardioplegia, problems with catheterizing the coronary sinus are rarely reported. 
(63-70). 
11.2.3. Venous vascularization of the heart 
1 ) Vascularization of the left atrium 
The venous drainage of the left atrium is effectuated by the ThV and by 
branches of LCV, CS, and LVOV. 
2) Vascularization of the right atrium 
The blood flows directly into the atrium, through the ThV; from the posterior 
right atrial wall the blood flows directly into the CS. The blood from the myocar-
dium of the sinus node area is drained through the right atrial vein which is a 
branch of the SCV (60). 
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3) Vascularization of the interatrial septum 
Principally the interatrial septum is drained by the ThV. Only small venous 
vessels from interatrial septum open into the LCV (71,72). 
4) Vascularization of the left ventricle 
The venous vascularization of the left ventricle consists of a multilayer plexus 
formed by collaterals of the LCM, LMV, PLVV, and ThV (57,72,73). 
5) Vascularization of the right ventricle 
From the right ventricular wall the venous blood flows mainly via the ARV, but 
also via LCV.PIV, and SCV (60,74). Collaterals of these vessels form a single 
layer plexus, which is interconnected with the ThV, and which is poorer develo­
ped than in the left ventricle. 
6) Vascularization of the ventricular septum 
As in the left ventricular wall, in the ventricular septum there is a well develo­
ped plexus of collaterals. This plexus connects with both ventricular cavities, 
but mainly with the right ventricle via ThV and via superficial cardiac veins 
draining into the LCV, PIV, and PLVV. 
The apical part of the ventricular septum is vascularized by anterior and posteri­
or veins of the ventricular septum and also by the medial part of the ThV. The 
superior, anterior, and posterior part of the ventricular septum is drained by 
branches of the AIV. 
II.2.4. Veno-venous anastomoses 
The veno-venous anastomoses are divided in three types. First the large veno-
venous anastomoses, more than 1 mm. These are commonly present between 
the epicardial veins at the apex of the heart. The most important venovenous 
anastomoses form a ring, connecting the posterior interventricular vein with the 
anterior ventricular vein (60), which is comparable with the ring formed by the 
left anterior and posterior descending coronary artery. Second, the medium 
veno-venous anastomoses, with a diameter that ranges from 500 to 1000 μπ\. 
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These are found ¡η the epicardium and are responsible for the venous plexuses 
in the ventricular and septal wall. Third, the small veno-venous anastomoses, 
which occur in the ventricular wall and have a diameter that ranges from 50 to 
500 μτη. 
11.2.5. Arterial-venous anastomoses 
The knowledge about arterial-venous anastomoses in the human myocardium is 
incomplete and controversial. Arterial-venous anastomoses are found in all 
hearts with atherosclerotic lesions in the coronary arteries (75). They are more 
frequent in the left ventricular wall and localized at various depths, but are 
usually subendocardial^ located. The fact that arterial-venous anastomoses 
appear to be more numerous in coronary artery disease (74,76) suggests that 
they become apparent in the presence of abnormal pressure gradients, as 
occurs distal of a coronary artery stenosis. 
11.2.6. Thebesian veins 
Thebesian veins were defined by Thebesius, (77) in 1708, as vascular structu­
res between the myocardial veins and the heart cavities. Contrary to other 
veins, the ThV drain blood from the myocardial veins into the atrial and ventri­
cular cavities. They are considered as a continuation of venous plexuses in the 
ventricular walls and of the small veins in the atria. However, there are also 
anastomoses between the ThV and the coronary arteries (78). The ThV are 
responsible for ± 9 % of the venous vascularization of the left ventricular 
myocardium, which percentage rises in atherosclerotic hearts. 
11.2.7. Differences in the coronary venous system in normal and atherosclerotic 
hearts 
In human normal hearts three zones of venous vascularization can be distinguis­
hed: First the external or epicardial zone, with a depth of approximately 0.1 mm 
and which is present in the free walls of the ventricle. Second, a medial zone 
which, together with the external zone, forms about two-thirds of the ventricu­
lar or septal wall, and third, an internal or subendocardial zone, which contains 
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the rest of the walls. The largest veins are situated in the subendocardial zone 
(79). 
In atherosclerotic hearts there is a richer venous vascularization in the subendo-
cardial zone as compared with the same zone in normal hearts. There is a 
greater number of small veins and ThV in the ventricular and septal walls of 
atherosclerotic hearts. Also in the left ventricular wall of such hearts the density 
of veins is greater than that of arteries (79,80). 
11.3 Retrograde delivery of cardioplegie solutions: methods 
The concept of retrograde delivery of cardioplegia is not new. In 1955, Lillehei 
(81) first used retrograde coronary sinus perfusion for aortic valve operations, 
and in 1957, Gott (82) used retrograde blood perfusion of the coronary sinus. 
With the development of selective anterograde cardioplegia and hypothermia, 
the anterograde technique has become the standard in myocardial protection in 
cardiac surgery. In 1967, Hammond (83) reappraised the retrograde technique 
as a method of myocardial protection to permit direct surgery on the left 
coronary artery. However, he failed to generate clinical interest in this method. 
Currently, there is an increasing interest in retrograde delivery of cardioplegia in 
aorto-coronary bypass surgery because of ¡nhomogeneous distribution of 
cardioplegie solution in case of anterograde delivery due to coronary artery 
stenosis and the use of the internal mammary artery as graft of choice, which 
prohibits anterograde delivery of cardioplegia. Also in valve surgery there is an 
increasing interest in the retrograde technique (55,84). A recent report (84), 
indicated that in the United States, in 1990, 72% of the cardiac surgeons have 
used retrograde cardioplegia, compared to 1985 when 9 1 % had never used 
this method. 
In the delivery of retrograde cardioplegia two main techniques can be distin-
guished: the delivery via the right atrium, or, directly via the coronary sinus. 
11.3.1 Methods 
The delivery of cardioplegia via the right atrium was described by Fabiani and 
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Carpentier (85), and also employed by Diehl (66) and Fiore (86). With this 
technique (fig. 2), bicaval cannulation, cavai snares, and a third tape passed 
through the transverse pericardial sinus for occlusion of the pulmonary artery, 
are needed. 
Fig. 2 Cardioplegia is directly administered through the atrial wall. With bicaval and 
pulmonary artery occlusion, the cardioplegia is forced through the right atrium and 
ventricle into the coronary sinus orifice and thebesian channels. The aorta is vented.1 
'Reprinted with permission from the Society of Thoracic Surgeons (The Annals of 
Thoracic Surgery,1992:52:252-5.). 
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The right atrium is punctured directly with a needle, and cardioplegia is pumped 
into the right atrium at a rate of 1 L over 3 to 4 minutes. Retrieval of the 
cardioplegie solution is obtained in the aortic root. This procedure avoids right 
atriotomy for cannulation which is also circumvented with the later described 
technique of blind cannulation, and insures against injury of the coronary sinus 
due to the catheter and inflation of the balloon. In addition, this technique 
assures retrograde perfusion not only of the coronary sinus, but also of the 
thebesian veins and other venous pathways. 
Additionally, temporarily release of one of the cavai tapes allows the right heart 
cavities to fill with blood; infusion of crystalloid cardioplegia into the right atrium 
then produces cold blood cardioplegia. 
The latter technique cannot be employed, however, in patients with an atrial or 
ventricular septal defect or with a patent foramen ovale. Criticism about 
potential right heart damage from overdistention is contradicted by several 
reports describing an excellent postischemic right ventricular recovery 
(66,85,86). However, the large volumes of cardioplegie solution needed to fill 
the right heart to produce arrest, has generated limited enthusiasm for accep-
tance of this technique. 
Using the second technique, retrograde cardioplegia is directly infused in the 
coronary sinus. With this technique, proposed by Menasene (49), the coronary 
sinus is cannulated under direct vision. The right atrium is opened for a short 
distance, after the two separately cannulated vena cavae have been snared. A 
balloon-tipped catheter is then introduced into the proximal portion of the 
coronary sinus. The balloon is inflated until the orifice of the coronary sinus is 
occluded, thus preventing backflow of the cardioplegie solution. Initially, a 12 
trench size Foley urinary catheter has been used, and later a discoid-shaped 
balloon, inflation of which does not prevent any venous branch to be perfused 
with cardioplegie solution, while crimping of the balloon helps secure the 
catheter in the proper position. With this technique there is selective infusion of 
cardioplegia into the coronary sinus, which results in an excellent cooling of the 
entire heart (87). An important condition to this technique is that the perfusion 
pressure in the coronary sinus should be limited, because a pressure exceeding 
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60 mm Hg during infusion may result in venous disruption and hemorrhage 
(88,89). With this direct infusion technique the problem of a large volume of 
cardioplegia to fill the right heart is avoided. The need for bicaval cannulation, 
cavai snares, and a right atriotomy however, persists. 
The construction of new cannulas, allowing blind, transatrial coronary sinus 
cannulation, was essential for the widespread use of retrograde cardioplegia. 
Two types of catheters are commercially available. The Gundry RSCP cannula 
(DLP, Ine, Grand Rapids, Michigan) (fig. 3) and the Buckberg cannula (Research 
Medical, Ine, Salt Lake City, Utah) (fig. 4). These two catheters, both having a 
malleable or shapeable stylet, have a coronary sinus pressure line. The Gundry 
catheter has a manual inflatable balloon and the Buckberg catheter an autoinfla-
table balloon at the tip of the catheter. 
For cannulation, a pursestring is placed just inferior to the junction of the right 
atrial appendage and the right atrium, a stab wound is made inside the purse-
string, and the catheter is placed into the right atrium. The catheter can be 
introduced from either the operator's or first assistant's side of the table as 
described by Gundry (67). 
Fig. 3 The Gundry cannula with inflatable balloon 
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Fig. 4 The Buckberg cannula with autoinflatable balloon 
The retrograde catheter can be placed before or after placement of the venous 
cannula (fig. 5). Confirmation of placement is obtained by manually palpating 
the catheter in the atrioventricular groove posteriorly, by observing black 
pulsatile blood in the cannula after withdrawing the stylet, or by observing a 
coronary sinus waveform tracing on the monitor (67). Good placement can be 
controlled by inflation of the balloon on the tip of the cannula (90,91). An 
alternative method is to place the right index finger through the atrial appendage 
via the venous cannula pursestring with direct palpation of the sinus orifice as 
described by Chitwood (84). 
Using this transatrial cannulation of the coronary sinus technique, the need for 
bicaval cannulation, cavai snares and a right atriotomy are circumvented. 
Currently this blind, transatrial coronary sinus cannulation, is the most com-
monly used retrograde method (84). 
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Fig. 5 Coronary sinus catheter with straight stylet in place being inserted into the right 
atrium (RA) anterior to the venous cannula. Note surgeon's finger on the diaphragmatic 
surface of the heart at the junction of the inferior vena cava (IVC) and atrioventricular 
groove, to guide the catheter into the coronary sinus' 
'Reprinted with permission from the Society of Thoracic Surgeons (The Annals of 
Thoracic Surgery,1992;52:714-5.). 
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Chapter III 
EXPERIENCE WITH RETROGRADE CARDIOPLEGIA 
111.1 Retrograde delivery of cardioplegia in aortic valve replacement 
L. Noyez, M.D., J.A.M, van Son, M.D., and L.K. Lacquet, M.D. 
(The Journal of Cardiovascular Surgery 1992;33:235-9) 
Abstract 
Myocardial protection is the cornerstone of cardiac surgery. In recent years 
there has been a renewed interest in the retrograde delivery of cardioplegia in 
coronary artery surgery and also in aortic valve replacement. Several reports 
have suggested the advantages of this technique. We describe our experience 
with retrograde cardioplegia in 25 patients undergoing aortic valve surgery, and 
discuss the advantages and limitations of this technique. 
Introduction 
The adequate distribution of a cardioplegie solution in the myocardium and 
adaptable strategies for its delivery in various clinical situations are two pre-
requisites for optimal myocardial protection described by Buckberg (1). Currently 
there is an increasing interest in the retrograde delivery of cardioplegia in aorto-
coronary bypass surgery because of its irregular distribution due to coronary 
artery stenosis and use of the internal mammary artery as the graft of choice. 
Recently, several reports have also described the use of retrograde coronary 
sinus perfusion in aortic valve replacement (2-4). Several techniques have been 
described, of which retrograde perfusion after transatrial cannulation of the 
coronary sinus may be the most practical and most selective technique(2,4-6). 
In this article we report our experience with retrograde cardioplegia in aortic 
valve replacement and discuss the advantages and disadvantages of this 
particular method. 
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Material and Methods 
Patient population 
The patient population of 25 patients consisted of 18 men and 7 women, 
whose ages ranged from 38 to 81 years (mean age 63 years). Seventeen 
patients were operated upon for aortic valve stenosis, 5 for aortic valve insuffi-
ciency, and 3 patients for a combination of both. Seventeen patients underwent 
aortic valve replacement alone but in 8 patients the procedure was combined 
with aorta-coronary bypass grafting. Twenty-one patients were subjected to 
their first cardiac operation, whereas 4 patients were reoperations. 
Surgical technique 
After adequate hepatization and cannulation of the aorta, a first purse-
string suture is placed in the right atrial appendage and a second just inferior to 
the junction of the appendage and the right atrium. Through the latter purse-
string the sinus coronarius is cannulated from the surgeon's side, as previously 
described by Gundry (2). With the left hand the cannula is inserted into the right 
atrium; with the fingers of the right hand at the inferior vena cava the catheter 
tip is guided into the coronary sinus and into the great cardiac vein. Use of a 
Gundry RSCP cannula with obturator (DLP,Ine,Grand Rapids.MI) was alternated 
with a Buckberg cannula (Research Medical, Inc.SL). After manual palpation to 
confirm that the cannula is in place (it's important to locate the catheter tip near 
the auricle of the left atrium) a two-stage venous cannula is inserted through 
the first pursestring. In all our patients a left ventricular vent was also placed 
through the right superior pulmonary vein, and all patients were cooled to a core 
temperature between 26°C and 28°C; slushed ice was used for topical cooling. 
Cardioplegia was induced by infusion of cold (4°C) St.Thomas'Hospital cardio-
plegia until asystole occurred, and maintained thereafter by reinfusion of 
100ml/m2 solution every 25-30 minutes or earlier as needed. The coronary sinus 
pressure never exceeded 50 mm Hg. 
After performing a transverse aortotomy, we confirm if the infusion is correct 
by inspection of its blackflow from the coronary ostia. In every patient a 
¿Я 
St.Jude Medical prosthesis was inserted by means of interrupted mattress 
sutures supported by pledgets directed to the ventricular cavity, and in patients 
with combined aortic valve replacement and myocardial revascularization, the 
valve was inserted first. 
Recover/ of cardiac function 
For evaluation of the recovery of cardiac function, only the patients with 
primary isolated aortic valve replacement (n = 15) have been described, because 
this is a homogeneous group. The hemodynamic variables were measured 
before cardiopulmonary bypass, 5 minutes after cessation of bypass, and 3 
hours postoperatively. The measurements included, mean systemic arterial 
blood pressure (MAP), mean right atrial pressure (RAP), mean pulmonary arterial 
pressure (PAP), heart rate (HR), mean pulmonary capillary wedge pressure 
(PCWP), and cardiac output (Q). Derived hemodynamic indexes were calculated 
as follows: 
-cardiac index(QI) = Q/body surface area(BSA) (L/min/m2) 
-stroke ¡ndex(SI) = QI/heart rate (ml/beat/m2) 
-left ventricular stroke work index 
(LVSWI) = SI.(MAP-PCWP).0.0136 (gm.m/m2) 
-right ventricular stroke work index 
(RVSWI) = SI.(PAP-RAP).0.0136 (gm.m/m2) 
Clinical outcome 
Four parameters were registered to assess the clinical outcome, namely: 
operative mortality, Incidence of low cardiac output, rhythm and conduction 
disturbances and the incidence of myocardial infarction. Special attention was 
also given to problems during, or due to, cannulation of the coronary sinus. 
Operative mortality was defined as peroperative death, or death occurring within 
the first 30 days after the operation. The incidence of low cardiac output was 
defined as the need for positive inotropic support (more than 4 ¿/g/kg of 
dopamine per minute for at least 12 hours) and/or a cardiac index below 
2.2L.min1,m'2. Preoperative and postoperative electrocardiograms were compa-
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red, and the incidence of new rhythm or conduction disturbances were noted. 
Myocardial infarction was defined as the appearance of a new Q wave and /or 
an increase of more than 1 0 % in the levels of the myocardial-specific isoenzyme 
of creatine kinase of the total creatine kinase content. 
Statistical Analysis 
Statistical analysis of the hemodynamic parameters was made by the 
unpaired Students t-test. Significance was assumed at ρ s 0.05. 
Results 
Table I shows the peroperative data. In the cases of aortic valve surgery in 
combination with coronary artery bypass surgery, at least 1 distal anastomosis 
Table I. Peroperative data 
Duration Value 
Primary single aortic valve replacement 
(n = 15) 
Time to reach asystole (seconds) 
Extracorporeal circulation (minutes) 
Aortic-cross-clamp time (minutes) 
45±4 (28-106) 
e S . 0 ± 1 1 . 6 (68-98) 
6 8 . 1 ± 1 0 . 2 (45-80) 
Primary aortic valve replacement with 
bypass grafting (n = 6) 
Time to reach asystole (seconds) 
Extracorporeal circulation (minutes) 
Aortic-cross-clamp time (minutes) 
47±2 (30-125) 
108.2±10.1 (76-120) 
74.2±9 (52-97) 
Reoperations (n = 4) 
Time to reach asystole (seconds) 
Extracorporeal circulation (minutes) 
Aortic-cross-clamp time (minutes) 
47±5 (29-100) 
9 5 . 7 ± 1 4 . 6 (64-170) 
8 0 . e ± 1 3 . 7 (55-143) 
Data are expressed as mean ± standard deviation 
ЦП 
was performed with the internal mammary artery. A mean of 2.4 distal anasto-
moses were performed with a mean of 1.4 distal anastomoses using the internal 
mammary artery. The time to reach asystole shows no significant difference 
between the reoperations, combined or primary operations. 
In the whole group, there was no operative mortality. One patient, with an 
isolated aortic valve replacement, had to be reexplored for bleeding not related 
to the technique of retrograde cardioplegia. No problems occurred during 
transatrial cannulation and decannulation of the coronary sinus. Four patients 
had a postoperative low cardiac output as we have defined it, but after 48 
hours all were free of inotropic support. No patients sustained an intraoperative 
myocardial infarction. Two patients with préexistent atrial fibrillation remained in 
atrial fibrillation. Of the 23 patients with a preoperative sinus rhythm 21 had 
return of this rhythm postoperatively. One patient had a transient heart block 
(<12 hours) and one patient (fourth reoperation) required insertion of a perma-
nent pacemaker. 
Analysis of the recovery of cardiac function concerns only the patients with an 
isolated aortic valve replacement. Table II, revealed no significant differences 
among the prebypass baseline values and the values 5 minutes and 3 hours 
postoperatively. 
Discussion 
In this discussion two aspects must be separated. First the efficacy of 
myocardial protection, and second the practicability of the method of delivery of 
the cardioplegie solution. In comparison with anterograde cardioplegia Parting-
ton and co-workers (7,8) reported, in an experimental study, superior myocardi-
al protection of the left ventricle with retrograde cardioplegia, even with patent 
coronary arteries, but less favorable protection of the right ventricle. This 
finding may be related to the different venous drainage of the right and left 
ventricle, and also because they used dogs in their experimental study. Anato-
mical studies in dogs (9) have shown that most of the right ventricle and the 
posterior part of the interventricular septum are not drained by the coronary 
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ТаЫв II. Hemodynamic data of 15 patients with primary single aortic valve replace 
ment. 
Variable 
HR (beats/min)' 
MAP ImmHgl' 
RAP (mmHg)' 
PAP (mrnHQ)·1 
PCWP (mmHg)" 
Q (l/min)' 
Ql (l/min/m2)" 
SI (ml/beat/m2)h 
LVSWI (gm.m/m2)' 
RVSWI (gm.m/m2)1 
Prebypass 
Values 
70±6.5 
S0110.6 
7.013.0 
16.414.2 
11.4±3.7 
5.812.1 
3.311.1 
47.8110.4 
44.7111.4 
5.612 
Postoperative 
5 minutes 
6317 
7519 
7.212.3 
14.313.7 
9.413.9 
5.312.0 
2.810.9 
44.118.3 
39.7111.4 
4 . 8 1 2 . 1 
Values 
3 hours 
7219.3 
8616.7 
6 . 5 1 3 . 1 
15.213.0 
10.012.4 
5.912.2 
3.211.3 
41.518.6 
41.819.8 
5.512.8 
Data are expressed as mean ± standard deviation. 
a: heart rate, b: mean systemic blood pressure, c: mean right atrial pressure, 
d: mean pulmonary pressure, e: mean pulmonary capillary wedge pressure, 
f: cardiac output, g: cardiac index, h: stroke index, i: left ventricular 
stroke work index, j : right ventricular stroke work index. 
sinus. The cardiac venous drainage in humans, however, seems to be more 
balanced (10). Our study showed excellent protection of both the right and left 
ventricles in primary isolated aortic valve replacement, and also Menasene (3) 
was not able to show any statistical difference in the functional recovery of the 
heart after anterograde or retrograde cardioplegia. The good distribution over 
the human heart is also confirmed by the excellent cooling of the entire heart 
obtained by retrograde cardioplegia (11). 
Hypertrophic ventricles are intrinsically more sensitive to ischemia (12,13) and 
myocardial damage, particularly of the subendocardium, is one of the incremen­
tal risk factors for premature late death in aortic valve surgery (14). The efficacy 
of retrograde cardioplegia in hypertrophic ventricles has been described (15,16), 
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but more importantly retrograde cardioplegie infusion is preferentially delivered 
to the subendocardial muscle, whether the coronary arteries are open or not. If 
there is an occlusion, antegradely infused cardioplegia is redistributed away 
from the subendocardial muscle and thus fails to provide optimal protection of 
the jeopardized myocardium (7,8,16,17). Delay of cardiac arrest is described as 
a disadvantage of retrograde cardioplegia. In a prospective study, in patients 
who were subjected to elective myocardial revascularization. Fiore (17) showed 
that the time to achieve complete electrocardiographic arrest was significantly 
longer in patients in whom retrograde cardioplegia was used, than in those in 
whom anterograde cardioplegia was used. Gundry (2) described that cardiac 
arrest occurred within 20 to 30 seconds after the retrograde delivery of cardio-
plegia, which is a substantially shorter time in comparison with our own expe-
rience. Many authors confirm that this potentially disadvantageous feature of 
retrograde cardioplegia has, however, no clinically detectable adverse effects on 
the postoperative outcome (4,17,18). 
The advantage of the technique described is that blind cannulation of the 
coronary sinus circumvents the principal limitations of the open technique, such 
as bicaval cannulation, cavai snares and an atriotomy for visualisation of the 
coronary sinus. We feel that there is a learning curve with regard to the techni-
que of blind cannulation of the coronary sinus and our experience with this 
technique in about 80 previous patients who underwent myocardial revasculari-
zation has certainly contributed to the fact that in this present series no pro-
blems were encountered with regard to the technique of blind cannulation. In 
the first group of patients in whom we applied the technique, blind cannulation 
was not easy and sometimes manipulation of the heart resulted in rhythm 
disturbances. Clinical symptoms of injuries of the sinus coronarius were not 
seen in any of our patients, neither in our previous patients nor in those inclu-
ded in this study. Menasché (3) reported an 0.6% incidence of retroperfusion-
related traumatic complications and compared this with the 1 % to 5% incidence 
of coronary complications reported after the use of direct ostial cannulation 
(6,19). This comparison, however, may be distorted by the fact that the true 
incidence of coronary arterial ostium injuries is not so clear (19), and additional-
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ly it is difficult to compare a commonly used technique with a new method only 
done by some surgeons. An additional advantage of delivering the cardioplegia 
retrogradely is the gain of time, because it is unnecessary to interrupt the 
surgical procedure to infuse cardioplegia; we are not sure, however, if the aortic 
cross-clamp time is significantly reduced by this gain of time and only prospecti-
ve randomized clinical trials can prove this. Another advantage of retrograde 
cardioplegia is the washing out of calcific debris from the coronary ostia, al-
though calcific debris may still fall in the ventricular cavity. Thus caution with 
regard to this potential complication is still necessary. 
It is likely that the application of retrograde cardioplegia will extend the use of 
the internal mammary artery in procedures of combined valve surgery and 
myocardial revascularization, because the jeopardized myocardium receives 
good protection retrogradely so that infusion of cardioplegia through the venous 
grafts is no longer necessary. However, clinical trials will be necessary to 
confirm the experimental experience. 
In conclusion, the technique of retrograde coronary sinus cardioplegia for aortic 
valve surgery is safe, efficient and easy. However, performance of a prospective 
randomized clinical trial is necessary and is set up to investigate whether or not 
it may be the technique of choice for the delivery of cardioplegie solution in 
aortic valve surgery. 
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III.2 Experience with retrograde cardioplegia in coronary reoperations 
Luc Noyez, M.D., Jacques A.M. van Son M.D. Ph.D., 
Leon K. Lacquet.M.D. 
(submitted) 
Abstract 
Myocardial protection is the cornerstone of cardiac surgery. Certainly in 
coronary reoperations where, despite the growing surgical expierence, the most 
striking problem is the frequency of perioperative myocardial infarction. Use of 
retrograde delivery of cardioplegie solution may be favorable in coronary 
reoperations. We describe our experience with retrograde cardioplegia in 48 
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elective reoperations for myocardial revascularization, and discuss the advanta-
ges and limitations of this technique. 
Introduction 
The number of reoperations for myocardial revascularization is still increa-
sing (1). Despite the growing surgical experience, the risks of coronary reopera-
tions are higher than for primary revascularization. The most striking difference 
in primary operations and reoperations is the frequency of perioperative myo-
cardial infarction. Furthermore, in primary operations there is a shift away from 
cardiac-related factors concerning perioperative mortality, whereas in reopera-
tions most deaths are due to myocardial dysfunction (1-4). Evidently myocardial 
protection is an important factor in decreasing the perioperative mortality in 
coronary reoperations. In this context, in comparison with anterograde delivery 
of cardioplegie solution, retrograde delivery of cardioplegie solution through the 
coronary sinus may be a good alternative (4-7). In this article we present our 
experience with retrograde delivery of cardioplegia in coronary reoperations and 
discuss the specific problems. 
Material and methods 
Patient population 
Between June 1990 and December 1991, in 48 consecutive elective re-
operations for myocardial revascularization, cardioplegie solution was adminis-
tered retrogradely. Table I shows the preoperative data. The left ventricular 
function was described subjectively as being normal or moderately or severely 
impaired. Obesity was defined as more than 10% overweight; diabetes, when 
there was a positive glucose tolerance test, peroral antidiabetic medication or 
insulin dependence. Hypertension was defined as a systolic blood pressure 
above 160 mm Hg or a diastolic pressure exceeding 100 mmHg. Hyperlipidemia 
was defined as a cholesterol level more than 6.4 mmol/l or a triglyceride level 
more than 2 mmol/l. 
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Table I. Preoperative data ( n « 4 8 ) 
Parameter 
Male 38 
Female 10 
Age (years) 65.617.45 
40-77 
NYHA 3 . 2 5 1 0 . 1 
3-4 
Interval between the operations (months) 90147 
10-192 
Left ventricular function 
normal 14 
moderately impaired 24 
severely impaired 10 
Obesity 10 
Hypertension 36 
Diabetes 10 
Hyperlipidemia 29 
group data are expressed as mean ± standard deviation 
NYHA = New York Heart Association 
Prior to the first operation, 28 patients had a myocardial infarction, and 14 
patients had a new infarction between the first and the second operation. In 35 
patients the angiographic indication for reoperation was progression of athero­
sclerosis as well in the native coronary vessels as well as in the grafts. In one 
patient there was an isolated graft failure, namely a stenotic internal mammary 
artery graft to the LAD. This patient was reoperated 10 months after the first 
operation. All previous medication, such as nitrates, Ca++-entry blockers, and 
beta-blockers, was continued until midnight before the operation. 
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Surgical technique 
The sternum was longitudinally opened with an oscillating saw and the 
aorta and the right atrium, enough for venous cannulation, were dissected free. 
Subsequently, one or both internal mammary arteries were harvested, synchro­
nously with the necessary length of saphenous vein. In one patient the right 
gastroepiploic artery was used. 
After adequate heparinization the ascending aorta was cannulated. In one 
patient the femoral artery was used for cannulation because there was an 
extensive bleeding and cannulation of the ascending aorta was technically 
difficult. A two stage cannula was inserted into the right atrium for venous 
return. The sinus coronarius was blindly cannulated as described by Gundry (7). 
A Gundry RSCP cannula with obturator (DLP, Ine, Grand Rapids, Ml) or a 
Buckberg cannula ( Research Medical, Inc.SL) was used. The retrograde 
cannula is passed over the venous cannula. Confirmation of the placement in 
the sinus coronarius is done by the "balloon inflation technique". With this 
technique the retrograde cannula is inserted through the right atrium. When we 
suppose that the cannula is placed in the sinus coronarius the balloon is 
inflated, an increase of the pressure confirms a good placement (fig. 1). 
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Fig. 1 Coronary sinus pressure; Inflation of the balloon in the coronary sinus Is followed 
by an increase of the coronary sinus pressure. Deflation Is followed by a decline back 
to the baseline. 
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First the patients are cooled to a core temperature of 30°C and the heart is 
further dissected free. In all patients a left ventricular vent was inserted through 
the right superior pulmonary vein. In some cases, where manipulation resulted in 
hemodynamic instability or rhythm disturbances, the patient was immediately 
cooled, cardioplegia infused until asystole, and then the heart was dissected 
free. All patients were cooled to a core temperature between 26°C and 28°C 
and slushed ice was used as topical cooling. Myocardial protection was ensured 
by infusion of cold (4°C) St.Thomas'Hospital cardioplegia until asystole occur­
red and was maintained by reinfusion of 100ml/m3 solution every 25-30 
minutes or earlier as needed. Coronary sinus pressure never exceeded 50 mm 
Hg. Through the new venous grafts, which were constructed first, an additional 
dose (±25ml) of cardioplegia was infused. 
Results 
The intraoperative data are shown in table II. There was a mortality of 2/48 
(4.1%). First patient was a 68 years old female who had been subjected to a 
reoperation using both mammaria arteries and the right gastroepiploic artery. 
She did well until she died on the fifth day postoperatively because of uncon­
trollable rhythm disturbances, followed by ventricular fibrillation. Autopsy 
showed patent grafts and no evidence of myocardial infarction. The second 
death was a 65 year old man, who had been revascularized with both mamma­
ry arteries and two venous grafts. One hour postoperatively his ECG suddenly 
showed signs of severe ischemia. Subsequent resuscitation was unsuccessful. 
Autopsy showed dissection of the ascending aorta and myocardial infarction. 
One patient was subjected to a resternotomy for bleeding. Four patients showed 
a low cardiac output syndrome (more than 4 μ$ of dopamine per minute for at 
least 12 hours) and three of them received an intraaortic balloonpump. Four 
patients showed a perioperative myocardial infarction (new postoperative Q 
wave or T-waves changes accompanied by elevated cardiac enzymes). One of 
these infarctions may be related to athero-embolism into the native coronary 
circulation. This was a male patient of 47 years of age. Six years after the first 
60 
Table II. Intraoperative patient data ( n = 4 8 ) 
Parameter 
Bypass time (min) 12Э.514В.В 
50-340 
Cross-clamp time (min) 74.6128.9 
27-185 
Number of grafts 3.2±1.2 
1-4 
Distal anastomoses (No,) 3.911.0 
1-7 
Single IMA-use 11 
Bilateral IMA-use 31 
Distal IMA-anast. (No.) 2.810.7 
0-4 
GEA-use 1 
IMA: internal mammary artery; GEA: right gastroepiploic artery 
single-(bilateral) IMA-use: number of patients with a single 
(bilateral) IMA as graft by the reoperation, 
distal IMA-anast.: distal anastomoses performed with the IMA 
GEA-use: number of patients with the GEA as conduit 
operation he developed angina pectoris NYHA class III, with angiographic 
narrowing of the venous graft to the obtuse marginal branch and atherosclerotic 
degeneration of the graft to the left anterior descending, and of the right native 
coronary artery. At reoperation the left internal mammary artery was anastomo­
sed to the left anterior descending artery, the right internal mammary artery to 
the dominant right coronary artery, and a venous graft to the obtuse marginal 
artery. Intraoperatively, after incision of the left anterior descending artery, 
there was a wash-out of athero-embolic particles during retrograde Infusion of 
cardioplegia. Postoperatively there was electrocardiographic and enzymatic 
evidence for an anterior myocardial infarction, later confirmed by echocardio­
graphy. 
Problems related to transatrial cannulation and decannulation of the coronary 
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sinus were not encountered. 
Discussion 
In contrast with primary operations in which a decrease of cardiac-related 
factors for perioperative mortality is observed, in reoperations the mortality 
remains high and is mainly due to perioperative myocardial infarction (1-4). 
Further analysis of this problem shows that in contrast with primary operations 
the incidence of perioperative myocardial damage has not decreased(4). Our 
mortality and perioperative myocardial infarction rate is not significant different 
from results described by Lyttle (4). The complex coronary arterial anatomy 
complicates homogeneous distribution of anterogradely delivered cardioplegia. 
Myocardial areas distal to occluded coronary arteries and grafts do not receive 
any protection (8). Another problem consists in the danger of embolization of 
atheromatous particles in case of anterograde perfusion of atherosclerotic 
venous grafts, what can result in a trash heart (6,8,9). Disconnecting these 
veins results in a minor perfusion of this myocardial area either by blood or 
cardioplegia. 
Retrograde delivery of cardioplegie solution seems to be a good alternative. In 
an experimental set-up in dogs, Partington reported, in comparison with 
anterograde cardioplegia, superior myocardial protection of the left ventricle 
with retrograde cardioplegia, even in case of patent coronary arteries, although 
the protection of the right ventricle was less favorable (10,11). These findings 
may be related to the different venous drainage of the right and left ventricle, in 
dogs, in which anatomic studies (12) have shown that most of the right 
ventricle and the posterior part of the interventricular septum are not drained by 
the coronary sinus. In humans, however, the cardiac venous drainage is more 
balanced (13). Several clinical studies have not been able to show any statisti-
cally significant difference in the recovery of right and left ventricular function 
between anterograde and retrograde cardioplegia (14,15). Retrograde delivery of 
cardioplegia results in good distribution of the cardioplegia in the myocardium as 
confirmed by excellent cooling of the entire heart (16) not related to the disease 
62 
of the coronary arteries. In patients with existing patent internal mammary 
artery grafts, it remains necessary to clamp the graft so that dissection of the 
pedicle is needed with the risk of damaging the graft. 
Delay of cardiac arrest is described as a limitation of retrograde cardioplegia 
(10,11). In a prospective study in patients who were subjected to primary 
elective myocardial revascularization, Fiore (17) showed that the time to achieve 
complete electrocardiographic arrest was significantly longer in patients in 
whom retrograde cardioplegia was used than in those in whom anterograde 
cardioplegia was used. Many authors confirm that this potentially disadvan-
tageous feature of retrograde cardioplegia has no clinically detectable adverse 
effects on postoperative outcome (15,17,14). All these clinical studies were, 
however, performed in patients who underwent a primary operation. In reopera-
tions the problem of adequate distribution of cardioplegia is more complex, and 
in our experience, in most patients the time to reach asystole in a reoperation is 
longer than in a primary operation. Also the total dose of delivered cardioplegia 
is greater in retrograde than in anterograde cardioplegia, but also in reoperations 
versus primary operations. 
Retrograde delivery of cardioplegie solution by blind cannulation of the coronary 
sinus obviates the need for extensive dissection, bicaval cannulation, cavai 
snares and an atriotomy for visualization of the coronary sinus (7). Confirmation 
of the placement of the retrograde cannula is done by the "balloon inflation 
technique". Gundry (7) described that confirmation of the placement is obtained 
by manually palpating the catheter in the atrioventricular groove posteriorly and 
by withdrawing the stylet and observing black pulsatile blood in the cannula. 
However, black pulsatile blood does not exclude that the catheter is in the right 
ventricle, and palpating in the atrioventricular groove needs dissection of the 
heart. Our technique confirms the correct placement in the sinus coronarius 
without extensive manipulation of the heart, and also that the balloon is in the 
sinus (18). Peroperative injuries of the coronary sinus were not seen in our 
patients, although they have been described with an incidence of 0.6% (19). 
A reported disadvantage of anterograde delivery of cardioplegie solution in 
coronary reoperations is the spreading of atheromatous debris into the coronary 
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arteries during infusion of the cardioplegie solution under high pressure (9). With 
retrograde delivery of cardioplegia this is avoided. In addition, also rhythm 
disturbances, changes in arterial systolic blood pressure, and manipulation 
during dissection can result in athero-embolism and give a "trash heart". During 
retrograde cardioplegia a retrograde wash-out of athero-embolic particles from 
the coronary arteries may occur (6,5) as observed in one of our patients. But it 
is never sure that everything is washed out, and probably the described myo-
cardial infarction was related to debris that was not washed out. Theoretically 
the only method to prevent spreading of debris consists in immediate and 
complete exclusion of all grafts, but in practice the problem is more complex. 
With exclusion, the perfusion of the myocardial area distal to totally obstructed 
native vessels becomes insufficient, and in addition the manipulation of a 
stenotic graft in order to occlude it can cause embolization. In this perspective it 
is important to recognize that not only stenotic but also totally occluded grafts 
can lead to distal embolism (6). In conclusion, our clinical experience with 
retrograde delivery of cardioplegie solution in coronary reoperations let suggest 
a good myocardial protection. Though it is clear that randomized prospective 
trials comparing anterograde versus retrograde delivery of cardioplegie solution 
are essential to evaluate both techniques. The complexity of reoperations, with 
all interfering variables, makes the set up of such a clinical trial, however, 
difficult. 
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Ill.3 Retrograde versus anterograde delivery of cardioplegie solution In aortic 
valve replacement. A hemodynamic evaluation 
Luc Noyez, M.D., Jacques A.M. van Son, M.D., Ph.D., Tjeerd van der 
Werf, M.D.,Wim N.J.C, van Asten, Ph.D., Leon K. Lacquet, M.D. 
(submitted) 
Abstract 
Fourty four patients undergoing isolated aortic valve replacement received 
either anterograde (20 patients) or retrograde (24 patients) delivery of cold St. 
Thomas 'Hospital cardioplegia. These patients were similar with respect to age, 
sex, left ventricular ejection fraction, left ventricular-aortic pressure gradient, 
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cross-clamp time, and mean dose of cardioplegia. Postoperatively, there were 
no differences between the two groups with regard to enzyme release, low 
cardiac output syndrome, rhythm disturbances, or clinical outcome. Analysis of 
the postoperative hemodynamic data, however, suggested a better preservation 
of the left ventricular contractility with retrograde delivery of cardioplegie 
solution. 
Introduction 
Adequate distribution of cardioplegie solution in the myocardium and 
adaptable strategies for its delivery in various clinical situations are two pre-
requisites for optimal myocardial protection as described by Buckberg (1). 
Currently there is an increasing interest in retrograde delivery of cardioplegia in 
aorta-coronary bypass surgery because of inhomogeneous distribution of 
cardioplegie solution due to coronary artery stenosis in anterograde delivery and 
widespread use of the internal mammary artery which prohibits delivery of 
cardioplegie solution through the graft. Recently, several reports have described 
use of retrograde coronary sinus perfusion in aortic valve replacement (2-6). 
Most of these are descriptive reports and do not use control groups (2,4,5). 
Only one study compared anterograde and retrograde delivery of cardioplegie 
solution in aortic valve replacement, but more than half of the included patients 
had an aortic valve replacement associated with another procedure (3). 
In this retrospective clinical study we compare the influence of anterograde 
versus retrograde delivery of cardioplegie solution on the recovery of the cardiac 
function and clinical outcome in patients who underwent isolated aortic valve 
replacement. 
Material and Methods 
Patient population 
Twenty four consecutive patients undergoing isolated aortic valve replace-
ment between July 1990 and December 1991, received myocardial protection 
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by retrograde delivery of cardioplegia. These patients were compared with 
twenty consecutive patients undergoing isolated aortic valve replacement with 
anterograde delivery of cardioplegia, and operated the two years before by the 
same surgeon (so called historical controls). Preoperative data are summarized 
in Table I. Patients with an isolated aortic regurgitation were not included in this 
retrospective study. Although the patients were not randomly assigned to one 
of the two techniques, statistical analysis indicated that the two groups patients 
were well matched with regard to preoperative and operative data. 
ТаЫ I. Preoperative patient data 
Parameter group A 
n=20 
Group В 
n=24 
p-Value 
Male/female 
Age (years) 
Ejection fraction 
LV-Aortic pressure gradient (mmHg) 
16/4 
6 2 . 2 1 7 . 8 
(44-74) 
5 9 . 3 1 8 . 3 
(32-75) 
9 9 . 3 1 2 4 . 2 
19/5 
5 9 . 5 1 9 . 7 
( 3 9 - 7 2 ) 
6 1 . 3 1 9 . 7 
( 3 4 - 7 8 ) 
105126.4 
NS 
NS 
NS 
NS 
NS = not significant. Group data are expressed as mean ± standard 
deviation. LV = left ventricle. 
Surgical technique 
Standard bypass techniques were used with a Cobe C.M.L.-Excel and 
Maxima membrane oxygenator, a roller pump, systemic hypothermia (rectal 
temperature 28°C), and moderate hemodilution. All patients were cooled to a 
core temperature between 26°C and 28°C and slushed ice was used as topical 
cooling. Myocardial protection was induced by infusion of cold (4°C) 
St.Thomas' Hospital cardioplegia until asystole occurred and was maintained by 
reinfusion of 100ml/m2 solution every 25-30 minutes or earlier as needed. In 
group A the cardioplegie solution was infused anterograde by direct coronary 
ostial perfusion. In group В retrograde delivery of cardioplegie solution was 
fifl 
performed. The sinus coronarius was cannulated transatrially as described by 
Gundry (2). A Gundry RSCP cannula with obturator (DLP, Ine, Grand Rapids, 
Michigan) or a Buckberg cannula (Research Medical, Ine, Salt Lake City, Utah) 
was used. Coronary sinus pressure never exceeded 50 mm Hg. 
In all patients a transverse aortotomy was performed and a St.Jude Medical 
prosthesis was inserted by means of interrupted mattress sutures supported by 
pledgets. 
Before weaning the patient off extracorporeal circulation, rewarming was 
initiated to a rectal temperature of 35°C and the hematocrit was increased to a 
minimum value of 0.24L/L. The aortic cannula was left in place until the patient 
remained 5 minutes hemodynamically stable. After cessation of cardiopulmona-
ry bypass, protamine hydrochloride was given to antagonize heparin, and 
subsequently the cannulas were removed. 
Indices used for evaluation of myocardial protection 
Recovery of cardiac function: systolic (SAP), diastolic (DAP), and mean 
arterial (MAP) blood pressure, mean right atrial pressure (RAP), mean pulmonary 
artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), and heart 
rate (HR) were monitored in all patients. Cardiac output (Q) was measured using 
the thermodilution technique. Derived hemodynamic indices were calculated as 
follows: 
Cardiac Index (Ql) = Q/Body Surface area (L/min/m2) 
Stroke Index (SI) = QI/HR (ml/beat/m2) 
Left Ventricular Stroke Work Index 
(LVSWI) = SKMAP-PCWP1.0.0136 (gm.m/m2) 
Right Ventricular Stroke Work Index 
(RVSWI) = SI(PAP-RAP).0.0136 (gm.m/m2) 
These hemodynamic variables were measured after induction of anesthesia, 
before removing the aortic cannula, and 3 hours postoperatively in the intensive 
care unit. 
Clinical outcome 
Incidence of myocardial infarction: intraoperative myocardial infarction was 
defined as the development of a new Q-wave. 
Incidence of low cardiac output: low cardiac output was defined as the need for 
inotropic support (dopamine need increasing 4/yg/kg/minute for at least 12 
hours) or as cardiac index below 2.2 l/min/m2. 
Incidence of rhythm and conduction disturbances: preoperative and postope­
rative electrocardiograms were compared and special attention was given to the 
appearance of atrioventricular conduction disturbances. 
Enzyme release: Postoperatively determination of the creatine kinase isoenzyme 
CK-MB was only performed when there was an ECG suspection of a myocardial 
infarction. GOT ( Glutamate Oxaloacetate Transaminase) levels however, are 
routinely obtained 24 hours after bypass. 
Statistical analysis 
Quantitative data were analyzed with the paired Students' t-test or a 
Wilcoxon test when appropriate. Significance was assumed at ρ s 0.05. 
Results are represented as mean values ± standard deviation. 
Results 
The duration of extracorporeal circulation [group A: 88.6 ± 9.4 (66-108) 
min. versus group B: 83.0 ± 12.3 (68-98) min.] and the aortic cross-clamp 
time [group A: 66.7 ± 1 1 . 3 (42-88) min. versus group B: 64.8 ± 10.9 (45-80) 
min] were not significantly different between the two groups. Neither the total 
dose of cardioplegia, group A: 1200 ± 190 ml versus group B: 1350 ± 2 1 0 
ml. The recovery of hemodynamics is summarized in table II. The recovery of 
myocardial performance is evaluated by LVSWI and RVSWI. The values at five 
minutes after cessation of bypass and three hours after the operation are 
compared with the basic preoperative values. Although we can not show statis­
tically significant difference in the hemodynamic recovery of left ventricular 
function, it is striking that the pulmonary capillary wedge pressure increased in 
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patients who received anterogradely cardioplegia and decreased in patients in 
whom retrograde delivery of cardioplegie solution was used. In order to further 
elucidate this finding we correlated the pulmonary capillary wedge pressure and 
the left ventricular stroke work index before and five minutes after bypass for 
both groups (fig. 1) being an indicator of the position and direction of the 
ventricular function curves before and after bypass, as proposed by Sarnoff (7). 
LVSWI (gm.m/m2) 
11 13 
PCWP (mmHg) 
15 17 
• A • A1 о В nüy 
Fig. 1 A plot of the relation between left ventricular stroke work Index (LVSWI) and 
wedge pressure (PCWP). A, B: group А, В before bypass. A1, B': group A, В five 
minutes after cessation of cardiopulmonary bypass. Data are shown as the 
mean ± standard deviation. 
In patients who received anterograde delivery of cardioplegia there is a decrease 
of the left ventricular stroke work index with an increase of the pulmonary 
capillary wedge pressure and in patients with retrogradely delivered cardioplegie 
solution the decrease of the left ventricular stroke work index is combined with 
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a decrease of the pulmonary wedge pressure. The difference in the direction of 
the lines connecting the pre- and post bypass measurements (five minutes after 
cessation of bypass) in the two groups is striking. 
It seems Justified to suppose that in patients with anterograde administration of 
cardioplegie solution the ventricular function curve has moved to the right and 
downward, suggesting decreased contractility compensated by increased filling 
pressure. On the other hand the changes in patients with retrograde administra-
tion of cardioplegie solution are more or less in the direction of the supposed 
ventricular function curve suggesting unaltered contractility. The decrease in 
stroke work is explained by a decrease in filling pressure. Statistical analysis of 
the individual difference in the pulmonary wedge pressure prebypass and five 
minutes postbypass (group A:+ 1.9 ± 0.9 mm versus group B:-1.8 ± 0.7 mm) 
was significant (p < 0.001), although the individual decrease of the LVSWI was 
not significantly different in both groups. Three hours after operation statistical 
analysis of the difference in the pulmonary wedge pressure reach no statistical 
significance. 
Problems did not occur during transatrial cannulation and decannulation of the 
coronary sinus nor with the direct coronary ostial perfusion technique. In all 
patients the clinical outcome was good. There was no operative mortality. Two 
patients, one in each group had to be explored for bleeding. Two patients (1 of 
group A and 1 of group B) had low cardiac output as defined. After 48 hours, 
however, all were free of inotropic support. None of the patients sustained an 
intraoperative myocardial infarction. In 5 patients préexistent atrial fibrillation 
was persistent. Of the 39 patients with a preoperative sinus rhythm 35 had 
return of this rhythm postoperatively. Four patients had a transient heart block 
that in all lasted for 12 hours. There was no statistical significant difference in 
the frequency of rhythm disturbances between the two groups, neither between 
the postoperative obtained values of GOT for both groups (29 ± 3 U/L for 
group A versus 32 ± 2 U/L for group B). 
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Discussion 
The good preservation of left ventricular function in aortic valve replace-
ment using retrograde delivery of cardioplegia has been reported by Menasene 
(3,5). Our study suggests even better preservation of the left ventricular 
contractility with retrograde delivery of cardioplegie solution than with antero-
grade delivery. Partington and associates, in their experimental study, reported 
superior left ventricular myocardial protection with retrograde cardioplegia, even 
with patent coronary arteries and showed that retrograde infusion delivers flow 
selectively to the subendocardial muscle (8,9). Thus this technique may be 
especially advantageous in hypertrophic ventricles because these, and in 
particular their subendocardial myocardium, are intrinsically more sensitive to 
ischemia (10). Our suggestion of the better preservation of myocardial contracti-
lity with retrograde delivery of cardioplegia, is based on the significant differen-
ce we noted for the individual patient data. That we were unable to show a 
statistically significant difference between the mean values of the pulmonary 
wedge pressure of both groups, is because the standard deviation of the mean 
values overlap the individual difference. 
The good preservation of right ventricular function with retrograde delivery of 
cardioplegia is confirmed and discussed by several clinical studies concerning 
myocardial revascularization (11-13) and aortic valve replacement (4). 
An other suggested advantage of retrograde delivered cardioplegia is the gain of 
time, mainly caused by the unnecessity to interrupt the surgical procedure to 
infuse cardioplegia. Our data could not show a statistical significant reduction of 
aortic crossclamp time between the two groups, however, it is easy to continue 
the operation without interruption. 
The type of our study, done retrospectively, is of course open to the usual 
criticisms. First, we compare patients operated in two different periods. Second-
ly, the number of patients is limited. This is because only one surgeon used the 
retrograde cardioplegia in aortic valve surgery, and because, to reduce the 
variability arising from different surgeons, only patients operated by the same 
surgeon are included in group A. Thirdly, several parameters to evaluate 
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myocardial protection, as septal temperature, CPK release, time to achieve 
asystole, are not furnished. Some of them are not routinely determinated, others 
were not available in all the patients. 
A recent published prospective study (14) confirms our data, although, the 
inclusion of patients with combined aortic valve replacement and myocardial 
revascularization, have distorted this prospective trial. 
Despite the limitations of our study, we conclude that retrograde coronary sinus 
cardioplegia in aortic valve surgery results in a better preservation of the left 
ventricular contractility versus anterograde delivery of cardioplegia. However, a 
prospective randomized clinical trial may be needed to investigate whether or 
not it may be the technique of choice for delivery of cardioplegie solution in 
aortic valve surgery. 
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Appendix: Retrograde cardioplegia and aortic valve replacement 
(letter to the editor) 
L. Noyez.M.D. 
The Journal of Thoracic and Cardiovascular Surgery (in press) 
To the Editor 
In their article (1), comparing retrograde and anterograde delivery of 
cardioplegia for myocardial preservation in patients undergoing aortic valve 
replacement, Dr. Fiore and coworkers conclude that coronary sinus cardioplegia 
is as safe as aortic root perfusion and besides they suggest an early improved 
diastolic compliance of the left ventricle in the retrograde group. 
These results confirm our retrospective study (2), comparing the hemodynamic 
data of 24 patients undergoing primary isolated aortic valve replacement for 
aortic stenosis operated with retrograde delivery of cardioplegia, with the data 
of 20 comparable patients operated with anterograde delivery of cardioplegia. 
We noted a ( not significant) decrease of the left ventricular stroke work index 
in both groups, however, in the anterograde group this decrease was associated 
with an increase of the wedge pressure, in contrast with the retrograde group, 
where there was a decrease of the wedge pressure. Correlating the filling 
pressures with the stroke work we have an impression of the preservation of 
the left ventricular contractility as proposed by Sarnoff (3). In the retrograde 
group, the decrease of the left ventricular stroke work index is partially related 
to a decreased preload and partially to a depressed contractility. In the antero-
grade group, the decrease of the left ventricular stroke work index is based on 
depression of the left ventricular contractility. 
However, despite the seeming concordance, and independent of the good 
working-out of the study by Dr. Fiore, the suggestion of an improved diastolic 
compliance of the left ventricle in patients undergoing aortic valve replacement 
using retrograde cardioplegie solution, seems premature. Fiore ea. included 
several patients with combined aortic valve replacement and myocardial 
revascularization in their study, nowhere in the study is mentioned how many 
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patients were included. Also it would be interesting to know if patients with an 
occluded or a critical stenosis (>90%) of the left anterior descending coronary 
artery or a critical stenosis of the left main were included. This may be impor­
tant in prohibiting the anterograde delivery of cardioplegia (4). So it may be 
possible that the slight improvement in the retrograde group is only due to an 
inhomogeneous distribution of cardioplegia in the anterograde group, as already 
mentioned by Dr. Follette in the discussion. 
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Chapter IV 
THE BASIC SETUP OF A PROSPECTIVE RANDOMIZED CLINICAL TRIAL 
RELATED TO MYOCARDIAL PROTECTION IN CARDIAC SURGERY 
IV. 1 Introduction 
Clinical trials are essential for testing the efficacy and or effectiveness of 
diagnostic or therapeutic innovations. No matter how overwhelming the 
evidence of success of a new technique, or how good our knowledge of the 
anatomy, physiology, pharmacology or other basic sciences is, each time we 
see a patient we are faced with a clinical situation, in which we have to decide 
what is the best for that specific patient. The only possibility to answer this 
question is to perform a controlled, practical tryout under field conditions: a 
randomized clinical trial. It is known that uncontrolled trials or poor constructed 
trials can provide distorted information. That in clinical trials the evaluation is 
done by clinical results, to be divided into "clinical endpoints" such as mortality, 
morbidity, quality of life, pain sensation, or "laboratory endpoints", such as 
ventricular function , both having a lower sensitivity than the " basic science 
endpoint" as described by Chiù (1), may not degrade the importance of a well 
constructed randomized clinical trial. 
Even a good constructed randomized clinical trial can, however.distort informa-
tion when the basic setup of the trial is not correct. In this section the problems 
with the basic setup of our prospective randomized clinical trial related to 
myocardial protection in coronary artery bypass surgery (2) are discussed. 
IV.2 Theoretical considerations by the basic setup of a clinical trial 
In the evaluation of the effectiveness of a therapeutic innovation several 
components are important (3). Firstly the "natural course" in which complaints 
may disappear independently of the therapy, or as a result of autosuggestion by 
the mere fact of "a" therapy. This can be called a "non-specific component". 
But also wrong information of the patient, or subjective information of the 
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investigator ( the " information gap"), can distort the evaluation of the "therapy 
related" effectiveness of an innovation. 
To select this therapy-related component of an innovation, a study comparing 
two groups is necessary. In such a study, the natural course, the non-specific 
components and the information-gap in the two groups must be the same, so 
that the therapy-related effect of an innovation, used in one group, is selected. 
By giving a placebo, the non-specific component, and by blinding the study, the 
information-gap is (mostly) eliminated. To equalize the "natural course", the two 
groups must be randomized. By randomization, each possible intended or not-
intended manipulation of a patient, by the investigator, in one of the groups, 
must be eliminated. Computer randomization, as used in our study, is preferable 
because it is unpredictable and impossible to manipulate for the investigator (4). 
In a clinical trial, comparing the results of two surgical techniques, blinding the 
study, or working with a placebo is of course impossible. 
Despite these principles of a comparative trial, a study can persist distorted 
information when the basic setup is wrong. For the basic setup of surgical trials 
two questions are very crucial. Firstly, is the studied group adequately selected, 
in relation to the question, to be solved? This relates to the problem of inclu-
sion and exclusion criteria. Secondly, are the interventions in both arms of the 
trial adequately performed. Hereby, the possible influence of different anesthe-
tic methods can best be eliminated by use of a standardized anesthetic techni-
que. 
IV.3 The clinical problem and the basic setup of the study 
Adequate distribution of cardioplegie solution in the myocardium and 
adaptable strategies for its delivery in various clinical situations are two pre-
requisites for optimal myocardial protection as described by Buckberg (5). 
Currently there is an increasing interest in retrograde delivery of cardioplegia in 
aorta-coronary bypass surgery because of inhomogeneous distribution of 
cardioplegie solution in case of anterograde delivery, due to coronary artery 
stenosis and use of the internal mammary artery as graft of choice, prohibiting 
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anterograde delivery of the cardioplegie solution (6). This problem of inadequate 
delivery of the cardioplegie solution is especially relevant in patients with severe 
multivessel disease. 
Consequently, in a clinical trial comparing anterograde versus retrograde delivery 
of cardioplegia, it is essential to exclude patients with minor coronary artery 
lesions. Thus to answer the clinically relevant question, only patients with three 
vessel coronary artery disease undergoing aorta-coronary bypass surgery with 
extensive use of the internal mammary artery should be included. 
This emphasizes three important points for the basic setup of the clinical trial. 
Firstly, it compares two different techniques of delivery of cardioplegia, second-
ly there must be an adequate patient selection and thirdly, the operation must 
be done with extensive use of the internal mammary artery as graft. 
IV.3.1 anterograde or retrograde delivery ? 
The fact that we compare two techniques of delivery of cardioplegia 
demands that the surgeons are familiar with both techniques. Every new 
technique has its learning curve and it is difficult to know how long a learning 
period takes for each different surgeon. As method to decide which surgeons 
are ready to take part in the trial, we reviewed the frequency of use of retrogra-
de cardioplegia per surgeon in our databank, the Coronary surgery databank 
Radboud hospital (CORRAD). We took the highest frequency as reference; 
surgeons with a statistical significant lower experience were excluded to take 
part in this trial. 
IV.3.2 Patients with three vessel coronary artery disease. 
This seems a rather clear inclusion criterium for patients. It is known as 
essential to have a minimal difference of the focussed problem (myocardial 
protection) between the included patients. Therefore in our study one of the 
exclusion criteria was coronary reoperations, because the problem of myocardial 
protection seems to be more complex in reoperations (7). Another reason to 
exclude patients can be because of objections of the ethical commission. In this 
case it must be deliberated if this exclusion does not distort the conclusion of 
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the study. 
In a previous trial, studying the effect of Lidoflazine (8), we were unable to 
demonstrate a better myocardial protection with Lidoflazine. Here the exclusion 
of patients with a left ventricular ejection fraction of less than 0.35, based on 
ethical considerations, may have played a role. The benefit of Lidoflazine to 
myocardial protection is perhaps minimal but can just be important in the high 
risk patientgroup that was excluded. 
When all inclusion and exclusion criteria are well defined, it can be chequed in 
the databank if enough patients are present, and how they are routinely 
operated, in relation to the needs of the study. 
IV.3.3 Extensive use of the interna/ mammary artery as graft. 
This criterium is very relative. Extensive use of the internal mammary artery 
as graft will be different for each surgeon. Also here our databank was helpful, 
and the highest frequency was taken as reference. Surgeons with a statistical 
significant lower frequency of internal mammary artery grafts were not allowed 
to take part in this trial. In this situation, the patient selection was the result of 
a surgeon related factor. Besides, our frequency of internal mammary artery 
use must be compared with the frequency of internal mammary artery use in so 
called " leading centres". 
І .4 Conclusion 
The importance of clinical trials in the evaluation of the scientific laboratory 
knowledge is out of discussion. However, a poor trial has serious long-term 
drawbacks, it can close the possibility for a new good trial, and it may lead to 
inadequate decisions in clinical situations. Structure, performance, the choice of 
the parameters, and the methods of analysis are determinating for the strength 
of the trial, and are regularly good described and discussed in the report. 
However, already at the basic setup, proper skepticism about the clinical 
problem and about own knowledge and possibilities is essential to perform a 
good trial. The existence of a routinely updated databank seems here crucial to 
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take decisions. 
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Chapter V 
RETROGRADE VERSUS ANTEROGRADE DELIVERY OF CARDIOPLEGIC 
SOLUTION IN MYOCARDIAL REVASCULARIZATION. 
A clinical trial in patients with three vessel coronary artery disease, undergoing 
myocardial revascularization with extensive use of the internal mammary artery 
Luc Noyez, M.D., Jacques A.M. van Son, M.D., Tjeerd van der Werf, M.D., 
Johannes T.A. Knape, M.D., Jules Gimbrère, M.D., Wim N.J.C, van Asten, 
Ph.D., Leon К. Lacquet, M.D., Wim Flameng, M.D. 
(The Journal of Thoracic and Cardiovascular Surgery 1993; in press) 
Abstract 
The effects of retrograde versus anterograde delivery of cardioplegie 
solution on myocardial function were evaluated and compared in 60 patients 
who underwent myocardial revascularization. All patients had three vessel 
coronary artery disease, and the revascularization was done with extensive use 
of the internal mammary artery. Seventy-five percent of the distal anastomoses 
was performed with the internal mammary artery. Myocardial protection 
consisted of St.Thomas Hospital cardioplegie solution, topical slushed ice, and 
systemic hypothermia (28°C). The patients were randomly separated into two 
groups: group A (n = 30), who received anterograde cardioplegia, and group В 
(η = 30) who received retrograde delivery of cardioplegie solution. With excep­
tion of the total dose of cardioplegie solution (p = 0.02), there was no significant 
difference between the two groups concerning septal myocardial temperature at 
the moment of asystole and after infusion of the total dose of cardioplegie 
solution. Cardiac function was assessed before and after the patient was 
weaned from cardiopulmonary bypass. In the immediate postoperative period 
there was a significant increase of the right atrial pressure of the patients 
operated with anterograde delivery of cardioplegia. For the other registered 
parameters there was no significant difference either in the immediate postope­
rative period, or 6 hours later. Release of MB creatine isoenzyme was the same 
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¡η the two groups. Clinical outcome in terms of mortality, incidence of periope­
rative infarction, incidence of low cardiac output, rhythm and conduction 
disturbances was similar in both groups. Technical problems related to cannula-
tion and decannulation of the coronary sinus were not encountered. Multivariate 
analysis showed that occlusion of the left anterior descending coronary artery 
(p = 0.012) is an essential parameter prohibiting anterograde delivery of cardio­
plegie solution. Analysis of the patients with an occlusion of the left anterior 
descending coronary artery operated with anterograde cardioplegia (n = 9) and 
with retrograde delivery of cardioplegia (n = 10) showed a significant difference 
in the total dose of cardioplegia (p = 0.02), septal myocardial temperature at the 
moment of asystole (p = 0.008) and after infusion of the total dose of cardiople­
gie solution (p = 0.015). The mean arterial systolic blood pressure in the 
anterograde group was significantly lower than in the group with retrograde 
delivery of cardioplegia (p = 0.003). Preservation of the left ventricular stroke 
work index was significantly better in the retrograde group (namely 85% of its 
initial value, versus 7 1 % in the group operated with anterograde delivery of 
cardioplegia ( ρ = 0.012)). We conclude that retrograde delivery of cardioplegia 
provides better myocardial protection than antegrade delivery in patients with 
three vessel coronary artery disease including occlusion of the left anterior 
descending coronary artery, who are subjected to myocardial revascularization 
with extensive use of the internal mammary artery. We also conclude that 
occlusion of the left anterior descending coronary artery is an essential parame­
ter in the ¡nhomogeneous distribution of anterogradely delivered cardioplegia. 
Introduction 
Adequate distribution of cardioplegie solution in the myocardium and 
adaptable strategies for its delivery in various clinical situations are two pre-
requisites for optimal myocardial protection as described by Buckberg and 
Rosenkranz (1). Currently there is an increasing interest in retrograde delivery of 
cardioplegia in aorta-coronary bypass surgery because of ¡nhomogeneous 
distribution of cardioplegie solution in case of anterograde delivery due to 
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coronary artery stenosis and use of the internal mammary artery as graft of 
choice, prohibiting anterograde delivery of cardioplegie solution (2). In experi­
mental studies there is evidence of superior myocardial protection of the left 
ventricle with retrograde cardioplegia, even with patent coronary arteries, but 
less favorable protection of the right ventricle (3,4). Clinical studies with 
retrograde cardioplegia however are few and not conclusive (5-7). This report is 
a prospective, randomized, clinical trial with anterograde and retrograde cardio­
plegia in patients with three vessel coronary artery disease, undergoing aortaco-
ronary bypass surgery with extensive use of the internal mammary artery. 
Because the most extreme situation of coronary artery disease, prohibiting 
anterograde delivery of cardioplegia, is an occlusion, special attention was given 
to patients with an occluded left anterior descending coronary artery (LAD). 
Material and methods 
Patient population 
Sixty patients undergoing aorta-coronary bypass surgery were the subject 
of this study. All patients had three vessel coronary artery disease. Exclusion 
criteria for the study were: reoperations, combined procedures, very poor left 
ventricular function (ejection fraction < 0.30) and emergency aorta-coronary 
bypass grafting (evolving myocardial infarction, ischemia not responding to 
medical therapy, cardiogenic shock). The patients were randomized into two 
groups : group A (n = 30), received anterograde cardioplegia and group В 
(η = 30), received retrograde delivery of cardioplegia. Ethical approval and 
informed consent was obtained. 
Table I shows the preoperative data. Obesity is defined as more than 10% over­
weight; diabetes, when there was a positive glucose tolerance test, peroral 
antidiabetic medication or insulin dependency. Hypertension is defined as a 
systolic blood pressure above 160 mm Hg or a diastolic pressure exceeding 100 
mmHg. Hyperlipidemia is defined as a cholesterol level more than 6.4 mmol/l, or 
a triglyceride level more than 2 mmol/l. All preoperative medication, such as 
nitrates, Ca++-entry blockers, beta-blockers, was continued until midnight 
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before the operation. 
Table I. Preoperative patient data 
parameter group A 
η = 30 
group В 
η = 30 
ρ-value 
Male/female 
Age (years) 
B.S.A. (m2) 
NYHA 
Obesity 
Hypertension 
Diabetes 
Hyperlipidemia 
LAD-occlusion 
23/7 
5 7 . 3 ± 8 . 
34-65 
1 .9410. 
1 . 6 - 2 . 
3 . 1 ± 0 . 
2-4 
β 
13 
5 
10 
9 
,1 
1 
15 
1 
59 
25/5 
5 6 . 1 1 8 . 1 
37-69 
1 . 8 6 1 0 . 1 0 
1 . 6 - 2 . 4 
3 . 1 1 0 . 5 
2-4 
6 
14 
3 
12 
10 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS = not significant, group data are expressed as mean ± standard 
deviation, В.S.A.: Body Surface Area, NYHA: New York Heart Association 
classification, LAD: Left anterior descending coronary artery 
Surgical technique 
A standardized anesthetic technique was used, with intravenously adminis­
tered fentanyl (60 //g/kg.) for anesthesia, pancuronium(0.1 mg/kg.) for muscle 
relaxation, and midazolam(0.07 to 0.1 mg/kg/min) for maintenance of anesthe­
sia. A Swan-Ganz catheter (Baxter Healtcare Corp., Edwards Division, Irvine, 
Calif.) was introduced into the pulmonary artery via the internal jugular vein. All 
operations were performed by one surgeon (L.N.) to reduce variability arising 
from different surgeons. The distal anastomoses were performed during a single 
period of crossclamping, proximal anastomoses were performed using a partial 
occluding clamp. Standard bypass techniques were used with a Cobe C.M.L.­
Excel and Maxima membrane oxygenator, a roller pump (Cobe BCT, Inc., 
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Lakewood, Colo.), systemic hypothermia (rectal temperature 28°C), and 
moderate hemodilution. Myocardial protection was performed by intermittent 
infusion of cold 4°C St.Thomas'Hospital cardioplegie solution (300ml/m2) or 
until asystole occurred and maintained by reinfusion of 100 ml/m2 solution 
every 25-30 minutes or earlier as needed. In group A the cardioplegie solution 
was infused in the aortic root, with a pressure of ±100 mm Hg (8), in group В 
retrograde delivery of cardioplegie solution was performed. In both groups an 
additional dose of cardioplegia (25ml) was infused through the venous grafts, 
which were constructed first. The sinus coronarius was cannulated transatrially 
as described by Gundry (15). A Gundry RSCP cannula with obturator (DLP, Ine, 
Grand Rapids, Michigan) or a Buckberg cannula (Research Medical, Ine, Salt 
Lake City, Utah) was used. Coronary sinus pressure never exceeded 50 mm Hg. 
In all patients a left ventricular vent was placed through the right superior 
pulmonary vein. All patients were cooled to a core temperature between 26°C 
and 28°C and slushed ice was used as topical cooling. Myocardial septal 
temperatures were registered at the moment of asystole and after infusion of 
the total dose of cardioplegia. 
Before weaning the patient off extracorporeal circulation, rewarming was 
initiated to a rectal temperature of 35°C and the hematocrit was increased to a 
minimum value of 0.24 L/L. Intravenous fluid therapy was aimed to achieve 
filling pressures which were optimal for the actual myocardial performance, 
using frequent determinations of cardiac filling pressures and calculations of 
stroke work index and cardiac index. The aortic cannula was left in place until 
the patient remained 5 minutes hemodynamically stable after cessation of 
cardiopulmonary bypass. Then protamine hydrochloride was given to antagonize 
heparin and aortic cannula removed. 
Indices used for evaluation of myocardial protection 
Recovery of cardiac function: systolic(SAP), diastolic (DAP) and mean 
arterial (MAP) blood pressure, mean right atrial pressure (RAP), mean pulmonary 
artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), and the 
heart rate (HR) were monitored in all patients. Cardiac Output (Q) was measured 
RQ 
using the thermodilution technique. Derived hemodynamic indices were calcula-
ted as fol lows: 
Cardiac Index (Ql) = Q/Body Surface area (L/min/m2) 
Stroke Index (SI) = QI/HR (ml/beat/m2) 
Left Ventricular Stroke Work Index 
(LVSWI) = SI(MAP-PCWP).0.0136 (gm.m/m2) 
Right Ventricular Stroke Work Index 
(RVSWI) = SKPAP-RAP1.0.0136 (gm.m/m2) 
Systemic Vascular Resistance Index (SVRI) = (MAP-RAP)/Q.80 (dynes.sec/cmB) 
These hemodynamic variables were measured after induction of anaesthesia, 
after cessation of cardiopulmonary bypass, when circulation remained five 
minutes stable, just before administration of protamine hydrochloride (this 
registration is further noted as "five minutes after cessation of cardiopulmonary 
bypass") and 6 hours postoperatively, in the intensive care unit. 
Enzyme Release. At 1, 3, 6, 12, and 24 hours postoperatively venous blood 
samples for determination of creatinekinase isoenzyme (CK-MB) were taken. 
Clinical outcome 
Incidence of myocardial infarction: intraoperative myocardial infarction was 
defined as the development of a new Q-wave or a CPK-MB% > 10%, or both. 
Incidence of low cardiac output: Low Cardiac Output (LCO) was defined as the 
need for inotropic support (dopamine need increasing 4//g/kg/minute for at least 
12 hours) or as cardiac index below 2.2 l/min/m2. 
Incidence of rhythm and conduction disturbances: preoperative and postoperati-
ve electrocardiograms were compared and special attention was given to the 
appearance of atrioventricular conduction disturbances. 
Special attention was given to problems due to cannulation and decannulation 
of the coronary sinus. 
Statistical Analysis 
Quantitative data were analyzed with the paired Students't-test or a 
Wilcoxon test when appropriate, and a multivariate analysis (ANOVA) was 
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performed. A p-vatue less than 0.05 indicates a difference unlikely to be due to 
chance alone. Data were expressed as mean values ± the standard deviation. 
Results 
The intraoperative data are shown in table II. 
Table II. Intraoperative data 
Parameter group A 
η = 30 
group В 
η = 30 
p-value 
Cardioplegia (ml) 
Asystole time (sec) 
Asystole temp. (°C) 
Myoeard. temp (°C) 
Bypass time (min) 
Cross-clamp time (min) 
Number of grafts 
Distal anastomoses (No.) 
Distal IMA-anast. (No.) 
913.3±131.6 
S7.5±27.5 
28-148 
20.812.3 
17-24 
16.413.1 
12-19 
120.1128.4 
65-165 
80.2113.8 
48-98 
3.110.3 
3-4 
5.211.1 
4-7 
3.510.5 
3-4 
11081204.6 
74.2126.9 
32-121 
18.312.3 
18-22 
14.912.8 
12-18 
127.8125.7 
78-165 
79.1110.6 
63-98 
3.210.4 
3-5 
4.611.0 
4-7 
3.310.6 
2-5 
p-0.02 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS = not significant. Group data are expressed as mean ± standard deviation 
asystole time: time to reach asystole, asystole temp.: septal temperature 
at the moment of asystole, myoeard. temp: septal temperature after infusion 
of the initial dosis of cardioplegia. 
distal IMA-anst.: distal anastomoses performed with the internal mammary artery. 
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The mean time to reach asystole in group В was longer than in group A, but did 
not reach statistical significance. Septal temperature at the moment of the 
asystole and after infusion of the initial dose cardioplegia were not significantly 
different between the two groups. The total doses of cardioplegie solution was 
significantly higher in group B, however, the hematocrits post bypass were 
comparable for both groups ( group A: 0.26±0.01 L/L group B: 0.26±0.02 
L/L). In all patients at least one internal mammary artery was used as graft, 
either single or sequential, with bilateral use of the internal mammary artery in 
80% of the patients. Of the distal anastomoses 75% were performed with the 
internal mammary artery. 
The recovery of hemodynamics is summarized in table 111. All pre- and post-
bypass variables were compared between the two groups and the post-bypass 
versus the preoperative values. In the prebypass values there was no signifi­
cant difference between group A and B. Comparing the prebypass values with 
those obtained 5 minutes after cessation of cardiopulmonary bypass, we 
observed an increase of the HR, PAP, PCWP, and a decrease of the MAP, 
LVSWI, and RVSWI, which were not significant. Right atrial pressure increased 
significantly ( ρ < 0.001) in the patients who received anterogradely cardiople­
gia and decreased, not significantly, in patients in whom the retrograde techni­
que was used. In both groups, peripheral vascular resistance was significantly 
decreased after bypass, but returned to normal values after six hours. Also for 
the other parameters, 6 hours after the operation there was no statistically 
significant difference comparing them with the prebypass values. 
During the study we experienced that patients with an occlusion of the LAD 
operated with anterograde delivery of cardioplegia, had a higher septal tempera­
ture at the moment of asystole and after infusion of the initial dose of cardiople­
gia, than other patients. Therefore, myocardial protection may be worse. To 
quantify this experience, we compared the difference in LVSWI prebypass and 
five minutes after cessation of cardiopulmonary bypass with the septal tempera­
ture reached after infusion of the initial dose of cardioplegia ( Fig. 1 and Fig. 2). 
Striking is that the patients with an occlusion of the LAD, receiving anterograde 
cardioplegia are especially in the right upper corner ( Fig. 1), and eight of the ten 
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Fig. 1 A plot comparing the difference in LVSWI {prebypass - five minutes after 
cessation of cardiopulmonary bypass. Δ LVSWI) with the septal temperature (°C) 
reached after infusion of the initial dose of cardioplegia of each patient operated with 
anterograde cardioplegia. 
patients with an occluded LAD, receiving retrograde cardioplegia are situated in 
the left under corner ( Fig. 2). 
The importance of the LAD occlusion was evaluated by a multivariate analysis. 
We found a statistical significant difference in the hemodynamic recovery of the 
left ventricle, five minutes after cessation of cardiopulmonary bypass ( ρ = 
0.012) depending on LAD-status. Therefore, we analysed separately the data of 
patients with an occlusion of the LAD ( anterograde group 9 patients , retrogra­
de group 10 patients). The septal temperature at the moment of the asystole 
( 2 2 . 6 ± 2 . 1 °C versus 1 9 . 3 ± 1 . 1 ° C , p = 0.008) and after infusion of the initial 
dose cardioplegia <17.2±2.1°C versus 1 3 . 5 ± 2 . 1 ° C , p = 0.005) was significant 
higher in the anterograde group. 
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Fig. 2 A plot comparing the difference in LVSWI (prebypass - five minutes after 
cessation of cardiopulmonary bypass. Δ LVSWI) with the septal temperature (°C) 
reached after infusion of the Initial dose of cardioplegia of each patient operated with 
retrograde cardioplegia. 
The recovery of the hemodynamics of these patients were summarized in table 
IV. Before bypass there was no significant difference between the MAP, PAP, 
PCWP of both groups, whereas there were significant differences for these 
values in the immediate postoperative period. In the immediate postoperative 
period, the patients operated with anterograde delivery of cardioplegie solution, 
showed a significant increase of the RAP, as in the whole group, but here now 
also the MAP was significantly (p = 0.0003) lower. In the two groups, heart rate 
increased, however not significantly and peripheral vascular resistance was 
significantly decreased after bypass, as in the whole group. In both groups the 
cardiac index, five minutes after cessation of bypass, was higher than the basic 
values, but the increase did not reach statistical significance. The left ventricular 
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Table IV. Hemodynamic data of patients with an occluded LAD 
HR" (beats/min) 
MAP* (mm Hg) 
RAP' (mm Hg) 
PAP" (mm Hg) 
PCWP· (mm Hg) 
Q' (l/min) 
Ql" (l/min/m2) 
SI" (ml/beat/m2) 
LVSWI' (gm.m/mä) 
RVSWI' (gm.m/m') 
SVRIk 
(dynes, sec/cm6) 
PREBYPASS 
ACP 
n - 9 
6 0 . 6 1 7 . 6 
8 1 . 6 1 1 0 . Э 
7 . 7 1 2 . 7 
1 8 . 2 1 4 . 9 
1 0 . 7 1 3 . 7 
4 . 8 1 1 . 0 
2 . 4 1 0 . 6 
4 1 . 1 1 1 0 . 8 
3 8 . 8 1 1 0 . 5 
6 . 1 1 1 . 8 
1 9 7 8 1 8 0 0 
RCP 
n = 10 
5 7 . 6 1 8 . 7 
7 6 . 6 1 6 . 5 
7 . 6 1 1 . 3 
1 5 . 4 1 4 . 4 
9 . 1 1 3 . 5 
4 . 7 1 0 . 8 
2 . 4 1 0 . 6 
4 2 . 8 1 7 . 7 
3 8 . 9 1 6 . 5 
5 . 9 1 2 . 6 
2 1 3 5 1 7 9 0 
5 MIN AFTER CESSATION 
ACP 
n = 9 
8 1 . 4 1 1 1 . 7 
S 6 5 . 2 1 1 1 . 1 
S 1 0 . 7 1 2 . 2 
2 0 . 7 1 2 . 7 
1 4 . 0 1 2 . 6 
6 . 2 1 1 . 3 
3 . 1 1 0 . 8 
3 9 . 9 1 1 2 . 1 
2 7 . 3 1 7 . 6 
5 . 1 1 1 . 5 
Ы 2 5 5 1 5 1 0 
RCP 
n = 10 
7 7 . 2 1 1 1 . 8 
7 5 . 8 1 6 . 7 * / 
5 . 5 1 2 . 4 * 
1 5 . 3 1 4 . 4 * 
9 . 6 1 3 . 1 « 
5 . 4 1 1 . 1 
2 . 8 1 0 . 6 
3 7 . 2 1 6 . 6 
3 3 . 3 1 4 . 5 * # 
5 . 0 1 1 . 9 
£ 1 4 2 0 1 4 6 0 
ACP= anterograde delivery of cardioplegia, RCP= retrograde delivery of cardioplegia. 
Data are expressed as meant standard deviation. 
a: heart rate, b: mean arterial blood pressure, c: mean right atrial pressure, d: mean 
pulmonary artery pressure, e: mean capillary wedge pressure, f: cardiac output, g: cardiac 
index, h: stoke index, i: left ventricular stroke index, j : right ventricular stroke index, k: 
systemic vascular resistance. 
• = ρ < 0.05 ACP versus RCP 
U = ρ < 0.05 ACP (pre-five minutes after cessation) versus RCP (pre-five minutes after 
cessation) 
& = ρ < 0.05 versus preoperative value 
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stroke work index was significantly different between both groups (p = 0.04) in 
the postoperative period, with a decrease in the anterograde group to 71 % of 
its control value, versus 85% in the group operated with retrograde delivery of 
cardioplegia (p = 0.012). In neither group there was a significant change in the 
right ventricular stroke work index before and after the operation. In Fig. 3 and 
Fig. 4, filling pressure and stroke work are represented in the classical diagram 
as proposed by Sarnoff (9). 
LVSWI (gm.m/m2) 
5 10 15 
PCWP (mmHg) 
• before bypass • 5 min. after bypass 
Fig. 3 A plot of the relation between left ventricular stroke work Index (LVSWI) and 
wedge pressure (PCWP) before bypass and five minutes after bypass of each patient 
operated with anterograde delivery of cardioplegia. 
In seven of the nine patients operated with anterograde delivery of cardioplegie 
solution (Fig. 3) there is a decrease of the left ventricular stroke work index 
with an increase of the wedge pressure. Contrasting with only two of ten pa-
97 
tients operated with retrograde delivered cardioplegia (Fig. 4) 
LVSWI (gm.m/m2) 
10 15 
PCWP (mmHg) 
о before bypass D 5 min. after bypass 
Fig. 4 A plot of the relation between left ventricular stroke work index (LVSWI) and 
wedge pressure (PCWP) before bypass and five minutes after bypass of each patient 
operated with retrograde delivery of cardioplegia. 
Analysis of the data of the patients without occlusion of the LAD, did not show 
a significant different preservation of the LVSWI between anterograde and 
retrograde delivery of cardioplegia. 
The release of the cardiacspecific enzyme CK-MB was not different between 
group A and group B, nor between both groups with an LAD-occlusion (Fig. 5). 
In all patients the clinical outcome was excellent. There was no mortality and no 
perioperative infarction. Three patients, two in the retrograde and one in the 
anterograde group, showed signs of low cardiac output. It were the same 
patients who needed positive inotropic support after weaning from bypass. 
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CK-MB(U/L) 
TIME (hours) 
anterograde delivery l l i i l retrograde delivery 
Fig. 5 Release of CK-MB isoenzyme in the first 24 hours postoperatively of the patients 
with an occlusion of the LAD. The data represent mean values ± standard deviation. 
Preoperatively all patients had a regular sinus rhythm, that returned postoperati-
vely either after defibrillation or spontaneously. No rhythm disturbance and 
technical problems due to delivery of cardioplegie solution were noted. 
Discussion 
Critical coronary artery stenoses and occlusions may result in ¡nhomogene-
ous distribution of anterogradely delivered cardioplegia and, consequently, poor 
local myocardial cooling (10,11). Experimental and clinical studies have shown 
an increase in myocardial energy needs in these jeopardized areas and a 
depression of the left ventricular function following reperfusion (12-14). Direct 
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anterograde graft perfusion can circumvent this limitation of anterograde 
delivery of cardioplegie solution, but with the increasing use of the internal 
mammary artery as graft this becomes technically impossible (2). In these 
situations retrograde cardioplegie administration via the coronary venous 
system, that is unaffected by atherosclerosis, is a valuable alternative strategy. 
With the experimental work of Partington (3,4) and the development of techni-
ques (15) for blind cannulation of the coronary sinus there is a renewed interest 
in the use of retrograde delivery of cardioplegie solution in myocardial revascula-
rization. 
In our study, we could not show better preservation of left ventricular myocard-
ial function with retrograde cardioplegia for the whole group. However, the 
preservation of the left ventricular function is significantly better with retrograde 
cardioplegia, when there is an occlusion of the LAD. In case of an occlusion of 
the LAD the left ventricular stroke work index decreased to 85% of the initial 
value when the patients received retrograde delivery of cardioplegia versus 7 1 % 
of the initial value when cardioplegia was anterogradely delivered. In the 
majority of patients with anterograde administration of the cardioplegie solution 
a decrease of LVSWI was accompanied by an increase in PCWP, while, on the 
contrary, in most patients with retrograde administration the ( smaller) decrease 
in LVSWI was accompanied by a decrease in PCWP. This observation suggests 
a better preservation of left ventricular contractility in patients with retrograde 
administration. This conclusion is, however, only valid if PCWP reflects left 
ventricular diastolic volume. An increase in PCWP may also be elicited by 
impaired relaxation or increased stiffness of the left ventricular myocardium, 
occurring in patients treated via the anterograde way. To further elucidate this 
question, volume derived indices should be studied in the future, for instance 
using esophageal echocardiography in the operation room. The observed 
decrease of the left ventricular stroke work index is comparable to a decrease in 
left ventricular myocardial performance that we noticed in our previous clinical 
trial (16) and other studies (6,17,18). 
The superior preservation of the left ventricular function in this retrograde 
group, as observed in this study for patients with a LAD-occlusion is caused to 
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a certain extent by patient selection and the extensive use of the internal 
mammary artery as bypass. This patient group approximates the experimental 
model of Partington (3,4),total occlusion of the LAD versus ligation of the LAD 
in the experimental setup. Previous clinical trials (5-7) were not conclusive, but 
in none of these studies there was extensive coronary pathology, and also the 
internal mammary artery was not extensively used as graft. Fiore (5) described a 
mean of 2.9 diseased vessels in his study, so we suppose that also patients 
with less than three vessel coronary artery disease are included. In addition, 
only 65% of the patients received internal mammary arteries as graft. In 
Guiraudon's study (6) the severity of coronary artery disease is not mentioned, 
neither if revascularization was done with the internal mammary artery. The 
importance of the extension of the coronary artery disease is clearly showed in 
our study, where multivariate analysis showed that LAD-occlusion is an essent-
ial variable in the distribution of cardioplegia. However, in our study with a 
limited number of patients, it was not possible to analyze at what degree of 
coronary artery disease, retrograde delivery of cardioplegia becomes superior to 
anterograde. On the other hand, in the study of Diehl (7), all patients had 
isolated three vessel coronary artery disease, and the internal mammary artery 
was used for 80% of the patients, but that study was flawed because each 
patient received an initial dose of cardioplegia through the aortic root. The fact 
that in our study, additional cardioplegia was administered down the vein grafts, 
and topical slush was used in all patients, may possible have reduced the 
difference in left ventricular preservation between antero and retrograde delivery 
of cardioplegia. In practice, however, we must ambiate optimal myocardial 
protection, and it should be incorrect not to use the possibility of delivering 
cardioplegia through vein grafts and topical cooling in both groups. 
We did not take myocardial biopsies, but it has been shown that in patients 
with three vessel disease and a significant stenosis in the left anterior descen-
ding coronary artery the preservation of energy-rich phosphates during ischemic 
cardiac arrest is better with retrograde than with anterograde cardioplegia (19). 
It is known that a decrease in high-energy phosphates is a trigger for a sequen-
ce of events leading to cell death. Better preservation of energy rich-phosphates 
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results in improved tolerance of ischemia and can prevent postischemic myocar-
dial dysfunction (20). 
The postoperative right ventricular stroke work index was not statistically 
different between the pre- and post-bypass situations in both groups. This is in 
contrast with the result of the experimental study of Partington (3,4), though 
we hypothesize that the less favorable protection of the right ventricle in dogs 
may be related to the anatomically difference in venous drainage of the right 
and left ventricle between dogs and humans. Anatomic studies in dogs (21) 
have shown that most of the right ventricle and the posterior part of the 
interventricular septum are not drained by the coronary sinus. The cardiac 
venous drainage, in humans, however, seems to be more balanced (22). The 
good distribution over the heart by the venous system is confirmed by excellent 
cooling of the entire heart by retrograde cardioplegia (23) and by application of 
radionuclide techniques (24). In the clinical setting this has been confirmed by 
several studies (5,6,25). Delay in cardiac arrest is described as a major disad-
vantage of retrograde delivery of cardioplegia (5). In our study we did not note a 
significant difference in the time to reach asystole between both groups. This is 
in contrast with Fiore (5) who reported times of 30 and 75 seconds in the 
anterograde and retrograde groups to achieve electromechanical arrest. In the 
retrograde group our time to achieve asystole is comparable, in the anterograde 
group our time is much longer, which is certainly related to the extent of the 
coronary artery stenoses in our patients. The good distribution of retrograde 
cardioplegia in cases of coronary artery occlusion is confirmed by significant 
lower septal temperature at the moment of asystole and after delivery of the 
total doses of the cardioplegie solution in the group with a LAD-occlusion. The 
total doses of cardioplegia is significant higher in group B, which is also related 
to the facility to give retrograde cardioplegia during the performance of the 
distal anastomoses. Especially when sequential grafts were constructed with 
the internal mammary artery, and during testing for leakage of a side to side 
anastomosis the grafted myocardial area shows little fibrillations, it is easy to 
infuse retrograde cardioplegia without interrupting the procedure. 
With the blind cannulation of the coronary sinus, the principal limitation of the 
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open technique, namely bicaval cannulation.caval snares and an atriotomy for 
visualization of the coronary sinus, are circumvented. There were no problems 
during cannulation and decannulation of the coronary sinus in our study, but our 
experience with this technique in previous patients has certainly contributed. 
The good clinical outcome in both groups is certainly also related to our patient 
selection. That the patients are young is a consequence of the aim to have a 
patientgroup with extensive ( bilateral) use of the internal mammary artery as 
graft. That we did not include patients with an ejection fraction < 0.30, has to 
do with ethical reflections. Acute patients are even excluded, because the 
problem of myocardial protection and revascularization of an acute ischemic 
myocardial region is related to several factors and not only the anatomical 
occlusion of a coronary artery. 
Although the clinical outcome in both groups of patients was excellent, early 
functional recovery of the left ventricular function in patients with an occluded 
LAD operated with retrograde delivery of cardioplegia was better. This obser-
vation correlates with the experimental results obtained by the group of Parting-
ton and Buckberg (3,4). Our results are certainly related to the design of the 
study, patient selection, and surgical strategies. 
We conclude that retrograde delivery of cardioplegia provides better myocardial 
protection in patients with three vessel coronary artery disease including 
occlusion of the LAD whom are subjected to myocardial revascularization with 
extensive use of the internal mammary artery. In addition, we conclude that 
occlusion of the LAD is a determinating factor in prohibiting anterograde delivery 
of cardioplegia. 
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Chapter VI 
RETROGRADE CORONARY SINUS CARDIOPLEGIA IN MYOCARDIAL 
REVASCULARIZATION: HEMODYNAMIC EVALUATION OF THE INFLUENCE 
ON THE RIGHT-VENTRICULAR FUNCTION 
Luc Noyez, M.D., Jacques A.M. van Son, M.D., Tjeerd van der Werf, M.D., 
Johannes T.A. Knape, M.D., Jules Gimbrère, M.D., Wim N.J.C, van Asten, 
Ph.D., Leon К. Lacquet, M.D., Wim Flameng, M.D. 
(The Thoracic and Cardiovascular Surgeon 1992;40:209-13) 
Abstract 
The problem of the efficacy of right ventricular protection with retrograde 
coronary sinus cardioplegia is studied. Sixty patients undergoing myocardial 
revascularization were prospectively assigned to receive cold St.Thomas'Hos-
pital cardioplegia into the aortic root (30 patients) or retrogradely in the corona­
ry sinus (30 patients). The two groups were similar concerning preoperative and 
operative data. The hemodynamic recovery postoperatively was good in both 
groups, the increase of the heart rate, the decrease of the mean aortic pressure 
and the right ventricular stroke work index were not significantly different in the 
two groups. However, right atrial pressure increased significantly (p < 0.001) in 
patients who received anterogradely cardioplegia and decreased not significantly 
in the retrograde group. These data suggest that the decrease of the right 
ventricular stroke work index in the anterograde group is related to a depressed 
contractility and in the group with retrograde delivery of cardioplegia to a 
decreased preload. There were no differences between the groups with respect 
to clinical outcome. We conclude that retrograde delivery of cardioplegia results 
in an excellent protection of the right ventricular function in elective myocardial 
revascularization. 
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Introduction 
Adequate distribution of cardioplegie solution in the myocardium is a 
prerequisite for optimal myocardial protection. Critical coronary artery stenoses 
and occlusions may result in inhomogeneous distribution of anterogradely 
delivered cardioplegia and, consequently, poor local myocardial protection (1). 
Although direct anterograde graft perfusion can circumvent this limitation, 
increasing use of the internal mammary artery as graft makes this technically 
impossible (2). In such circumstances retrograde administration of cardioplegie 
solution through the coronary venous system, that is unaffected by atheroscle­
rosis, is a valuable alternative strategy. Experimental studies have shown that in 
the presence of coronary artery occlusions, retrograde cardioplegia results in 
better myocardial cooling and more complete recovery of left ventricular 
function, with varying recovery of right ventricular function (11,12). None of 
the clinical studies on the subject of the use of retrograde cardioplegia in 
myocardial revascularization focus on the problem of right ventricular protection 
(3-5). In this paper we compare the recovery of right ventricular function in 
patients with three vessel coronary artery disease undergoing myocardial 
revascularization with extensive use of the internal mammary artery. 
Material and methods 
Patient population 
Sixty patients undergoing myocardial revascularization were the subject of 
this study. All patients had three vessel coronary artery disease. Exclusion 
criteria for the study were: reoperation, combined procedure, poor left ventricu­
lar function (ejection fraction < 0.30) and emergency aorta-coronary bypass 
grafting (evolving myocardial infarction, ischemia not responding to medical 
therapy, cardiogenic shock). In all patients at least one internal mammary artery 
was used as graft, either single or sequential, with bilateral use of the internal 
mammary artery in 80% of the patients. The patients were randomized into two 
groups: group A (n = 30) who received anterograde cardioplegia and group В 
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(η = 30) who received retrograde cardioplegia. Ethical approval and informed 
consent was obtained. 
Table I shows the preoperative data. 
Table I. Preoperative patient data 
parameter group A 
n = 30 
Male/female 
Age (years) 
B.S.A. (ma) 
NYHA 
Obesity 
Hypertension 
Diabetes 
Hyperlipidemia 
group В 
n = 30 
23/7 
57.3±8. 
34-6S 
1.94±0. 
1.6-2. 
3.1±0. 
2-4 
θ 
13 
5 
10 
1 
1 
15 
1 
59 
25/5 
56.118.1 
37-69 
1.8810.10 
1.6-2.4 
3.110.5 
2-4 
6 
14 
3 
12 
There were no significant inter-group differences 
Group data are expressed as mean ± standard deviation and range 
BSA = Body Surface Area 
NYHA = New York Heart Association classification 
Obesity was defined as presence of more than 10% overweight; diabetes, when 
there was a positive glucose tolerance test, peroral antidiabetic medication or 
insulin dependency. Hypertension was defined as a systolic blood pressure 
above 160 mm Hg or a diastolic pressure exceeding 100 mmHg. Hyperlipidemia 
was defined as a cholesterol level higher than 6.4 mmol/l, or a triglyceride level 
higher than 2 mmol/l. All previous medication, such as nitrates, Ca++-entry 
blockers, beta-blockers, was continued until midnight before the operation. 
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Surgical technique 
A standardized anesthetic technique was used, with intravenously adminis-
tered fentanyl (60 ¿/g/kg.) for anaesthesia, pancuronium{0.1 mg/kg.) for muscle 
relaxation, and midazolam(0.07 to 0.1 mg/kg/min) for maintenance of anesthe-
sia. A Swan-Ganz catheter (Baxter Healtcare Corp., Edwards Division, Irvine, 
Calif.) was introduced into the pulmonary artery via the internal jugular vein. All 
operations were performed by one surgeon (L.N.) to reduce variability arising 
from different surgeons. The distal anastomoses were performed during a single 
period of crossclamping, proximal anastomoses were performed using a partial 
occluding clamp. Standard bypass techniques were used with a Cobe С M.L.­
Excel and Maxima membrane oxygenator, a roller pump (Cobe BCT, Inc., 
Lakewood, Colo.), systemic hypothermia with rectal temperature of 28°C, and 
moderate hemodilution. Myocardial protection was performed by intermittent 
infusion of cold 4 °C St.Thomas'Hospital cardioplegie solution (300ml/m2) or 
until asystole occurred, and maintained by reinfusion of 100 ml/m2 solution 
every 25-30 minutes or earlier as needed. In group A the cardioplegie solution 
was infused into the aortic root with a pressure of ± 1 0 0 mm Hg, whereas in 
group В retrograde cardioplegie solution was delivered retrogradely. The 
coronary sinus was cannulated transatrially as described by Gundry (7). A 
Gundry RSCP cannula with obturator (DLP, Ine, Grand Rapids, Michigan) or a 
Buckberg cannula (Research Medical, Ine, Salt Lake City, Utah) was used. In 
both groups an additional dose of cardioplegia (25ml) was infused through the 
venous grafts, which in all patients were constructed first. Coronary sinus 
pressure never exceeded 50 mm Hg. In all patients a left ventricular vent was 
inserted through the right superior pulmonary vein. All patients were cooled to 
a core temperature between 26°C and 28°C and slushed ice was used as 
topical cooling. Myocardial septal temperatures were registered at the moment 
of asystole and after infusion of the total doses of cardioplegia. 
Before weaning the patient off extracorporeal circulation, rewarming was 
initiated to a rectal temperature of 35 °C and the hematocrit was increased to a 
minimum value of 0.24 L/L. Intravenous fluid therapy was aimed at achieving 
filling pressures which were optimal for the actual myocardial performance, 
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using frequent determinations of cardiac filling pressures and calculations of 
stroke work index and cardiac index. The aortic cannula was left in place until 5 
minutes after cessation of cardiopulmonary bypass. When the patient remained 
hemodynamically stable, protamine hydrochloride was given to antagonize 
heparin and cannulas were removed. 
Indices that were used for evaluation of myocardial protection 
Recovery of cardiac function: systolic (SAP), diastolic (DAP) and mean 
arterial (MAP) blood pressure, mean right atrial pressure (RAP), mean pulmonary 
artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), and heart 
rate (HR) were monitored in all patients. Cardiac Output (Q) was measured 
using the thermodilution technique. Derived hemodynamic indices were calcula-
ted as follows: 
Cardiac Index (Ql) = Q/Body Surface area (L/min/m2) 
Stroke Index (SI) = QI/HR (ml/beat/m2) 
Left Ventricular Stroke Work Index 
(LVSWI) = SKMAP-PCWP1.0.0136 (gm.m/m2) 
Right Ventricular Stroke Work Index 
(RVSWI) = SI(PAP-RAP).0.0136 (gm.m/m2) 
The hemodynamic parameters were measured after induction of anesthesia, five 
minutes after cessation of cardiopulmonary bypass, and 6 hours postoperatively 
in the intensive care unit. 
Clinical outcome 
Incidence of myocardial infarction: intraoperative myocardial infarction was 
defined as the development of a new Q-wave or a CPK-MB% > 10%, or both. 
Incidence of low cardiac output: low cardiac output (LCO) was defined as the 
need for inotropic support (dopamine need increasing 4//g/kg/minute for at least 
12 hours) or as cardiac index below 2.2 l/min/m2. 
Incidence of rhythm and conduction disturbances: preoperative and postoperati-
ve electrocardiograms were compared and special attention was given to the 
appearance of atrioventricular conduction disturbances. 
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Statistical Analysis 
Quantitative data were analyzed with the paired Students't test or a 
Wilcoxon test when appropriate. A p-value less than 0.05 indicates a difference 
unlikely to be due to chance alone. Results were presented as mean values ± 
standard deviation. 
Results 
The intraoperative data are shown in table II. The mean time to reach 
asystole was longer in the group with retrogradely delivered cardioplegia than in 
the group with anterogradely delivered cardioplegia although this difference did 
not reach statistical significance. Septal temperature registration at the moment 
of asystole and after infusion of the initial dose of cardioplegia was not signifi­
cantly different between the various subgroups. 
The recovery of hemodynamics is summarized in table III. Comparing the 
prebypass values with those obtained immediately and 6 hours after bypass we 
observed an increase of the heart rate, a decrease of mean aortic pressure, and 
a decrease of the right ventricular stroke work index, which were not signifi­
cantly different. Although there was no statistically significant difference in the 
hemodynamic recovery of the right ventricular function immediatly after bypass, 
right atrial pressure increased significantly (p < 0.001) in the patients who 
received anterogradely cardioplegia and decreased, not significantly (p = 0.07), 
in patients in whom the retrograde technique was used. This resulted in a 
statistical difference of the right atrial pressure between group A and В imme­
diately after bypass. 6 Hours after bypass there was no more statistically signifi­
cant difference. Correlating the filling pressures and the stroke work we have 
an impression of the preservation of the right ventricular contractility as 
proposed by Sarnoff (9) ( fig.1). In patients who received anterograde delivery 
of cardioplegia there is a decrease of the right ventricular stroke work Index 
with an increase of the right atrial pressure, based on a depression of the right 
ventricular contractility. In patients with retrogradely delivered cardioplegie 
solution the decrease of the right ventricular stroke work index is combined with 
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Table II. Intraoperative patient data 
Parameter group A group В 
n = 30 n = 30 
57.5±27.5 
26-148 
20.Θ12.3 
17-24 
16.4±3.1 
12-19 
120.1128.4 
65-165 
80.2113.8 
48-98 
3.110.3 
3-4 
5.211.1 
4-7 
3.510.5 
3-4 
74.2126.9 
32-121 
18.312.3 
18-22 
14.912.8 
12-18 
127.8125.7 
78-165 
79.1110.6 
63-98 
3.210.4 
3-5 
4.611.0 
4-7 
3.310.6 
2-5 
There were no significant inter-group differences 
Group data are expressed as mean ± standard deviation and range 
asystole time: time to reach asystole, asystole temp.: septal 
temperature at the moment of asystole, myocard. temp: septal tempera­
ture after infusion of the initial dosis of cardioplegia, distal IMA-
anst.: distal anastomoses performed with the internal mammary artery. 
Group A: anterograde; group B: retrograde application 
a decrease of the right atrial filling pressure. The decrease of the right ventricu­
lar stroke work index in this group is partially related to a decreased preload and 
less to a depressed contractility. Statistical analysis of the individual differences 
in the right atrial filling pressure prebypass and immediately postbypass (group 
A: + 1.7 ± 0.7 versus group B: -1.4 ± 1.0) was significant (p < 0.001), 
although the individual decrease of the right ventricular stroke work index was 
Asystole time (sec) 
Asystole temp. (°C) 
Myocard. temp (°C) 
Bypass time (min) 
Cross-clamp time (min) 
Number of grafts 
Distal anastomoses (No.) 
Distal IMA-anast. (No.) 
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not significant ( group A: -1.2 ± 0.6 versus group B: -0.9 ± 0.5, ρ = 0.16). 
Clinical outcome was good. There was no mortality and no perioperative 
infarction. Three patients, two in the retrograde and one in the anterograde 
group, showed signs of low cardiac output. Preoperatively all patients had a 
regular sinus rhythm, which returned postoperatively either after defibrillation or 
spontaneously. 
RVSWI ( g m . m/m2) 
7 
6 
5 
4 
L·// I I I I I • • I I 1 I I 
5.5 6 6.5 7 7.5 8 8.5 9 9.5 10 10.5 11 
RAP (mmHg) 
• A • A1 ο Β α BÌ 
Fig. 1 Relationship between right ventricular stroke work index (RVSWI) and right atrial 
pressure (RAP). 
A: group A before bypass. A,: group A five minutes after cessation of cardiopulmonary 
bypass. B: group В before bypass, B,: group В five minutes after cessation of cardiopul­
monary bypass. 
Data are shown as mean ±standard deviation. 
~ = * ^ 
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Discussion 
Our study shows a better preservation of the right ventricular contractility 
with retrograde delivery of cardioplegie solution than with anterograde delivery, 
although this resulted not in statistical significant difference in the performance 
( stroke work) of the right ventricle. 
The good preservation of the right ventricular function, stroke work index, with 
retrograde delivery of cardioplegia has been confirmed in other clinical studies 
(3-5) and also in the study of Menasene concerning patients undergoing isolated 
aortic valve replacement (9), but is in contrast with experimental data of 
Partington (11.12), who showed superior cooling, protection and recovery of 
the left ventricular function but a poor distribution and an inconstant recovery of 
the right ventricular function when retrograde delivery of cardioplegie solution 
was used. This discrepancy between the clinical efficacy of coronary sinus 
cardioplegia in preserving right ventricular function and the experimental 
observations made in dogs may be due to several factors. First, the venous 
drainage of the right and left ventricle is different in dogs and humans. Anatomi-
cal studies in dogs have shown that most of the right ventricle and the posterior 
part of the interventricular septum are not drained by the coronary sinus, but by 
anterior cardiac veins that empty directly into the right atrium by separate 
orifices (15). In humans the cardiac venous drainage, however, seems to be 
more balanced (8). The blood from the right ventricular wall is not only drained 
through the anterior right ventricular veins, which enter directly into the right 
atrium, but also via the left coronary vein, the posterior interventricular vein, 
and the small cardiac veins, which directly enter into the coronary sinus. The 
veins of the posterior part of the interventricular septum are connected with the 
veins of the anterior part of the septum and drain into the left coronary vein. 
The balanced venous distribution in the human heart is also confirmed by 
excellent cooling of the heart after retrograde delivered cardioplegie solution 
(10) and by application of radionuclide techniques (9). This anatomical differen-
ce between the human and canine heart is certainly a reason for the inferior 
right ventricular protection in dogs. A second factor that may influence the 
116 
venous distribution in the human heart is coronary arterial atherosclerosis. 
Postmortem studies on human hearts with atherosclerotic lesions in the corona-
ry arteries showed a uniform and rich venous vascularization in the subendocar-
dial zone of both ventricles as compared with normal hearts (13). The fact that 
there is a better preservation of the right ventricular contractility in the group 
with retrogradely delivered cardioplegia suggests that this factor may be 
important. That the observed advantage in preservation of right ventricular 
contractility is not correlated with a statistically significant difference in the 
recovery of the right ventricular performance is due to the increased preload, 
compensating the decreased contractility, in the group who received anterogra-
de cardioplegia. But also other factors are important in the clinical setting. The 
use of topical cooling contributes to right ventricular preservation (10), and the 
revascularization of the right coronary artery may be important. In our operation 
strategy we prefer to revascularize the left ventricle with the internal mammary 
artery graft.In this study, in only one patient a dominant right coronary artery 
was grafted with an internal mammary artery, whereas the other patients 
received venous grafts. Infusion of cardioplegie solution through such venous 
grafts may further blurr the differences of retrograde delivery of cardioplegie 
solution versus the anterograde technique. 
We conclude that in the clinical setting the use of retrograde delivered cardiople-
gie solution in myocardial revascularization did not result in a less superior 
protection of the right ventricular function. Contrariwise, depending on the 
extent of atherosclerosis, and thus development of venous collateral circulation, 
retrograde delivery of cardioplegie solution results in a better protection of right 
ventricular contractility. 
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Appendlx:Retrograde versus antegrade cardioplegia: impact on right ventricular 
function (letter to the editor) 
L. Noyez, M.D., T. van der Werf, M.D. 
(The Annals of Thoracic Surgery (in press)) 
To the Editor 
In their article Douville and associates (1) compare the effects of anterogra­
de and retrograde delivery of cardioplegia on the preservation of the right 
ventricular (RV) function. Correlating filling pressures and the stroke work, as 
proposed by Sarnoff (2), we deduct from the results of the study of Douville 
(fig.1) that in the group operated with retrograde delivered cardioplegia, there is 
an increase of the RVSWI with a decrease of the right atrial pressure (RAP), 
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suggesting an increased contractility of the RV. In the group with anterograde 
delivered cardioplegia, the increased RVSWI is combined with an increased RAP, 
suggesting a decreased contractility of the RV. This is confirmed 30 minutes 
after bypass, showing a significant RV dilation in the anterograde group 
compared with the retrograde group. Their results are in accordance with those 
of our hemodynamic evaluation of RV function in myocardial revascularization 
with either anterograde or retrograde delivery of cardioplegia (3). 
R V S W I (dynes.s/cm5.m2) 
5.5 6 6.5 7 7.5 8 8.5 
RAP (mmHg) 
10 
4 OB DB, 
Fig. 1 Relationship between right ventricular stroke work Index (RVSWI) and right atrial 
pressure (RAP). A: group with anterograde delivery of cardioplegia before bypass. A,: 
five minutes after bypass. B: group with retrograde delivery of cardioplegia before 
bypass, B,: five minutes after bypass. Data are shown as mean ± standard error of the 
mean. 
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Notwithstanding the seeming concordance, the tonality of the conclusion is, 
however, different. Douville et al state: "Except for a minor advantage of 
retrograde cardioplegia early after bypass, these results suggest that the right 
ventricular protection during myocardial revascularization is similar with retrogra-
de and antegrade cardioplegia". We have stated: "Retrograde delivery of 
cardioplegie solution results in a better protection of the right ventricular 
contractility"(3). It is especially this last word: "contractility", upon which we 
want to stress in this comment. 
We constantly have to critically examine the questions underlying a study, 
compared to the thoughts and expectations in our minds. The general ( and 
remote) question underlying both studies is: "Which way of delivery of the 
cardioplegie solution gives the least morbidity and mortality?". In the context of 
the very low morbidity and mortality of coronary artery bypass surgery in 
general, one has to study hundreds or thousands of patients for this purpose. 
This must be ascribed to the nearly inexhaustible adaptative resources of the 
heart, and more specifically of the ventricles, which can compensate for a 
temporary or permanent decrease in contractility by adaptations of preload, 
afterload and heart rate. This leads to the conclusion that the question stated 
above, only can be solved with enormous effort and over many years. Therefore 
the question may be restricted to: "Which way of delivery of the cardioplegie 
solution leads to preservation of the primary quality of the myocardium: "con-
tractility", without the necessity of the recruitment of adaptative mechanisms?" 
If the latter question can be answered, one may suppose by inference that the 
answer might be relevant to the first question. 
We demonstrated that right ventricular stroke work index remained preserved 
after bypass equally well in both groups, however, in the anterograde group at 
the cost of significantly higher filling pressures ( adaptive mechanism of the 
preload) compared to the normal filling pressures in the group with retrograde 
delivery of cardioplegie solution. The results of Douville point in the same 
direction but do not allow statistical confirmation due to the greater variability. 
This explains the difference in tonality: Douville states that both techniques 
provide the same results and we state that with retrograde delivery contractility 
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is better preserved, not necessitating the right ventricle to recruit compensatory 
mechanisms. Our conclusion may lead to the tought that retrograde cardioplegia 
is really better than anterograde. 
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Chapter VII 
THE IMPORTANCE OF THE CORONARY COLLATERAL CIRCULATION FOR THE 
DISTRIBUTION OF ANTEROGRADELY AND RETROGRADELY DELIVERED 
CARDIOPLEGIC SOLUTION IN AORTO-CORONARY BYPASS SURGERY 
Luc Noyez, M.D., Jacques A.M. van Son, M.D., Tjeerd van der Werf, 
M.D..Johannes T.A. Knape, M.D., Jules Gimbrère, M.D., Wim N.J.C, van 
Asten, Ph.D., Leon К. Lacquet, M.D., Wim Flameng, M.D. 
(submitted) 
Abstract 
The importance of coronary collateral circulation for homogeneous distribu­
tion of anterograde and retrograde delivery of cardioplegia was evaluated in 36 
patients undergoing myocardial revascularization. All patients had three vessel 
coronary artery disease, with a stenosis of the right coronary artery of at least 
80%. The patients were randomized into two groups: group A (n = 19) received 
anterograde and group Β (η = 17) received retrograde cardioplegia. Both groups 
were further subdivided depending on the pathology of the right coronary 
artery, as evaluated on preoperative coronary angiography. In group A, (n = 8) 
and group B, (n = 7) there was no visualization of collateral circulation from the 
left to the right coronary arterial system, whereas in group A2 (n = 11 ) and group 
B2 (n = 10) there was retrograde filling of the right coronary artery by collateral 
circulation. Right atrial pressure increased significantly (p <0.05) in group A, 
and increased also, but not significantly ( ρ = 0.07) in group A2. On the other 
hand right atrial pressure decreased in both subgroups of group B. Analysis of 
the individual differences in the right atrial filling pressure showed statistical 
significance between the two subgroups (group B,: -1.0 ± 0.5 versus group 
B2 -1.8 ± 1.1, ρ <0.05), although the individual decrease of the right ventricu­
lar stroke work index was not significant. We conclude that collateral circulation 
is important for an adequate distribution of anterogradely delivered cardioplegia 
and is also beneficial in case of retrograde delivery of cardioplegie solution. 
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Introduction 
Adequate distribution of cardioplegie solution in the myocardium is a 
prerequisite for optimal myocardial protection. Critical coronary artery stenoses 
and occlusions may result in inhomogeneous distribution of anterogradely 
delivered cardioplegia and consequently poor local myocardial protection 
resulting in poor recovery of the ventricular function (1-3). In anterograde 
delivery of cardioplegie solution the presence of collateral circulation combined 
with coronary artery stenoses may be important in the distribution of cardiople-
gia in jeopardized myocardium. Retrograde delivery of cardioplegia via the 
coronary venous system, which is known to be unaffected by atherosclerosis, is 
a valuable alternative strategy to circumvent such inhomogeneous distribution 
(4,5). However, the degree of development of venous vascularization seems to 
be related to the extent of the atherosclerotic lesions in the coronary arteries 
(6). 
In this clinical study we evaluated the importance of collateral circulation in the 
distribution of anterogradely and retrogradely delivered cardioplegie solution. 
Because there are numerous potential collateral pathways in atherosclerotic 
hearts we focus this study on the collateral circulation between the left and 
right coronary arterial systems in patients with three vessel coronary artery 
disease undergoing myocardial revascularization. 
Material and methods 
Patient population 
Thirty six patients undergoing myocardial revascularization were the 
subject of this study. All patients had three vessel coronary artery disease with 
a right coronary arterial stenosis of at least 80%. Exclusion criteria for the study 
were: reoperation, combined procedure, poor left ventricular function (ejection 
fraction < 0.30), and emergency aorto-coronary bypass grafting (evolving 
myocardial infarction, ischemia not responding to medical therapy, and cardioge-
nic shock). Patients with an occlusion of the left anterior descending coronary 
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artery (LAD) were also excluded. The patients were randomized into two 
groups: group A (n = 19) received anterograde cardioplegia and group Β (η = 17) 
received retrograde cardioplegia. Both groups were further subdivided based on 
the pathology of the right coronary artery, as evaluated on preoperative corona­
ry angiography. In group A, (n = 8) and group B, (n = 7) there was no visualiza­
tion of collateral circulation from the left to the right coronary arterial system, 
whereas in group A2 (n = 11) and group B2 (n = 10) there was retrograde filling 
of the right coronary artery by collateral circulation during visualization of the 
left coronary arterial system. In all patients at least one internal mammary artery 
was used as graft, either in a single or sequential fashion, with bilateral use of 
the internal mammary artery in 80% of the patients. Ethical approval and 
informed consent was obtained. 
Table I shows the preoperative data. There were no significant inter-group 
differences. 
Table I. Preoperative patient data 
parameter 
Male/female 
Age (years) 
B.S.A. (mJ) 
NYHA 
Obesity 
Hypertension 
Diabetes 
Hyperlipidemia 
group A, 
n = 8 
6 / 2 
5 6 . 3 ± 8 . 2 
34-6Θ 
1 . 9 3 1 0 . 1 5 
1 . 6 - 2 . 1 
3 . 1 1 0 . 5 
2 - 4 
1 
2 
2 
2 
group A, 
n = n 
1 0 / 1 
5 7 . 4 1 8 . 3 
3 6 - 6 9 
1 . 9 4 1 0 . 1 6 
1 . 9 - 2 . 1 
3 . 1 1 0 . 6 
2 - 4 
3 
3 
2 
3 
group B, 
n - 7 
5 / 2 
5 6 . 4 1 8 . 1 
3 7 - 6 9 
1 . 9 1 1 0 . 1 1 
Ι . β - 2 . 2 
3 . 1 1 0 . 6 
2 - 4 
1 
2 
0 
2 
group B, 
n=10 
β/2 
5 6 . 3 1 Θ . 2 
4 1 - 6 5 
1 . 8 5 1 0 . 0 8 
1 . 7 - 2 . 2 
3 . 1 1 0 . 6 
2 - 4 
3 
2 
1 
2 
Group data are expressed as mean ± standard deviation 
B.S.A. = Body Surface Area 
NYHA = New York Heart Association 
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Obesity was defined as presence of more than 10% overweight; diabetes, when 
there was a positive glucose tolerance test, peroral antidiabetic medication or 
Insulin dependency. Hypertension was defined as a systolic blood pressure 
above 160 mm Hg or a diastolic pressure exceeding 100 mm Hg. Hyperlipe-
mia was defined as a cholesterol level more than 6.4 mmol/l, or a triglyceride 
level more than 2 mmol/l. All preoperative medication, such as nitrates, Ca++-
entry blockers, and beta-blockers, was continued until midnight before the 
operation. 
Surgical technique 
A standardized anesthetic technique was used, with intravenously adminis-
tered fentanyl (60//g/kg) for anesthesia, pancuronium (0.1 mg/kg) for muscle 
relaxation, and midazolam (0.07 to 0.1 mg/kg/min) for amnesia. A Swan-Ganz 
catheter (Baxter Healthcare Corp., Edwards Division, Irvine, Calif.) was introdu-
ced into the pulmonary artery via the internal jugular vein. All operations were 
performed by one surgeon (L.N.) to reduce variability arising from different 
surgeons. The distal anastomoses were performed during a single period of 
crossclamping and the proximal anastomoses with use of a partial occluding 
clamp. Standard bypass techniques were used with a Cobe C.M.L.-Excel and 
Maxima membrane oxygenator, a roller pump (Cobe BCT, Inc., Lakewood, 
Colo.), systemic hypothermia with rectal temperature of 28°C, and moderate 
hemodilution. Myocardial protection was performed by initial infusion of cold 
(4°C) St.Thomas'Hospital cardioplegie solution (300ml/m2) or until asystole 
occurred and was maintained by reinfusion of 100 ml/m2 solution every 25-30 
minutes or earlier as needed. The cardioplegie solution was infused into the 
aortic root with a pressure of ±100 mm Hg, or retrogradely by a coronary sinus 
cannula (4,5). Coronary sinus pressure never exceeded 50 mm Hg. An additio-
nal dose of cardioplegia (25ml) was infused through the venous grafts, which 
were constructed first in all patients. A left ventricular vent was inserted 
through the right superior pulmonary vein. Slushed ice was used as topical 
cooling. 
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Before weaning the patient off extracorporeal circulation, rewarming was 
initiated to a rectal temperature of 35°C and the hematocrit was increased to a 
minimum value of 0.24 L/L. Intravenous fluid therapy was aimed to achieve 
cardiac filling pressures which were optimal for myocardial performance, using 
frequent determinations of cardiac filling pressures and calculations of stroke 
work index and cardiac index. The aortic cannula was left in place until 5 
minutes after cessation of cardiopulmonary bypass. When the patient remained 
hemodynamically stable protamine hydrochloride was given to antagonize 
heparin and cannulas were removed. 
Indices that were used for evaluation of myocardial protection. 
Recovery of cardiac function: systolic (SAP), diastolic (DAP) and mean 
arterial (MAP) blood pressure, mean right atrial pressure (RAP), mean pulmonary 
artery pressure (PAP), pulmonary capillary wedge pressure (PCWP), and heart 
rate (HR) were monitored in all patients. Cardiac Output (Q) was measured 
using the thermodilution technique. Derived hemodynamic indices were calcula-
ted as follows: 
Cardiac Index (Ql) = Q/Body Surface Area (L/min/m2) 
Stroke Index (SI) = QI/HR (ml/beat/m2) 
Left Ventricular Stroke Index (LVSWI) = SI(MAP-PCWP).0.0136(gm.m/m2) 
Right Ventricular stroke Work Index (RVSWI) = SI(PAP-RAP).0.0136(gm.m/m2) 
The hemodynamic parameters were measured after induction of anesthesia, five 
minutes after cessation of cardiopulmonary bypass, and 6 hours postoperatively 
in the intensive care unit. 
Clinical outcome 
The development of an intraoperative or early postoperative myocardial 
infarction was defined as the presence of a new Q-wave or a CPK-MB% 
a 10%, or both. 
Low cardiac output was defined as the need for inotropic support (dopamine 
need increasing 4//g/kg/minute for at least 12 hours) or as cardiac index below 
2.2 l/min/m2. 
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incidence of rhythm and conduction disturbances: preoperative and postope­
rative electrocardiograms were compared and special attention was given to the 
appearance of atrioventricular conduction disturbances. 
Statistical Analysis 
Quantitative data were analyzed with the paired Students't test or Wil-
coxon test when appropriate. A p-value of 0.05 or less indicates a difference 
unlikely to be due to chance alone. Data were expressed as mean values ± the 
standard deviation. 
Results 
The intraoperative data are shown in Table II. 
Table II. Intraoperative patient data 
parameter group A, group A2 group B, group B2 
n = 8 n = l l n=7 n=10 
16.013.1 
12-19 
120.1±28.6 
65-160 
80.2113.θ 
50-90 
3.1±0.3 
3-4 
5.111.0 
4-5 
3.510.3 
3-4 
16.212.9 
12-1β 
119.8128.6 
68-165 
80.3114.0 
45-98 
3.110.4 
3-4 
5.211.0 
4-7 
3.510.5 
3-4 
14.912.6 
12-18 
127.5128.8 
78-160 
78.3112.1 
63-89 
3.110.4 
3-4 
4.610.8 
4-7 
3.210.5 
2-4 
14.812.7 
12-18 
128.1129.: 
84-165 
78.8110 
65-98 
3.410.8 
3-4 
4.510.9 
4-6 
3.310.6 
2-5 
Group data are expressed as mean ± standard deviation 
Myocard. temp.: septal temperature after infusion of the initial dose of 
cardioplegia; AOX: aortic cross clamp time; distal IMA-anast.: distal 
anastomoses performed with the internal mammary artery 
12a 
Myocard. temp.(°) 
Bypass time (min) 
AOX time (mini 
Number of grafts 
Distal anast. (No) 
IMA-anast. (No) 
There was no statistically significant difference between the groups and 
subgroups. 
The hemodynamic data of the patients operated with anterograde delivery of 
cardioplegia ( A1 and A2) is summarized in Table III. Comparing the prebypass 
values with those obtained immediately after bypass, we observed an increase 
of the heart rate, a decrease of the mean aortic pressure, and a decrease of the 
right and left ventricular stroke work index, which were not significantly diffe­
rent. Although there was no statistically significant difference in the hemodyna­
mic recovery of the right ventricular function immediately after bypass, the right 
atrial filling pressure increased significantly (p <0.05) in patients without 
collateral circulation to the right coronary artery whereas the increase in right 
atrial filling pressure was not significant (p = 0.07) in patients with such 
collateral circulation. 
The hemodynamic data of the patients operated with retrogradely delivered 
cardioplegia ( B, and B2) is summarized in Table IV. The heart rate, mean aortic 
pressure, and right and left ventricular stroke work indices show the same trend 
as in the anterograde subgroups. However, the right atrial filling pressure 
decreased in both subgroups operated with retrograde delivery of cardioplegia, 
although this did not reach statistical significance ( B, versus Β,1 ρ =0.08; B2 
versus B2' ρ = 0.09). There was no statistically significant difference in the 
hemodynamics among the different subgroups, 6 hours after cardiopulmonary 
bypass. 
Correlation of the right atrial filling pressure with the stroke work index provides 
a parameter for the preservation of the right ventricular contractility as proposed 
by Sarnoff (7). In patients in whom cardioplegia was delivered anterogradely 
there was a decrease of the right ventricular stroke work index with an increase 
of the right atrial pressure, based on a depression of the right ventricular 
contractility. In patients without collateral filling of the right coronary artery the 
need of an increased preload was significantly higher than in patients with 
collateral circulation to the right coronary artery suggesting a less superior 
preservation of the right ventricular contractility in the former group. 
In patients in whom cardioplegie solution was delivered retrogradely the 
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decrease of the right ventricular stroke work index was combined with a 
decrease of the right atrial filling pressure. The decrease of the right ventricular 
stroke work index in this group is partially related to a decreased preload and 
less to a depressed contractility, suggesting superior myocardial protection with 
retrograde delivery of cardioplegia versus anterograde delivery. The individual 
difference in the right atrial filling pressure prebypass and immediately postby-
pass was significantly different in both subgroups: group B,: -1.0 ± 0.5 versus 
group B2 -1.8 ± 1.1, ρ < 0.05. The individual decrease of the right ventricular 
stroke work index, however, was not significantly different: group B,: -0.7 ± 
0.3 versus group B2: -1.0 ± 0.3, ρ > 0.05. This data suggest that in the 
subgroup with collateral circulation to the right coronary artery there is better 
preservation of the right ventricular contractility than in the subgroup without 
such collateral circulation. 
In both groups the clinical outcome was excellent. There was no mortality and 
no perioperative myocardial infarction. One patient of the retrograde subgroup 
(B,(, had a transiently low cardiac output. Both pre-and postoperatively, all 
patients had a regular sinus rhythm. 
Discussion 
This study demonstrates that the hemodynamic recovery of the right 
ventricle in patients subjected to myocardial revascularization may be influenced 
by the technique of delivery of the cardioplegia and by the presence or absence 
of collateral circulation supplying the right coronary arterial bed. 
The relationship between coronary artery stenosis and poor myocardial protec­
tion is well known (1-3). In a previous paper we have described superior preser­
vation of the right ventricular contractility with retrograde delivery of cardiople­
gia (5). This study focuses on the relationship between the presence or absence 
of collateral circulation to the right coronary artery and preservation of right 
ventricular function in two groups of patients who either received anterograde 
or retrograde cardioplegia. Because occlusion of the LAD prohibits anterograde 
delivery of cardioplegia (4), patients with an occlusion of the LAD were exclu-
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ded in this trial. 
When cardioplegie solution is delivered anterogradely in patients with severe 
mul ti vessel coronary artery disease, it can obviously only reach the jeopardized 
myocardium by means of the collateral circulation. Because collaterals are 
formed only distal to a coronary arterial obstruction, however, such circulation 
results in a considerably fall-off in perfusion pressure and flow. Therefore, 
maintenance of a sufficiently high infusion pressure of anterogradely delivered 
cardioplegia is essential for adequate perfusion of the jeopardized myocardial 
areas. In contrast with the findings in the patients who received anterograde 
cardioplegia, the presence or absence of collateral circulation to the right 
coronary artery did hardly influence the preservation of right ventricular function 
in patients who received retrograde cardioplegia. This finding supports the 
observation that in atherosclerotic hearts there is a uniform and rich venous 
vascularization in the subendocardial zone of both ventricles as compared with 
normal hearts (6). Also the current extensive use of the internal mammary 
artery as a graft for revascularization of the left ventricle, when used in combi-
nation with anterograde delivery of cardioplegia, may accentuate the less 
superior preservation of the right ventricular contractility, because the IMA 
prohibits anterograde infusion of cardioplegia through the graft. 
The fact that the observed advantage, in preservation of the right ventricular 
function in the patients in whom retrograde cardioplegia was used, has not 
resulted in a statistically significant difference in the recovery of the right 
ventricular performance, is due to the increased preload in the group of patients 
who received anterograde cardioplegia, thus compensating the decreased 
contractility of the right ventricle. Also other factors, such as the use of topical 
cooling and the use of a venous graft to revascularize the right coronary artery, 
may blurr the differences between both groups and subgroups as discussed in 
our previous report (5). 
Despite the limited number of patients, we conclude that collateral circulation is 
important for an adequate distribution of anterogradely delivered cardioplegia. 
The presence of collateral circulation is also beneficial for myocardial preserva-
tion in case of retrograde delivery of cardioplegie solution, although less appa-
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rent. Consequently we advocate the use of retrograde delivery of cardioplegia in 
patients with three vessel coronary artery disease, who are subjected to aorto-
coronary bypass surgery with extensive use of the internal mammary artery, 
especially when collateral circulation is absent or poorly developed. 
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CHAPTER Vili 
THE BALLOON INFLATION TECHNIQUE TO CONFIRM GOOD PLACEMENT OF 
THE RETROPLEGIA CANNULA 
Luc Noyez, M.D. 
(The Journal of Thoracic and Cardiovascular Surgery (in press)) 
To the editor 
Transatrial cannulation of the coronary sinus, circumventing the need for 
bicaval cannulation, snares and an atriotomy, is an important technical point 
leading to the widespread use of retrograde cardioplegia (1). Several techniques 
for cannulation are described (1,2). Confirmation of the placement is mostly 
obtained by manual palpation of the catheter in the atrioventricular groove 
posteriorly. Other possibilities are the observation of black pulsatile blood in the 
cannula and the registration of a coronary sinus waveform by means of a 
pressure line (1). Black pulsatile blood, however, can also come from the right 
ventricle and the coronary sinus waveform registration can be difficult in 
hemodynamic unstable patients, and do not assure that the balloon, preventing 
backflow of the cardioplegia in the right atrium, is correctly placed in the sinus. 
Confirmation by manual palpation is of course the best method, but in reopera-
tions, where the heart should be handled as little as possible to prevent athe-
roembolism (3), it is mostly impossible to palpate the atrioventricular groove. 
With the "balloon inflation technique" the catheter is inserted into the right 
atrium as described by Gundry (1), then gently pushed into the coronary sinus. 
When we suppose that the catheter is well placed, pressure is monitored and 
the balloon inflated with three to five milliliters of blood or saline solution. By 
correct placement of the catheter, the balloon will obstruct the coronary sinus 
and there will be a rapid rise of the pressure, deflation of the balloon is followed 
by a decline in coronary sinus pressure back to the basic value (fig. 1). When 
the cannula is in the right ventricle, inflation of the balloon will not have any 
consequence for the pressure. In unstable patients, or patients with a very low 
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pressure, where recognition of the coronary sinus waveform is sometimes 
difficult, the increase of the pressure assures the correct placement, not only of 
the tip of the catheter but also of the balloon, and in reoperations, there is no 
need for dissection of the posterior side of the heart. 
This method can be used with the Gundry RCSP catheter (DLP, Ine, Grand 
Rapids, Ml), which has a separate balloon inflation line, but also with the 
ECG 
E 
E 
40 
20 
JL—JL·—J— 
balloon inflation balloon deflation 
Fig. 1 Coronary sinus pressure. Inflation of the balloon in the coronary sinus is followed 
by an increase of the coronary sinus pressure, deflation is followed by a decline back to 
the baseline. 
Buckberg cannula (Research Medical, Ine SU with a self inflatable balloon. After 
withdrawing the stylet, some milliliters of blood or saline are infused in the 
catheter; the catheter is so constructed that the balloon is inflated first (the 
shown registration is done with a Buckberg cannula). 
With this " balloon inflation technique " an easy and usable method for confir-
mation of the correct placement of the retrograde coronary sinus catheter is 
described. 
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Chapter IX 
PRACTICE OF RETROGRADE DELIVERY OF CARDIOPLEGIC SOLUTION IN 
MYOCARDIAL REVASCULARIZATION 
IX. 1 Early results with bilateral internal mammary artery grafting in coronary 
reoperations 
Luc Noyez, M.D., Tjeerd van de Werf, M.D., Douglas P.B. Janssen, M.D., 
Theo J . Klinkenberg, M.D., Gilles L. Kaan, M.D., Wim N.J.C, van Asten, 
Ph.D., Leon К. Lacquet.M.D. 
(The American Journal of Cardiology 1992;70:1113-6) 
Abstract 
In recent years, use of the internal mammary artery (IMA) as first graft of choice 
has been expanded with bilateral and sequential grafts in primary myocardial 
revascularization. The use of bilateral IMA grafts in reoperation has rarely been 
reported. In this study we describe our experience and early results with 
bilateral IMA grafting in 47 patients undergoing coronary reoperation. Hospital 
mortality was 6.3%. Four patients showed postoperative signs of low cardiac 
output and 4 had a perioperative myocardial infarction. In the follow-up 
( 1 8 ± 1 8 months), 2 cardiac related late deaths were noted. 13 patients (29%) 
improved one New York Heart Association Class, 28 (63%) > 1. In 1 of the 44 
surviving patients operation did not result in a decrease of the angina. On basis 
of our early results the bilateral use of the IMA in coronary reoperation seems 
justified. 
Introduction 
The number of reoperations for myocardial revascularization is still increasing. 
The angiographic indication for reoperation evolved from progression of athero­
sclerosis in the native coronary vessels to venous graft failure or a combination 
of both. Furthermore, the interval between the initial operation and the reopera-
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tion increased from 4 to 5 years at the end of the 1970s to 7 to 9 years today 
(1-3). Patients undergoing a coronary reoperation at this moment were mostly 
operated before the worldwide use of the internal mammary artery (IMA) as 
graft, which began after the publication of the study by Loop et al in 1986 (4). 
Because a third or fourth reoperation is possible, but with a progressively 
increasing risk, "maximal surgery" should be performed at reoperation. The best 
conduits available should be used, and there is no question regarding the 
superiority of the IMA's (4-8). The use of a single IMA in reoperations is 
common (1-3,9-12). However, the use of bilateral IMA grafts has been seldom 
described and occasionally mentioned in larger series (1,10,13-15). In this study 
we describe our experience and early results using bilateral IMA grafts in 47 
patients undergoing a reoperation. 
Material and methods 
Patient Population: Between January 1987 and December 1991, 206 
coronary reoperations were performed in our department. All pre-, peri-, and 
postoperative data were registered in the coronary databank Coronary Surgery 
Databank-Radboud Hospital "CORRAD". In 47 patients (23%) the revasculariza-
tion was performed with both IMA's and supplemental vein grafts. Table I 
presents preoperative data of the total group and the 47 patients with bilateral 
IMA grafting ( bilateral IMA-group). Obesity was defined as presence of > 10% 
overweight; diabetes mellitus, when there was a positive glucose tolerance test, 
peroral antidiabetic medication or insulin dependency. Hypertension was defined 
as a systolic blood pressure > 160 mm Hg or a diastolic pressure > 100 mm 
Hg. Hyperlipemia was defined as a total cholesterol level > 250 mg/dl (6.4 
mmol/l) or triglyceride level > 200 mg/dl (2 mmol/l). Poor left ventricular 
function is noted when ejection fraction was below 0.35. No significant 
difference could be shown between the bilateral IMA-group and total group. 
1 4 2 
ТаЫе I. Comparison of preoperative variables 
Bilateral 
IMA Group Total Group 
Variables (n = 47) (%) (n - 206) (%) 
Sex 
Men 
Women 
Age (mean ± SD) (year) 
Range 
Obesity ( > 1 0 % above ideal weight) 
Diabetes mellitus 
Systemic hypertension 
Total cholesterol > 250 mg/dl 
or triglyceride level > 200 mg/dl 
Cigarette smoking 
Family history of cardiovascular 
disease 
Peripheral vascular atherosclerosis 
Poor left ventricular function 
Myocardial infarction 
Before first operation 
Between first and reoperation 
Mean interval ( ± SD) between 
operations (mos.) 
IMA = internal mammary artery. 
Indications for reoperation: The clinical indication for reoperation in all 
patients was angina at least New York Heart Association class III despite 
medical therapy with ß-blockers, Calcium antagonists and/or nitrates. 14 
patients of the total group and 3 patients of the bilateral IMA-group underwent 
emergency aorta-coronary bypass grafting ( evolving myocardial infarction, 
ischemia not responding to medical therapy, cardiogenic shock). The angiogra-
32 (68) 
15 (32) 
S 9 . 0 ± 9 . 4 
40-76 
17 (36) 
9 (19) 
40 (85) 
31 (66) 
38 (81) 
44 (93) 
17 (36) 
12 (25) 
35 (74) 
10 (21) 
96±52 
137 (66) 
70 (34) 
6 0 . 0 1 9 . 1 
38-78 
90 (43) 
45 (21) 
164 (80) 
143 (68) 
179 (86) 
184 (89) 
64 (32) 
44 (21) 
136 (67) 
40 (19) 
84±46 
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phic indication for reoperation is summarized in table II. 
Indication for bilateral use of the internal mammary artery as graft: Over 
the 5 years studied, there is an increasing incidence of bilateral IMA-use in 
reoperations, from 18% (7/40) in 1987 to 5 1 % (28/54) in 1991. That surgeons 
decisions are variable is well known: in 1991 there was a statistical significant 
(p < 0.05) variability of 0% to 75% (24/34) bilateral IMA-use in reoperations 
per surgeon. 
In 4 of the 47 patients we were obliged to use both IMA's because of lack of 
suitable graft material. In the other patients the surgeon was free to choose 
whether or not to use both IMA's. 
Table II. Angiographic Indication for Reoperation 
Bilateral 
IMA Group Total Group 
Indication (n - 47) (%) (n - 206) (*) 
Graft failure 12 (25.5) 35 (18) 
Progression of atherosclerosis in 2 ( 4 . 7 ) 14 ( 6 . 7 ) 
native coronary vessels 
Late oraft failure and progression 33 (69.β) 157 ( 7 5 . 3 ) 
of atherosclerosis in native 
coronary vessels 
IMA = internal mammary artery. 
Surgical technique: The sternum was longitudinally opened with an 
oscillating saw and the aorta and right atrium were identified. Subsequently, 
both internal mammary arteries were harvested, synchronously with the 
necessary length of saphenous vein. After adequate heparinization the ascen­
ding aorta was cannulated and a two stage cannula was inserted in the right 
atrium for venous return. A left ventricular vent was inserted through the right 
superior pulmonary vein. First the patient was cooled to a core temperature of 
1 4 4 
30°C and the heart was further dissected free, then the patient was further 
cooled to a core temperature between 26°C and 28°C and slushed ice was 
used as topical cooling. Myocardial protection during aortic cross-clamping was 
accomplished with infusion of cold (4°C) St.Thomas 'Hospital cardioplegia until 
asystole occurred and maintained by reinfusion of 100ml/m2 solution every 25-
30 minutes or earlier as needed. In 40 patients (85%) cardioplegia was delive­
red retrogradely by means of a coronary sinus cannula (16); in the others 
cardioplegia was delivered anterogradely. This is significantly different ( ρ < 
0.05) with the whole group where only 28% (58/206) received retrograde 
cardioplegia. 
For the group of patients operated with bilateral use of the IMA, the mean 
bypass time was 147 ± 51.2 minutes ( range 80 - 300 minutes) , and the 
mean duration of aortic cross-clamping was 82 ± 32.9 minutes ( range 32 -
185). There was a mean of 3.6± 1.0 distal anastomoses ( range 2-7). 
The left IMA-grafts with either single or sequential distal anastomoses were 
constructed to anterior side in 55% (26/47) and in 45% (21/47) to the lateral 
side of the heart. The right IMA-grafts,single or sequential, in 45% (21/47) to 
the anterior, in 43% (20/47) to the lateral side, with the pedicle placed through 
the transverse sinus and in 10% (5/47) to the right coronary artery. One (2%) 
right IMA-graft, a sequential to the obtuse marginal artery and the circumflex 
artery, was used as a free graft. 
Patient Follow-up: Postoperative data were obtained from the coronary 
artery surgery databank "CORRAD". Follow-up information was collected from 
cardiologists and by telephone interview with the patients. 
Statistical analysis: Data were analyzed with the paired Students't-test or a 
Wilcoxon test when appropriate. Significance was assumed at ρ s 0.05. 
Results were represented as mean values ± standard deviation. 
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Results 
Only the results of the patients operated with bilateral use of the IMA are 
presented. The results are evaluated by mortality, hospital morbidity and follow-
up. 
Mortality: The hospital mortality was 6.3 % (3/47). The first death, a 
female of 68 years, had been subjected to a reoperation using both mammary 
arteries and the right gastroepiploic artery. She did well until she died on the 
fifth day postoperatively because of uncontrollable rhythm disturbances, 
followed by ventricular fibrillation. Autopsy showed patent grafts and no 
evidence of myocardial infarction. The second death was a 65-year-old man, 
who had been revascularized with both mammary arteries and 2 venous grafts. 
Peroperatively there were problems with a calcified aorta. One hour postoperati­
vely his electrocardiogram suddenly showed signs of severe ischemia. Subse­
quent resuscitation was unsuccessful. Autopsy showed dissection of the 
ascending aorta and myocardial infarction. The third death was a 51-year-old 
man, who showed postoperatively low cardiac output, despite inotropic support 
and the use of an intra aortic balloon pump. He died the second postoperative 
day due to a low cardiac output syndrome. Autopsy showed a massive myo­
cardial infarction. 
Table III. Postoperative Morbidity (bilateral internal mammary artery group; 
η = 47) 
Variable No.of Pts. 
Reoperation for bleeding 2 
Ventilatory support > 3 days 3 
Sternal wound problems l 
Renal failure without dialysis 2 
Renal failure with dialysis 1 
Intraaortic balloon pump 2 
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Hospital Morbidity: Table III presents the postoperative morbidity. Four 
patients showed a low cardiac output syndrome (more than 4;/g/kg dopamine 
per minute for at least 12 hours) and 4 patients ( 8.5%) showed a perioperative 
myocardial infarction ( defined as new postoperative Q waves or T-waves 
changes accompanied by elevated cardiac enzymes). 
Follow-up: The follow-up of the 44 hospital survivors was complete. The 
mean duration was 18 ±18 months (range 1 - 5 8 months). Two patients died 
during the follow-up period. Both patients died in the first 6 months after the 
operation; their death was cardiac related. With exception of 1 patient, all the 
other patients improved; 13 patients (29%) improved one New York heart 
Association class, 28 patients (63%) > 1 . Additionally the patients were asked 
for sternal wound problems. No patient had serious complaints about the 
sternotomy wound; 2 patients occasionally had paresthesia lateral of the inci-
sion, corresponding with the localization of the harvested IMA pedicle. 
Discussion 
In the present study we describe our experience with 47 patients under-
going a coronary reoperation with use of both internal mammary arteries. The 
selection of these patients is of course a point of discussion. By comparing the 
preoperative data of the total group with the group receiving bilateral IMA grafts 
we could not demonstrate any statistical significant difference concerning risk 
factors. We will not negotiate that in the first years, there was a selection of 
"good candidates" for bilateral IMA use. However, there has been an increase of 
bilateral IMA-use over the years, and the last year the indication for bilateral 
IMA use in reoperations seems more "surgeon dependent" than patient depen-
dent. That we did not extend this comparison for the operative data and the 
results is because there is a significant difference in the way of delivery cardio-
plegie solution between the total group and the bilateral IMA group. The pro-
blems with anterograde delivery of cardioplegia due to the complex anatomy of 
myocardial blood supply in patients undergoing reoperations is an important 
factor influencing the high perioperative myocardial infarction rate and cardiac 
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related mortality (1). The use of retrograde cardioplegia, delivered via the 
venous coronary system, not affected by atheroscelosis, providing better 
myocardial protection, certainly when there is extensive use of the IMA's as 
graft (17,18), can influence the perioperative morbidity and mortality. Further-
more, we did not compare the results of the bilateral IMA group with a compu-
ter-matched reference group of primary operations as Galbut (13). We are 
convinced that specific problems, as myocardial protection, possibility of 
embolization of debris from atherosclerotic veins, vessel identification, and lack 
of bypass conduits resulting in incomplete revascularization in reoperations are 
so determinant for the results (1,3,19,20) of reoperations, that comparison with 
primary operations is only justified in larger series. The operative mortality is 
comparable with previous reports using bilateral IMA's for revascularization in 
reoperations (1,13,14), and also with the mortality ( 4%-8%) of larger series of 
reoperation (1,3,19). The operative morbidity in reoperations is higher than in 
primary operations (1,19), and the most important parameter involved is the 
perioperative myocardial infarction. The incidence of perioperative myocardial 
infarction ( 8.5%) in our serie is similar to other reports (1,11,13,19), as are the 
incidence of low cardiac output and the other parameters mentioned in table III. 
The prolonged assisted ventilation in three patients may be related to impaired 
phrenic nerve function liable to the use of slushed ice. 
No special problems were encountered, during the dissection of the IMA's. 
Because in most patients the pleuras were not opened at the first operation, 
there were no adhesions, interfering with harvesting the IMA's. Even in patients 
where there were adhesions, they did not hinder the use of the IMA's. In 
patients where there was lack of suitable graft material, preoperative asses-
sment of the IMA is advisable. Preferably, the IMA's should be visualized 
angiographically, alternatively, duplex imaging is a suitable technique in the 
preoperative anatomic and physiologic assessment of the IMA (21). 
The follow-up was short, but produced good results. Two late deaths were 
cardiac related and occurred in the first six months after the operation. Because 
the postoperative patency rate of an isolated IMA graft in reoperations is 
comparable with the results in primary revascularization (10,22) long-term 
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follow-up results may be excellent. After surgery, no major sternal wound 
complications were found; 1 patient underwent a sternal re fixation. In this 
patient there was a clear relationship between coughing and the development of 
the sternal instability. Wound complications due to bilateral IMA use is uncertain 
and in several reports even contradicted (23,24). That some patients mentioned 
vague pain, paresthesia lateral of the sternum , corresponding with the place of 
the harvested IMA-pedicle, ¡s a phenomenon due to nerve damage during 
harvesting the IMA, which normally disappears after several months. 
Because repeat coronary artery bypass operation using bilateral IMA- grafts can 
be done with a normal operation risk, and the survival and functional improve-
ment is comparable with patients undergoing a primary revascularization using 
the bilateral IMA's, we conclude that bilateral IMA grafts are the grafts of first 
choice in coronary reoperations. 
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IX.2 Initial clinical results of myocardial revascularization with the internal 
mammary artery for evolving myocardial infarction 
Luc Noyez, M.D., Gilles Kaan, M.D., Leon К. Lacquet, M.D. 
(Submitted) 
Abstract 
In ten patients undergoing emergency revascularization for an evolving 
myocardial infarction, the internal mammary artery (IMA) was used as graft. To 
bridge the time needed for harvesting the IMA, the left ventricle was totally 
decompressed by means of the extracorporeal circulation. Cardioplegia was 
delivered retrogradely, in order to have a good distribution in the jeopardized 
area. Operative mortality was 0 % , and one patient showed a postoperative 
myocardial infarction. This initial results suggest that, with an adapted operative 
strategy, even in emergency revascularization the IMA can be used as graft. 
Introduction 
The internal mammary artery (IMA) is the first graft of choice in elective 
myocardial revascularization. There is a superior early and long-term patency 
rate compared with venous conduits, and patients with an IMA graft to the left 
anterior descending coronary artery, show an improved long-term survival, 
reduction in rate of reoperation, and late cardiac events, compared with patients 
who received a venous graft to the left anterior descending coronary artery. 
Recently it is suggested that there is even an improved freedom from coronary 
artery interventional therapy when two IMA grafts were used (1,2). In the 
clinical setting of an evolving infarction, early revascularization limits infarct 
size, enhances functional recovery and may be lifesaving (3,4). As time con­
straints in this situation, most surgeons prefer to use the saphenous vein, 
because of its shorter harvesting time. 
In this report we describe our initial results with the use of the IMA in emergen­
cy coronary bypass surgery. 
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Material and Methods 
Patients: Ten patients with an evolving myocardial infarction undergoing 
coronary artery bypass surgery with the use of the IMA are included in this 
study. Myocardial infarction was defined as prolonged chest pain associated 
with Pardee waves on the ECG, which persisted despite maximal antianginal 
therapy (3) [a Pardee curve is defined as an ST elevation of 2 mm or more in a 
standard lead, or 3 mm or more in a precordial lead]. All patients developed this 
Pardee waves during their hospital stay, in four patients the evolving myocardial 
infarction was related to a failed percutaneous transluminal coronary angioplas-
ty. The mean age of the patients ( nine men, one woman) was 64 ± 7 ( range 
58 - 68) years. In four patients there was single vessel disease, in two patients 
two vessel, and in four patients three vessel disease. Three patients were 
preoperative^ in cardiogenic shock, defined as a systolic blood pressure below 
80 mm Hg, although, no patients in this study needed cardiac massage. All 
patients were revascularized within six hours after the onset of symptoms. 
Surgical technique: after median sternotomy and adequate heparinization, 
the ascending aorta was cannulated, a two stage cannula was inserted into the 
right atrium for venous return, and the extracorporeal circulation was started. A 
left ventricular vent was inserted through the right superior pulmonary vein, and 
a cannula for retrograde delivery of cardioplegia was introduced into the 
coronary sinus as described by Gundry (5). The patient was initially cooled to a 
core temperature of 30°C and the IMA was harvested. Subsequently, the 
patient was further cooled to a core temperature between 26°C and 28°C and 
slushed ice was used as topical cooling. Myocardial protection was accom-
plished with retrograde infusion of St.Thomas'Hospital cardioplegia until 
asystole occurred and was maintained by reinfusion of 100 rnl/m2 solution every 
25-30 minutes or earlier as needed. 
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Indices that were used for evaluation: 
-Enzyme release: at 1,3,6,12 and 24 hours postoperatively venous blood 
samples for determination of creatinekinase isoenzyme (CK-MB) were taken (6). 
-Incidence of myocardial infarction: Intraoperative myocardial infarction was 
defined as the development of a new Q-wave or a CPK-MB%&10%, or both. 
-Incidence of low cardiac output: Low cardiac output (LCO) was defined as the 
need for inotropic support ( Dopamine need increasing 4//g/kg/minute for at 
least 12 hours) or as a cardiac index below 2.2 l/min/m2. 
-Incidence of rhythm and conduction disturbances. Preoperative and postopera-
tive electrocardiograms were compared, and the incidence of new rhythm or 
conduction disturbances were noted. 
-Postoperative morbidity and mortality. 
Results 
The mean bypass time was 69 ± 10 minutes ( range 48 - 98 minutes), 
and the mean duration of aortic cross-clamping was 25 ± 9 minutes ( range 14 
- 68). The mean time between the start of the bypass and the placement of the 
aortic cross clamp was 14 minutes ( range 12 - 19). This time can be conside-
red as the time needed for harvesting the IMA. There was a mean of 1.6 grafts 
( range 1-3) and a mean of 2.1 distal anastomoses (range 1 - 5). The IMA was 
used in 9 patients as graft to the left anterior descending coronary artery ( 4 
times sequential with the diagonal branch) and one to the circumflex coronary 
artery. 
In all patients there was a fade away of the ST elevation during left ventricular 
decompression, and no problems were encountered during harvesting the IMA, 
The release of the CK-MB is summarized in fig 1. In one patient there was a 
CPK-MB> 10%, he also developed a new Q-wave, this is the only patient with 
a postoperative myocardial infarction as defined. One patient showed postope-
ratively a bundle branch block and another nonspecific ST-segment changes. 
Two patients showed a low cardiac output syndrome, one of them was the 
patient with the myocardial infarction. There was no postoperative mortality. In 
one patient a postoperative pneumothorax develloped. 
CK-MB (U/L) 
60 , 
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Fig. 1 Release of CK-MB Isoenzyme in the first 24 hours postoperatively. The data 
represent mean values ± standard deviation. 
Discussion 
The superiority of the IMA as graft in myocardial revascularization is out of 
discussion (1,2). Also the benefits of early revascularization, and of reperfusion 
of an acutely ischemic myocardium are not the subject of this discussion (3,4). 
The problem by using the IMA as graft in emergency coronary bypass grafting is 
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related to the prolonged ischemic period of the myocardium during harvesting 
the IMA. In situations where distal reperfusion could be reestablished preoperati-
ve^ with a transluminal reperfusion catheter the IMA can be used. However, 
this is only possible in special situations, as post-(failed)-angioplasty (7). To 
bridge the time needed for harvesting an IMA, we place the patient on cardio-
pulmonary bypass with left ventricular decompression. The effectiveness of left 
ventricular decompression during ischemia, with reduction of the ST elevation , 
has also been described (8,9). Total left heart decompression minimizes the left 
ventricular oxygen demands and is superior to aortic counterpulsation (10) and 
left atrial decompression (11) by limiting the extent of myocardial ischemic 
damage. During this period the patient is cooled to a core temperature of 30°C, 
to reduce the myocardial metabolism and the oxygen consumption, reducing the 
process leading to myocardial cell death. 
The use of retrograde delivered cardioplegia is important. It is known that 
coronary artery stenosis and occlusion result in inhomogeneous distribution of 
anterograde delivered cardioplegia and consequently poor local myocardial 
cooling and protection (12). The use of the IMA as graft prohibits anterograde 
infusion of cardioplegia through this graft. Using retrograde delivered cardiople-
gia, there is a homogeneous distribution in the myocardium of cardioplegia, 
through the coronary venous system, unaffected by atherosclerosis, resulting in 
a superior myocardial protection (13-16). 
An interesting and recurrent discussion point, is the flow rate of the IMA graft. 
Initially it was suggested that the flow through an IMA graft was lower than in 
the saphenous vein (17), but several clinical and experimental studies concer-
ning sequential IMA grafts, show that blood flow through an IMA is satisfactory 
for most coronary branches (18,19). In experimental set up it is shown that an 
IMA is capable of substantial early increase in flow and can support the entire 
left coronary circulation, even after acute occlusion of the left main coronary 
artery (20). This experiment, however, was designed to assess the flow in the 
IMA, and not the salveability of the myocardium, also the IMA was already 
anastomosed to the left anterior descending coronary artery prior to ligation of 
the left main. 
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Our results of emergency coronary bypass grafting using the IMA as graft are 
good and comparable with other reports (3,4). Interesting is that the release of 
the CK-MB isoenzyme in this emergency group is higher than the release we 
described in previous reports concerning elective myocardial revascularization 
(15,21). This is demonstrating the severity of the preoperative ischemia. We 
admit that our limited patient group represents a "low-risk" group (3); in the 
"high risk" group, defined as patients with a systolic blood pressure below 70 
mm Hg or necessitating cardiac massage, we did not use the IMA as graft till 
now. In this situation we propose to infuse directly retrograde cardioplegia, so 
that the heart becomes asystolic before harvesting the IMA. Important in this 
cases may be the role of substrate-enriched cardioplegie solutions (22,23), 
retrogradely delivered, as they can reach the ischemic area. Possibly this results 
in a superior recovery of the ischemic tissue than with the left ventricular 
decompression that we use for the moment. 
In conclusion, our preliminary results of myocardial revascularization of an 
evolving myocardial infarction using the IMA, are satisfactory. The small number 
and no control group make it impossible to judge whether or not the internal 
mammary artery grafting in this situation is the preferred method of choice. The 
better understanding of the pathophysiology of ischemic and reperfusion 
damage, and the use of operative strategies, as ventricular decompression, 
retrograde delivery of substrate-enriched cardioplegie solutions, may further 
increase the use of the IMA as first graft of choice even in emergency myocard-
ial revascularization. 
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CHAPTER IX 
SUMMARY AND CONCLUSIONS 
Chapter 1 
After a review of the evolution of myocardial protection in cardiac surgery and a 
historical survey on clinical trials, the objectives of this thesis are outlined: 
1. A comparison of the preservation of left ventricular function in myocardial 
revascularization, using anterograde or retrograde delivery of cardioplegie 
solution. 
2. A comparison of the preservation of right ventricular function in myocardial 
revascularization, using anterograde or retrograde delivery of cardioplegie 
solution. 
Chapter 2 
In part one, the principles of cold crystalloid cardioplegie myocardial protection 
are discussed. 
1. The lowering of the cardiac temperature to reduce the metabolic rate. 
2. The influence of composition of the cardioplegie solution, on cardioplegia, 
membrane stabilization, intracellular ionic changes, prevention of edema, and 
the possibility of substrate enrichment. 
3. The different strategies for distribution and maintenance of cardioplegia. 
In part two a review of the human coronary venous anatomy is provided. With 
increasing interest in retrograde delivery of cardioplegia in cardiac surgery the 
knowledge of the coronary venous vascular system has become more impor-
tant. In atherosclerotic hearts there is a richer venous subendocardial vasculari-
zation as compared with normal hearts. 
In part three, different methods of retrograde delivery of cardioplegie solutions 
are presented. The construction of cannulas, which allowed blind, transatrial 
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coronary sinus cannulation, was essential in the widespread use of the retrogra-
de technique. 
Chapter 3 
In three reports our initial experience with retrograde delivery of cardioplegie 
solution is discussed. 
First, in aortic valve surgery, we describe our experience with retrograde 
delivery of cardioplegie solution in 25 patients. Factors which make retrograde 
delivery of cardioplegia attractive in this patients are the fact that cardioplegia is 
distributed well by the venous system in these frequently hypertrophied hearts 
and that it is unnecessary to interrupt the procedure to infuse cardioplegie 
solution. 
Second, in coronary reoperations, where despite the growing surgical experien-
ce, the most striking problem is the high frequency of perioperative myocardial 
infarction. The complex anatomy of the myocardial blood supply in these 
patients adversely influences homogeneous delivery of cardioplegie solution. 
Therefore, use of retrograde delivery of cardioplegie solution may be favorable 
in coronary reoperations. Our experience with retrograde cardioplegia in 48 
elective reoperations for myocardial revascularization is discussed. 
Third, in a retrospective study, a comparison of left ventricular preservation in 
aortic valve surgery using anterograde and retrograde delivery of cardioplegie 
solution is described. Our hemodynamic data suggest that retrograde delivery of 
cardioplegie solution results in better myocardial preservation than anterogradely 
delivered cardioplegia. The type of our study, done in a retrospective fashion, is 
of course open to the usual criticisms. A prospective study seems to confirm 
our results. The inclusion of combined procedures in this study, may, however, 
blur the conclusion, which aspect is discussed in the subjoined letter to the 
editor. 
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Chapter 4 
In this chapter, the preparation of our clinical trial is discussed. Not only a 
review of the literature is necessary, but also a critical analysis of the own 
possibilities in relation with the goals of the study is needed. The existence of a 
routinely updated databank is essential in this perspective. 
Chapter 5 
The effect of retrograde versus anterograde delivery of cardioplegie solution on 
myocardial function was evaluated in 60 patients undergoing myocardial 
revascularization. All patients had three vessel coronary artery disease, and the 
revascularization was done with extensive use of the internal mammary artery. 
Seventy-five percent of the distal anastomoses was performed with the internal 
mammary artery. Myocardial protection consisted of St.Thomas' Hospital 
cardioplegia, topical slushed ice, and systemic hypothermia (28 °C). The 
patients were randomized in two groups: Group A (n = 30) receiving anterograde 
and group Β (η = 30) receiving retrograde cardioplegia. 
With exception of a higher total dose of cardioplegia (p = 0.02) in patients 
operated with retrograde delivery of cardioplegie solution, and a significant 
increase of the right atrial pressure in the patients operated with anterograde 
delivery in the immediate postoperative period, there was no significant differen­
ce between the two groups concerning septal myocardial temperature, other 
registered hemodynamic parameters ,in the immediate postoperative period, nor 
6 hours later, release of MB creatine isoenzyme, and clinical outcome. 
Multivariate analysis shows that LAD-occlusion (p = 0.012) is an essential 
parameter prohibiting anterograde delivery of cardioplegie solution. Analysis of 
the patients with a LAD-occlusion operated on with use of anterograde (n = 9) 
and retrograde cardioplegia (n = 10) shows a significant difference in the total 
dose of cardioplegia (p=0.02), and septal myocardial temperature at the 
moment of asystole <p = 0.008) and after infusion of the total dose of cardiople­
gie solution (p = 0.015). The mean arterial systolic blood pressure in the 
anterograde group was significantly lower than in the group with retrograde 
delivery of cardioplegia (p = 0.003). Preservation of the left ventricular stroke 
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work index was significantly better in the retrograde group, namely 85% of its 
initial value, versus 7 1 % in the group operated with anterograde delivery of 
cardioplegia ( ρ = 0.012). 
Based on these findings, we conclude 1. that retrograde delivery of cardioplegia 
provides better myocardial protection than anterograde delivery in patients with 
three vessel coronary artery disease including occlusion of the left anterior 
descending coronary artery, who are subjected to myocardial revascularization 
with extensive use of the internal mammary artery, 2. that LAD-occlusion is an 
essential parameter in the non-homogeneous distribution of anterogradely 
delivered cardioplegia. 
Chapter 6 
Experimental studies, in dogs, show inferior cooling, protection, and recovery of 
the right ventricle when retrograde delivery of cardioplegie solution is used. 
There were, however, no signs of right ventricular failure. The difference in 
venous drainage of the right and left ventricle between dogs and humans is 
important. To evaluate the efficacy of right ventricular protection with retrogra­
de coronary sinus cardioplegia, 60 patients undergoing myocardial revasculari­
zation were prospectively assigned to receive cold St.Thomas'Hospital cardio­
plegia into the aortic root { 30 patients) or retrogradely into the coronary sinus 
(30 patients). The two groups were similar concerning preoperative and operati­
ve data. The postoperative hemodynamic recovery was excellent in both 
groups. However, the right atrial pressure increased significantly (p < 0.001) in 
patients who received anterograde cardioplegia and decreased significantly in 
the retrograde group. These data suggest that the decrease of the right ventri­
cular stroke work index in the anterograde group is related to a depressed 
contractility and in the group with retrograde delivery of cardioplegia to a 
decreased preload. Our study indicates that retrograde delivery of cardioplegia 
results in excellent protection of the right ventricular function in elective 
myocardial revascularization. In an appended letter a similar study, which 
confirms our conclusion, is discussed. 
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Chapter 7 
Postmortem investigations on collateral venous circulation in atherosclerotic 
hearts showed that the density of veins is much greater than that of the 
arteries. This finding may be important with regard to homogeneous distribution 
of anterograde or retrograde delivered cardioplegia. Because there are numerous 
potential collateral pathways in atherosclerotic hearts, the study focused on the 
collateral circulation between the left and right coronary arterial system in 36 
patients with three vessel coronary artery disease and with a stenosis of the 
right coronary artery of at least 80%, who underwent myocardial revasculariza­
tion. The patients were randomized into two groups: group A (n = 19) receiving 
anterograde and group Β (η = 17) receiving retrograde cardioplegia. Both groups 
were further subdivided depending on the pathology of the right coronary 
artery, as evaluated on preoperative coronary angiogram. In group A, (n = 8) and 
group B, (n = 7) there was no visualization of collateral circulation from the left 
to the right coronary arterial system, whereas in group A2 (n = 11 ) and group B2 
(n = 10) there was retrograde filling of the right coronary artery by collateral 
circulation. Right atrial pressure increased significantly (p <0.05) in group A, 
and increased Insignificantly ( ρ = 0.07) in group A2. The right atrial pressure on 
the other hand decreased in the patients operated with retrograde delivery of 
cardioplegia. Analysis of the individual differences in the right atrial filling 
pressure showed statistical significance between the two subgroups (group B,: 
-1.0 ± 0.5 versus group B2 -1.8 ± 1.1, ρ <0.05), although the individual 
decrease of the right ventricular stroke work index was not significant. Based 
on these results we conclude that the subgroups with collateral circulation have 
a better preservation of the right ventricular contractility, and that the importan­
ce of this collateral circulation is more pronounced in anterograde delivery of 
cardioplegie solution. 
Chapter 8 
In this chapter the balloon inflation technique to confirm proper placement of 
the retrograde cannula is proposed. With this technique, the position of the 
retrograde coronary sinus catheter is verified by pressure monitoring after 
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inflation of the balloon on the tip of the catheter. This technique is particularly 
useful in coronary reoperations, where the heart should be handled as little as 
possible. 
Chapter 9 
Two reports present situations where the use of retrograde delivery of cardiople-
gie solution may be important. 
First: Coronary reoperations with use of bilateral internal mammary artery as 
graft. 
Due to a more complex coronary circulation, atherosclerotic vein grafts, and 
occluded native arteries, myocardial preservation is more difficult to accomplish 
during reoperation than during a primary operation. The use of the internal 
mammary arteries as graft, precludes perfusion of cardioplegie solution through 
the graft. Retrograde delivered cardioplegia is an appealing solution for this pro-
blem. We describe our experience and early results with bilateral IMA grafting in 
47 patients undergoing coronary reoperation. Hospital mortality was 6.3% ( 3 
patients). Four patients presented postoperative signs of low cardiac output and 
4 had a perioperative myocardial infarction. In the follow-up (18±18 months), 
2 cardiac related late deaths were noted. 13 patients (29%) improved one New 
York Heart Association Class, 28 (63%) > 1. In 1 of the 44 surviving patients 
operation did not result in a decrease of angina. On basis of our early results 
bilateral use of the IMA in coronary reoperation seems justified. 
Second: Myocardial revascularization for evolving myocardial infarction, using 
the internal mammary artery. 
Using retrograde delivery of cardioplegie solution it is possible to provide good 
protection of the regional myocardium distal to an occluded coronary artery. In 
case of an acute occlusion, such protection allows time to harvest the internal 
mammary artery. Our experience in ten patients undergoing emergency revascu-
larization with the internal mammary artery for an evolving myocardial infarction 
is discussed. There was no operative mortality. One patient showed a postope-
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rative myocardial infarction. These initial result suggests that with an adapted 
operative strategy, even in emergency revascularization the IMA can be used as 
graft. 
CONCLUSIONS 
1. Retrograde delivery of cardioplegie solution provides better myocardial 
protection than anterograde delivery in patients with three vessel coronary 
artery disease including occlusion of the left anterior descending coronary 
artery. 
2. The occlusion of the left anterior descending coronary artery is an essential 
parameter in the non-homogeneous distribution of anterograde delivered 
cardioplegie solution. 
3. The use of retrograde delivered cardioplegie solution does not result in 
inferior protection of the right ventricle. 
4. In patients with three vessel coronary artery disease retrograde delivery of 
cardioplegie solution results in a better protection of the right ventricular 
contractility. 
5. In patients with three vessel coronary artery disease, who are subjected to 
aorto-coronary bypass surgery with extensive use of the internal mammary 
artery, retrograde delivery of cardioplegie solution is advocated, especially 
when collateral circulation is absent or poorly developed. 
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SAMENVATTING EN CONCLUSIES 
Hoofdstuk 1 
Na een overzicht van de evolutie van de myocardprotectie ïn de hartchïrurgie en 
een korte historische schets betreffende klinische trials worden de doelstellingen 
van het proefschrift uiteen gezet. 
1. Een vergelijking van het behoud van de linker ventrikel functie tijdens 
myocardrevascularizatie, gebruik makend van anterograde of retrograde 
toediening van cardioplegische vloeistof. 
2. Een vergelijking van het behoud van de rechter ventrikel functie tijdens 
myocardrevascularizatie, gebruik makend van anterograde of retrograde 
toediening van cardioplegische vloeistof. 
Hoofdstuk 2 
In het eerste deel worden de verschillende elementen van de koude crystalloide 
cardioplegie ter bescherming van het myocard besproken. 
1. De myocardkoeling om het energieverbruik te doen afnemen. 
2. De samenstelling van de cardioplegische vloeistof, eventueel met toevoeging 
van energierijke stoffen, resulterend in asystolie, membraan stabilizatie, 
minimale intracellulaire ionen uitwisseling en oedeem verhindering. 
3. De verschillende mogelijkheden van toediening van de cardioplegische 
vloeistof en het behoud van de cardioplegische toestand. 
In het tweede deel, wordt de anatomie van het veneuse systeem van het hart 
beschreven. Belangrijk is dat de veneuse collateraal circulatie in atherosclero-
tische harten veel uitgebreider ontwikkeld is dan in normale gezonde harten. 
In het laatste deel worden de verschillende manieren om retrograad cardioplegie 
toe te dienen besproken. De mogelijkheid om blind, transatriaal een catheter in 
de sinus coronarius te plaatsen, heeft de grote doorbraak van de retrograde 
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cardioplegie mogelijk gemaakt. 
Hoofdstuk 3 
In drie artikels wordt onze eerste ervaring met retrograde cardioplegie bespro-
ken. 
Ten eerste in aortaklepchirurgie. Naast een goede protectie van zowel linker en 
rechter ventrikel, lijkt vooral het feit dat de operatie niet hoeft onderbroken te 
worden voor het toedienen van cardioplegie een chirurgisch interessant aspect 
te zijn. 
Ten tweede in coronaire reoperaties. Juist in deze groep patiënten, is de η ¡et-
homogene verspreiding van de anterograad toegediende cardioplegie een 
belangrijke oorzaak van de hoge morbiditeit en mortaliteit. Onze ervaring met 
retrograad toedienen van cardioplegie bij 48 patiënten wordt besproken. 
Ten derde wordt het hemodvnamisch herstel van de linker ventrikel functie, bij 
aortaklepchirurgie, vergeleken gebruik makend van anterograde of retrograde 
toediening van cardioplegische vloeistof. Met enig voorbehoud, gezien het een 
retrospectieve studie betreft, lijkt er met retrograde toediening van cardioplegie 
een betere bescherming van de contractiliteit van de linker ventrikel te zijn. Onze 
resultaten worden bevestigd door een prospectieve studie. Echter de aanwezig-
heid van patiënten met een gecombineerd aortaklep- en coronairlijden zwakt de 
resultaten van deze studie af. 
Hoofdstuk 4 
In dit hoofdstuk wordt dieper ingegaan op de voorbereiding van de klinische 
trial. Naast een analyze van de probleemstelling, lijkt een kritische analyze van 
eigen mogelijkheden noodzakelijk voor het opzetten van een goede klinische 
trial. Het gebruik van een databank lijkt essentieel. 
Hoofdstuk 5 
De resultaten van onze klinische trial worden besproken. 60 patiënten werden 
gerandomizeerd in twee groepen, groep Α (η = 30) verkreeg anterograad 
St.Thomas 'Hospital cardioplegie, groep Β (η = 30) verkreeg retrograad cardio-
170 
plegie toegediend. Alle patiënten hadden een drietaks coronairlijden, en 75% 
van de distale anastomoses werd aangelegd met een arteria mammaria. 
Met uitzondering van een hogere totale dosis cardioplegie (ρ = 0.02) bij de 
patiënten geopereerd met retrograde cardioplegie, en significante stijging van de 
rechter atrium druk in de direct postoperatieve periode, bij patiënten geopereerd 
met anterograde toediening van cardioplegie, waren er geen significante 
verschillen waar te nemen tussen beide groepen. 
Multivariant analyse (p = 0.012) toonde aan dat een afsluiting van de LAD een 
belemmerende faktor is bij anterograde toediening van cardioplegie. Specifieke 
analyse van de patiënten met een afgesloten LAD (anterograde groep = 9, 
retrograde groep = 10) toont een significant verschil voor verschillende parame-
ters. Totale dosis cardioplegie (ρ = 0.02), septale myocardtemperatuur bij 
asystolie (p = 0.008), myocardtemperatuur na toediening van de totale hoeveel­
heid cardioplegie (ρ = 0.015), alsook de gemiddelde arteriële systolische bloed-
druk waren significant lager in de anterograde groep(p = 0.003). Het behoud van 
de linker ventrikel stroke work index was significant beter in de retrograde groep 
(85% versus 71%, p = 0.012). 
Hieruit besluiten we; 1. dat retrograad toegediende cardioplegie een betere 
myocardbescherming geeft dan anterograde bij patiënten met een afgesloten 
LAD, die myocardrevascularisatie ondergaan met uitgebreid gebruik van de 
arteria mammaria. 2. dat afsluiting van de LAD, een compromitterende faktor is 
bij anterograde toediening van cardioplegie. 
Hoofdstuk 6 
Experimentele studies bij honden, wijzen op het probleem van rechter ventrikel 
falen bij retrograde toediening van cardioplegie. In klinische trials kan men dit 
echter niet terugvinden, doch belangrijk is in dit verband het verschil van 
veneuse drainage bij mens en hond. Bij 30 patiënten geopereerd met antero-
graad toegediende cardioplegie, en 30 met retrograad toegediende cardioplegie 
werd in een prospectief onderzoek het behoud van de rechter ventrikel functie 
vergeleken. Postoperatief werd tussen beide groepen geen verschil gevonden 
qua behoud van rechter ventrikel stroke work index. Echter, in de patiënten-
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groep geopereerd met anterograad toegediende cardioplegìe, was er postopera-
tief een significante stijging van de rechter atrium druk, en een niet-significante 
daling in de retrograde groep. Hieruit besluiten we dat de contractiliteit van de 
rechter ventrikel beter beschermd wordt met retrograde toediening van cardio-
plegie. Dit resultaat werd bevestigd door recent uitgevoerd onderzoek, hetgeen 
in een bijlage wordt besproken. 
Hoofstuk 7 
Gezien postmortem studies aantonen dat naast de arteriale ook de veneuse 
collateraal circulatie uitgebreider is in atherosclerotische harten dan in gezonde 
harten, werd nagegaan in welke mate de verspreiding van de cardioplegie 
afhankelijk is van deze collateralen. Een groep van 36 patiënten, met drietaks 
coronairlijden en een minimale sténose van 80% van de rechter coronair werd 
geopereerd, ofwel met anterograde cardioplegie (η = 19) ofwel met retrograde 
toediening (η = 17). Beide groepen werden verder opgesplitst in functie van de 
collateraal circulatie tussen het rechter en linker coronair systeem. Analyse 
toonde aan dat de groep patiënten geopereerd met anterograde toedienig van 
cardioplegie en een beperkte collateraal circulatie een minder goed behoud heeft 
van de contractiliteit van de rechter ventrikel, dan de anterograde groep met 
uitgebreide collateraal circulatie, en dat de retrograde groep met uitgebreide 
collateraal circulatie het beste behoud van de contractiliteit had. 
Hoofdstuk 8 
In dit hoofdstuk wordt de "ballon opblaas techniek" voor de localisatie van de 
retrograde catheter besproken. Het is een eenvoudige techniek, die steunt op 
drukregistratie na het opblazen van de ballon op de tip van de catheter. Deze 
techniek is vooral handig bij reoperaties, waar men liefst zo weinig mogelijk het 
hart manipuleert. 
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Hoofdstuk 9 
Twee artikels beschrijven situaties waar het gebruik van retrograde cardioplegie 
belangrijk kan zijn. 
1. Coronair reoperaties met gebruik van beiderzijdse arteria mammaria als graft. 
De problematiek van niet-homogene distributie van anterograad toegediende 
cardioplegie bij reoperaties wordt nog versterkt bij uitgebreid gebruik van de 
arteria mammaria als graft, gezien de mogelijkheid om via de graft cardioplegie 
toe te dienen dan vervalt. Retrograde toediening van cardioplegie is een goede 
oplossing. Wij beschrijven onze ervaring met 47 patiënten met bilateraal gebruik 
van de arteria mammaria bij coronair reoperatie. De hospitaal mortaliteit was 
6.3% ( 3 patiënten). 4 patiënten hadden postoperatief een low cardiac output 
syndroom, en 4 een peroperatief myocardinfarct. De follow-up toonde een late 
mortaliteit bij 2 patiënten, bij één patiënt resulteerde de operatie niet in een 
afname van de angina pectoris, bij 41 wel. 
2. Met retrograde cardioplegie, wordt ook het myocard distaal van een arteriole 
afsluiting geperfundeerd. In situaties van een acute afsluiting van een coronair 
arterie, laat dit toe de ischemische myocardzone toch adequaat te beschermen. 
Hierdoor is het mogelijk ook in deze acute situaties, de arteria mammaria te 
gebruiken als graft. Onze eerste resultaten (10 patiënten) toonden geen mortali-
teit en slechts één perioperatief myocardinfarct. 
BESLUITEN 
1. Retrograde toediening van cardioplegie geeft een betere myocard bescher-
ming dan anterograde toediening bij patiënten met drietaks coronairlijden en 
een afsluiting van de ramus descendens anterior. 
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2. Afsluiting van de ramus descendens anterior is een bepalende factor bij de 
niet-homogene verdeling van anterograad toegediende cardioplegie in het 
myocard. 
3. Retrograde cardioplegie toediening resulteert niet in een verminderde be-
scherming van de rechter ventrikel in vergelijking met anterograde cardiople-
gie. 
4. Bij patiënten met drietaks coronairlijden geeft retrograde cardioplegie een 
betere bescherming van de rechter ventrikel contractiliteit. 
5. Bij patiënten met drietaks coronairlijden en een beperkte collateraal circulatie, 
die myocardrevascularisatie ondergaan met uitgebreid gebruik van de arteria 
mammaria, is retrograde toediening van cardioplegie aangewezen. 
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RESUME ET CONCLUSIONS 
Chapitre 1 
Après une revue de l'évolution de la protection du myocarde dans la chirurgie 
cardiaque et un bref exposé historique des expérimentations cliniques, les buts 
de cette thèse sont exposés. 
1. Une comparaison de la préservation de la fonction ventriculaire gauche lors 
de la revascularisation du myocarde au moyen de la cardioplegie infusée soit 
par voie anterograde soit par voie rétrograde. 
2. Une comparaison de la préservation de la fonction ventriculaire droite lors de 
la revascularisation du myocarde au moyen de la cardioplegie infusée soit par 
voie anterograde, soit par voie rétrograde. 
Chapitre 2 
Dans la première partie nous décrivons différents éléments de la cardioplegie 
cristalloide froide pour la protection du myocarde. 
1. Le refroidissement pour diminuer la dépense d'énergie du myocarde. 
2. La composition du liquide cardioplégique, éventuellement enrichi de matières 
énergétiques, qui provoquera une asystolie, une stabilisation membranaire, et 
une diminution des échanges ioniques intracellulaires diminuant l'oedème. 
3. Les possibilités d'administration du liquide cardioplégique et la conservation 
de l'asystolie. 
Dans la seconde partie nous décrivons l'anatomie du système veineux du coeur. 
Il est important de constater que dans les coeurs athérosclereux, la circulation 
collatérale est plus développée que dans les coeurs normaux. 
Dans une dernière partie nous discutons les différentes manières d'administrer 
une cardioplegie rétrograde. La possibilité de placer à l'aveugle un cathéter 
transatrial dans le sinus coronarien a été l'élément essentiel à l'usage croissant 
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de la cardioplegie rétrograde. 
Chapitre 3 
Nos premières expériences avec l'utilisation de la cardioplegie rétrograde sont 
passées en revue. 
1. Dans la chirurgie valvulaire aortique, elle permet une bonne protection aussi 
bien du ventricule gauche que droit et il est intéressant que l'opération ne doit 
pas être interrompue pour administrer la cardioplegie. 
2. Dans les réinterventions coronariennes la diffusion non-homogène de la 
cardioplegie anterograde provoque une haute morbidité et mortalité. Nous 
discutons notre expérience avec la cardioplegie rétrograde dans 48 reoperations. 
3. Dans une étude rétrospective comparant la reprise hémodynamique de la 
fonction ventriculaire gauche après chirurgie de la valve aortique sous admini-
stration de la cardioplegie soit anterograde, soit rétrograde, nous pouvons 
conclure qu'il existe une meilleure protection de la contracture du ventricule 
gauche avec l'administration de la cardioplegie rétrograde. Nos résultats sont 
confirmés dans une étude prospective, quoique la présence de patients combi-
nant une pathologie valvulaire aortique à une pathologie des coronaires diminue 
la valeur de cette étude. 
Chapitre 4 
Une étude approfondie des préparatifs de notre expérimentation clinique est 
faite. Outre l'analyse du problème, une analyse critique des propres moyens 
semble nécessaire pour effectuer une bonne expérimentation clinique. L'aide 
d'une banque de données est essentielle. 
Chapitre 5 
Nous discutons les résultats de notre expérimentation clinique. Une étude rando-
misée de 60 patients divise les patients en groupe A (n = 30) recevant la 
cardioplegie par voie anterograde et en groupe Β (η = 30) recevant la cardio­
plegie par voie retrograde. Tous les patients présentaient une atteinte des trois 
branches des coronaires et 75% des pontages ont été réalisé avec une artère 
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mammaire. 
Il n'existait pas de différences significatives entre les 2 groupes si on fait 
abstraction d'une plus haute dose de cardioplegie (ρ = 0.02) chez les patients du 
groupe В et d'une hausse significative de la pression de l'oreillette droite 
immédiatement après l'opération dans le groupe A. 
Des analyses spécifiques de patients avec une occlusion du rameau descendant 
antérieur (groupe anterograde η = 9, groupe rétrograde η = 10) démontrent une 
différence marquée de plusieurs paramètres. La dose totale de la cardioplegie 
(ρ = 0.02), la température septale lors de l'asystolie (p = 0.008) et après infusion 
de la dose totale de la cardioplegie (ρ = 0.015) ainsi que la pression artérielle 
svstolique étaient nettement inférieures dans le groupe A (p = 0.003). Par contre 
la préservation de l'index de travail du ventricule gauche était nettement 
meilleure dans le groupe В (85% contre 7 1 % , ρ = 0.012). 
Nous pouvons donc conclure: 1. que le myocarde est mieux protégé lors d'une 
cardioplegie rétrograde chez les patients avec le rameau descendant antérieur 
obturé que l'on révascularise avec les artères mammaires. 2. que l'occlusion du 
rameau descendant antérieur est un facteur compromettant pour la distribution 
de la cardioplegie anterograde. 
Chapitre 6 
Des études expérimentales chez le chien démontrent l'échec de la préservation 
du ventricule droit en administrant une cardioplegie rétrograde, mais ceci n'est 
pas confirmé dans les recherches cliniques. Il existe évidemment une grande 
différence du drainage veineux entre l'homme et le chien. Nous avons comparé 
la conservation de la fonction ventriculaire droite dans une étude prospective de 
30 patients du groupe A et 30 patients du groupe B. On ne peut pas constater 
de différence dans les 2 groupes en ce qui concerne la conservation de l'index 
de travail du ventricule droit. Mais il existait une élévation significative de la 
pression de l'oreillette droite dans le groupe A alors qu'elle diminuait d'une 
manière non significative dans le groupe B. 
Nous concluons que la contractilité du ventricule droit est mieux protégée avec 
la cardioplegie rétrograde. Ces résultats sont confirmés dans une étude récente. 
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qui est discutée en appendice. 
Chapitre 7 
Comme il est prouvé que non seulement la circulation collatérale artérielle mais 
aussi la circulation collatérale veineuse est plus développée dans les coeurs 
athérosclereux que dans les coeur sains, nous avons étudié dans quelle mesure 
la diffusion du liquide cardioplégique pouvait dépendre des collatérales. 
Un groupe de 36 patients avec une atteinte des trois branches coronariennes et 
une sténose minimale de 80% de la coronaire droite était opéré soit avec 
cardioplegie anterograde (η = 19) soit avec cardioplegie rétrograde (η = 17). Les 
deux groupes sont subdivisés en fonction de la circulation collatérale entre le 
système coronarien droit et gauche. Il fut démontré que les patients opérés avec 
cardioplegie anterograde avaient une moins bonne préservation de la contracti-
lité du ventricule droit que les patients opérés avec cardioplegie rétrograde 
lorsqu'il y avait une circulation collatérale importante. 
Chapitre 8 
Nous discutons la technique de gonflement du ballonnet en relation avec la 
localisation du cathéter rétrograde. C'est une technique simple qui se base sur 
l'enregistrement de la pression après remplissage du ballon sur la pointe du 
cathéter, obstruant le sinus coronarien. 
Cette technique est très pratique dans les réinterventions où on préfère manipu-
ler le coeur le moins possible. 
Chapitre 9 
Nous discutons les situations où l'emploi de la cardioplegie rétrograde peut être 
important: 
1. Les réinterventions sur les coronaires avec emploi des deux artères mammai-
res comme greffon. En utilisant la cardioplegie anterograde, et en constatant 
une diffusion non homogène de celle-ci, ce problème sera encore accentué 
lorsqu'on utilise les artères mammaires comme greffons, car à ce moment on 
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n'a pas la possibilité de donner la cardioplegie par le greffon. L'administration 
rétrograde de la cardioplegie sera à ce moment une bonne solution. 
Nous décrivons notre expérience avec 47 patients avec emploi bilatéral de 
l'artère mammaire lors d'une réintervention coronarienne. La mortalité hospita-
lière était de 6.4% (3 patients). 4 patients présentaient un syndrome de bas 
débit en période postopératoire et 4 patients ont fait un infarctus pendant 
l'opération. Dans le suivi 2 patients sont décédés tardivement. Chez 41 patients 
l'opération apportait une diminution de l'angine de poitrine, alors que chez 1 
malade celle-ci persistait. 
2. Lorsqu'on utilise la cardioplegie rétrograde le myocarde sera également 
perfusé au delà de l'occlusion de la coronaire. Dans des situations d'occlusion 
brutale des coronaires la zone du myocarde ¡schémique sera quand même 
protégée lors de la perfusion rétrograde de la cardioplegie. C'est ainsi qu'il est 
possible d'utiliser les artères mammaires comme greffon dans des cas urgents. Il 
n'y avait pas de décès dans nos premiers cas (10 patients) et il n'y avait qu'un 
seul infarctus du myocarde en peropératoire. 
CONCLUSIONS 
1. La cardioplegie rétrograde donne une meilleure protection du myocarde que 
la cardioplegie anterograde chez les patients coronariens avec une occlusion 
du rameau descendant antérieur. 
2. L'occlusion du rameau descendant antérieur est un facteur déterminant lors 
de la diffusion non homogène lorsqu'on administre la cardioplegie anterogra-
de. 
3. La cardioplegie rétrograde ne résulte pas en une diminution de la protection 
du ventricule droit en comparaison avec la cardioplegie anterograde. 
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4. La cardioplegie rétrograde donne une meilleure protection de la contractilité 
du ventricule droit chez le patient avec une atteinte des trois branches 
coronariennes. 
5. L'usage de la cardioplegie rétrograde est indiqué chez les patients avec une 
atteinte des trois branches coronariennes, lorsqu'ils présentent une circula-
tion collatérale réduite et qu'ils subissent une revascularisation du myocarde 
avec les artères mammaires. 
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